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Abstract
Compounds directly involved in the pathogenesis of cerebral malaria (CM) remain unclear 
due to lack of robust methods of identifying and quantifying proteins expressed in low 
abundance. New developments in proteomics have now made it possible to identify low 
abundant proteins and provided new tools for studying host-parasite interactions. With 
these new tools, it may be possible to identify proteomic signatures for patients with 
various complications associated with severe malaria.
A global proteomic strategy was used to identify differentially expressed proteins in 
archived plasma and CSF drawn from children diagnosed with cerebral malaria (CM) 
compared to those with acute bacterial meningitis (ABM) and slide negative 
encephalopathy (EN). Samples were first separated using two-dimensional gel 
electrophoresis (2-DE) or two-dimensional liquid chromatography (2D-LC) and analysed 
using mass spectrometry. The data collected was analyzed using various bio-informatics 
tools. Finally, a CM mass profile was created using MALDI-ToF mass spectrometry.
Averages of about 150 spots per gel were resolved from CSF from CM and EN patients 
and 80 spots from ABM patients. In the gels from the CM and EN groups, 45 human 
proteins were found whilst 20 human proteins were unique to ABM compared to CM. For 
CSF, a total of 202 human proteins were identified using the 2D-LC system. Of these 13 
were unique to CM, 124 to ABM and 32 to EN. 6 proteins were found in both CM and 
ABM and 18 were found in EN and ABM. 9 proteins were common to all 3 disease 
groups. A total of 66 P. falciparum proteins were identified but of these 48 were 
hypothetical proteins. Of the non-hypothetical proteins, 2 were found in both CM and 
ABM and the rest were found only in ABM.
Results show that proteomics can be used to create protein profiles of different disease 
groups. Majority of the human proteins identified by 2-DE were found to be high 
abundant proteins found in CSF and plasma. The use of 2D-LC enabled the identification 
of more low abundant proteins but some of the P. falciparum proteins identified by 2-DE 
were not seen in the 2D-LC method. Majority of the human proteins found were acute 
phase response plasma proteins including common circulating proteins such as albumin 
and apolipoproteins, blood transporters and binding proteins, protease inhibitors, enzymes, 
cytokines and hormones, and channel and receptor -derived proteins. There seems to be a 
correlation between the number of proteins found in the CSF and the level of blood brain 
barrier break down.
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1 Introduction and Literature Review
1.1 Introduction
Malaria still causes many childhood deaths in Africa, but the mechanisms leading to severe 
malaria are poorly understood. Understanding the moleular basis o f the pathogenesis is 
critical to the development o f new strategies for treatment o f malaria. With developments 
in proteomics and the completion of the human and Plasmodium falciparum genome 
projects, new tools for studying host-parasite interactions have become available. With 
these new tools, it may be possible to identify new proteomic signatures for patients and to 
use this information to develop more sensitive diagnostic methods for malaria, novel 
methods for determining disease prognosis and new therapeutic interventions.
Studies described in this thesis use global proteomic strategies to identify differentially 
expressed proteins produced at various stages of severe malaria, and also attempt to define 
a protein mass profile for cerebral malaria (CM) - the most severe neurological 
complication o f malaria.
1.2 The Global Burden of Malaria
Malaria has plagued humans throughout recorded history and is the most important 
parasitic disease worldwide, accounting for about 300-500 million clinical episodes and 
about a million child deaths per year o f which 90% are children under the age o f 5yrs 
(WHO, 2003, Korenromp, 2005). About 80% of the infections and practically all the 
severe forms o f malaria and deaths are caused by Plasmodium falciparum, the most 
virulent plasmodium species in man (Korenromp, 2005). Recent estimates indicated that 
there were 515 (range 300-600) million episodes o f clinical P. falciparum  malaria in 2002, 
o f which 365 million (70%) were in Africa (Snow et al., 2005).
1
Malaria remains a daunting health problem in tropical countries, but lack of data makes it 
even more difficult to ascertain the exact numbers of childhood cases and deaths. About 
75% of the 550 million people in Africa live in areas of highly endemic stable 
transmission. Another 18% live in epidemic prone areas where malaria transmission is 
seasonal and unstable, with all age groups being vulnerable to infection and disease (WHO 
1996). The sub-Saharan African region accounts for 70% of the disease burden, and this is 
mainly in children below the age of five years (Snow et al., 2005)(Figure 1.1).
v
Figure 1.1 P. falciparum  endemicity distribution within the global limits of risk.
Endemicity classes: light green, hypoendemic (areas in which childhood infection prevalence is less than 
10%); medium green, mesoendemic (areas with infection prevalence between 11% and 50%); dark green, 
hyperendemic and holoendemic (areas with an infection prevalence o f 50% or more) Unclassified areas 
(yellow) represent only 6% o f the global population at risk. Grey areas are a combined mask of areas outside 
o f the transmission limits and areas of population density less than 1 person per km ' Adapted from Snow et. 
al. (Snow et al., 2005).
P. falciparum malaria is the most important parasitic disease infecting the central nervous 
system (CNS) of humans worldwide. The parasite may infect humans at any time from 
conception to adulthood, but little is understood about the pathogenesis of the disease. 
Features of severe malaria include cerebral malaria (CM), severe anaemia, respiratory 
distress (acidosis), repeated convulsions, hypoglycaemia and hyperparasitaemia. The 
clinical symptoms and signs of falciparum malaria are non-specific and are characteristic
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of a number o f other febrile illnesses found in the malaria endemic areas. A key question 
in trying to understand the pathogenesis of severe malaria, and especially CM, is how the 
parasite developing within the erythrocytes, sequestered within the blood vessels, disrupts 
the function of tissues, particularly the CNS (Gitau and Newton, 2005). Studies aimed at 
answering this question may lead to development o f new tool for treatment o f malaria and 
management o f associated complications.
Chemotherapy is the main control strategy for malaria; however, the development o f drug 
resistance to most o f the current drugs available is causing a crisis in the use and 
deployment o f these drugs for prophylaxis and treatment o f the disease (Cowman, 2001). 
Without effective control, clinical episodes of malaria will more than double over the next 
20 years. The current problems with chemotherapy in malaria and the incomplete 
understanding o f its pathophysiology justify the search for new tools for better diagnosis 
and treatment o f malaria and associated complications.
1.3 The Malaria Parasite and its Life Cycle
Malaria is a disease caused by protozoan parasites belonging to the genus Plasmodium. 
Four species o f Plasmodium cause disease in humans: P. malariae -Laveran, 1881, P. 
v/vax-Grassi and Feletti, 1890, P. falciparum -Welch, 1897 and P. ovale - Stephens, 1922 
(Bruce-Chwatt, 1988) but P. falciparum causes most problems as a result o f its prevalence, 
virulence, pathophysiological consequences and drug resistance patterns. The Plasmodium 
life cycle takes place in two phases- a sexual replication stage (sporogony) within the 
mosquito and an asexual stage (schizogony) within the humans. In the first phase, the 
female mosquito ingests male and female gametocytes (micro- and macro-gametocytes, 
respectively) while taking a blood meal from an infected human. These undergo 
maturation within the mosquito, and then come together during fertilisation in the 
gut o f the mosquito to form a globular zygote. The zygote, which is initially immotile, 
becomes elongated and motile to form an ookinete. The ookinete invades the midgut wall
3
of the mosquito to develop into a static oocyst. After maturation, the oocyst ruptures to 
release motile sporozoites which migrate to the mosquito salivary glands and are injected 
into humans during the next blood meal (Gamham, 1988a, Gamham, 1988b).
In the human host, sporozoites which survive the body’s defences, invade the liver cells 
(exo-erythrocytic stage), which culminates in the rupture of the resultant schizont releasing 
thousands of merozoites into the blood stream. In P. vivax and P. ovale, some sporozoites 
remain in liver cells to form hypnozoites, which often lead to relapsing malaria. 
Circulating merozoites infect red blood cells (erythrocytic stage), undergo development 
into a schizont, which raptures releasing the merozoites into the plasma to infect more red 
cells. Some merozoites differentiate into gametocytes, which are ingested by mosquitoes 
during a blood meal; and undergo a cycle of maturation within the mosquito gut to form 
sporozoites, which infect hosts in the next blood meal (Figure 1.2).
H u m a n  L iv o r  S t a g e :
R u p tu red
O o c y s t
.yi'n
Figure 1.2 Life cycle of Plasmodium in man and in the mosquito
(http://www.cdc.gov/malaria/biology/life cycle.htm, accessed 27/07/07).
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1.4 Pathogenesis of Severe Malaria
Understanding the pathogenesis o f severe malaria is critical to improving its management. 
However, the pathogenesis o f severe malaria is complex and remains poorly understood. 
The clinical symptoms and signs of falciparum malaria are non-specific and are 
characteristic o f a number o f other febrile illnesses found in the malaria endemic areas. A 
key question in the pathogenesis o f severe malaria, and especially CM, is how the parasite 
developing within the erythrocytes, sequestered within the blood vessels, disrupts the 
function o f tissues, particularly the (CNS), suggests that there may be factors associated 
with the presence of parasites within the vascular system that affect CNS function.
A study from Kilifi, Kenya suggests that P. falciparum isolates that bind to multiple 
receptors are involved in the causation o f severe malaria and several receptor-ligand 
interactions work synergistically in bringing about severe disease (Heddini et al., 2001). 
Cell to cell interactions between the parasite and host involving adherence/invasion appear 
generally but not exclusively to correlate with severe disease (Pasvol, 2001). These cell 
interactions, including but not limited to rosetting, sequestration and the induction o f pro- 
inflammatory cytokines by parasitised red blood cells (PRBC) are all associated with 
production o f specific proteins and other compounds whose identification and 
quantification would help in understanding the pathogenesis o f severe malaria. These 
compounds could be the result o f parasite metabolism or host-specific changes as a result 
o f parasite invasion. For example, in a pilot study using Nuclear Magnetic Resonance 
(NMR) spectroscopy on cerebral spinal fluid (CSF) from children with cerebral malaria, 
the spectra were different from patients with stroke or multiple sclerosis, and suggested the 
presence o f unidentified compounds that could have arisen from the malaria parasite 
metabolic activity or from host-specific changes (Figure 1.3). The significance o f these 
findings remains unknown, and are explored in this thesis.
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Multiple sclerosis
Figure 1.3 NMR Spectra from the CSF of patients with stroke, multiple sclerosis and 
cerebral malaria. The peak (?) one the spectra could not be assigned to a known compound 
(From: Parkes et al., Unpublished data).
1.4.1 Neurological Complications of P. falciparum Malaria
Understanding the neurological complications of severe malaria may hold the key to the 
development of improved ways of management of malaria and associated complications, 
especially in children. CM is the most severe neurological syndrome of falciparum malaria 
with features of a diffuse encephalopathy which besides coma, also has brainstem signs 
and occasionally focal neurological signs (Newton and Warrell, 1998). There is a 
difference in the clinical complications between children living in endemic areas and non- 
immune adults.
CM in Adults
In adults, severe falciparum malaria is only seen in patients who have never acquired 
malaria or have lost their immunity (Newton and Warrell, 1998). The neurological 
manifestations of falciparum malaria in adults include seizures, agitation, psychosis, and 
impaired consciousness to coma. A number of post-malarial neurological syndromes 
(PMNS) have been described. Cerebellar ataxia following falciparum malaria has been
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described in Sri Lanka (Senanayake and de Silva, 1994) but the pathogenesis is unclear. In 
Vietnam PMNS have been described where patients develop psychosis, seizures and 
tremors following symptomatic malaria (Nguyen et al., 1996)
CM  in Children
In African children growing up in malaria endemic areas, severe P. falciparum malaria 
usually manifests as seizures, impaired consciousness or metabolic acidosis presenting as 
respiratory distress or severe anaemia (Marsh et al., 1995). CM is rarely encountered after 
the age o f 10 years in people exposed to P. falciparum since birth. African children have a 
higher incidence o f seizures than non-immune adults with evidence o f brain stem injury 
(Molyneux et al., 1989, Marsh et al., 1995). Mortality ranges from 15-30% and 11% of 
children have neurological deficits on discharge (Newton and Krishna, 1998). This is 
likely to be an under estimate since recent studies suggest that up to a quarter have 
persistent deficits in language and other cognitive functions. The other neurological 
manifestations are usually transient but may also have sequelae. The pathogenesis o f 
severe childhood malaria and mechanisms underlying impaired microvasculature 
circulation are briefly discussed below.
1.4.2 The Role of the Blood Brain Barrier (BBB) in Cerebral Malaria1
Various theories have been put forward to explain the pathogenesis o f CM. In 1948 
Maegraith and colleagues (Maegraith and Fletcher, 1972) proposed that the breakdown of 
the blood brain barrier (BBB) might cause CM. This ‘permeability’ hypothesis, based upon 
animal models o f malaria (vide infra), suggested that a leaky BBB allowed compounds to 
enter the brain and thus cause neurological dysfunction. The ‘mechanical theory’ suggests 
that cytoadherence o f PRBCs to endothelial cells (sequestration) leads to obstruction o f the
1 A review o f  the Blood Brain Barrier in Falciparum Malaria has been published in Tropical Medicine and 
International Health, see details in bibliography under Gitau and Newton (2005)
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microcirculation and ischaemic anoxia. In vitro studies have shown that this is mediated 
by the interaction o f a parasite protein P. falciparum membrane protein-1 (PfEMP-1) 
expressed on the surface o f the infected erythrocytes (MacPherson et al., 1985, Warrell, 
1987, Turner, 1997, Pongponratn et al., 1991). This theory has been disputed mainly 
because in some CM patients there has been a lack o f sequestration and the fact that most 
patients recover without evidence o f ischemic damage (Newton and Krishna, 1998).
It has also been hypothesised that sequestration is associated with activation o f cerebral 
endothelial cells, as demonstrated by the up-regulation of cell surface antigens (Turner et 
al., 1994) and that PRBCs binding to receptors on cerebral endothelial cells in culture 
causes changes in the integrity o f the BBB (Brown et al., 1999). The pathogenesis also 
features a systemic response characterised by increased levels o f circulating cytokines 
(Grau et al., 1989). Receptor mediated signalling across the BBB then influences 
parenchymal cells to release local neuroactive mediators such as nitric oxide (NO), which 
is released by leukocytes and endothelial cells and contributes to coma in CM (Clark et al., 
1993)
1.4.3 Rosetting and Aggregation
Rosetting is the adherence o f non-parasitised red blood cells (NPRBCs) to PRBCs. 
Aggregation on the other hand is the clumping together of PRBCs in ex vivo cultures. An 
association between aggregation and severe disease has been reported (Pain et al., 2001). 
Both these phenomena may play a role in the pathogenesis o f CM. Rosetting is pH and 
heparin sensitive and is dependant upon the presence o f divalent cations (Carlson et al., 
1990a, Carlson et al., 1990b) and the presence o f ligands (PfEMPl, complement-receptor 1 
(CR1) coded for by vor genes (Rowe et al., 1997). Rosettes can be disrupted by antibodies 
to P. falciparum, glycosaminoglycans and sulfated glycoconjugates. Increased rosette 
formation was found in Gambian children with CM (Treutiger et al., 1992) with a 
corresponding lack o f anti-rosetting antibodies. In Kenyan children with malaria, rosetting
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was correlated with severity o f disease and was influenced by ABO blood group type 
(Rowe et al., 1997). Whether rosetting and aggregation plays a direct role in the 
pathogenesis o f severe malaria or is a marker for some other causal factor and the 
association with specific parasite phenotype remains unclear (Rowe et al., 1995, Roberts et 
al., 2000).
1.4.4 Sequestration
Mechanical obstruction o f cerebral blood vessels as a cause o f CM was first proposed by 
Lavaran in 1893. It has remained a favourable explanation but the mechanism is not well 
understood to date. Initially the obstruction was thought to be due to thrombi formation 
(Dudgeon and Clark, 1917), although the agglutinates in the vessels lack fibrin and 
platelets. The other view is that the cytoadherance o f the PRBCs to the endothelium of 
cerebral capillaries causes obstruction (sequestration). Sequestration results from adhesive 
interactions between parasite derived proteins expressed on the surface o f pRBCs and a 
number of host molecules on the surface o f endothelial cells, placental cells and uninfected 
RBCs (Beeson and Brown, 2002). One o f the best characterised ligands is P. falciparum 
erythrocyte membrane protein (PfEMP)-l, which is exported by the parasite onto the RBC 
membrane at adhesive loci called knobs (Adams et al., 2002).
1.1.1 Red cell deformability
This is a phenomenon where PRBCs become less flexible and are unable to pass through 
the microvasculature with diameters < 7.5 pm, the diameter o f normal red blood cells. 
This has been reported in P.falciparum PRBC (Nash et al., 1989). This deformability 
could contribute to appreciable microcirculatory obstruction and grossly abnormal cells 
might cause delay at capillary entrances. Moreover, in vessels lined with adhered cells, the 




(Clark et a l, 1991) have suggested that host over production o f pro-inflammatory 
cytokines such as tumor necrosis factor (TNF) and interleukin (IL)-1 are capable of 
inducing cerebral symptoms in patients with malaria. Induction o f these inflammatory 
cytokines could be triggered by the PRBC or by parasite derived material (Newton and 
Krishna, 1998)
1.5 Murine Model for Cerebral Malaria
Some of the biochemical changes that occur in severe malaria (type, amount and location 
o f production o f protein) may vary with time. As such, it is difficult to fully characterise 
the production o f such compounds from samples obtained from patients during routine 
clinical examination. An animal model of malaria may be more useful in the initial efforts 
to characterise the production of such proteins, even though they may not be the same 
compounds as found in the human form of malaria. One such animal model that is used to 
study certain aspects o f severe malaria is the murine model. Cerebral malaria is induced in 
susceptible strains o f mice following infection with Plasmodium berghei ANKA (PbA) 
strain. This murine model of cerebral malaria has been used in the past to throw light on 
the pathogenesis o f the human condition (Jennings et al., 1997, Neill et al., 1993, Reed et 
al., 1997, Rest, 1982, Thumwood et al., 1988). CBA/T6 inbred strain o f mice infected 
with P. berghei ANKA strain (PbA-CBA) develop severe neurological symptoms and die 
between 6-9 days post infection (Jennings et al., 1997, Neill et al., 1993, Reed et al., 1997, 
Rest, 1982, Thumwood et al., 1988) whereas DBA/2J mice infected with the same (PbA- 
DBA) develop a non-fatal cerebral malaria (Neill et al., 1993). When infected with P. 
berghei K173 strain (Pb), both CBA and DBA mice develop a non-cerebral form o f
2 This name consists o f a contraction o f ANtwerpen, where the Prince Leopold Institute is, and KAsapa, the 
province o f  Katanga where the finding was made.
10
malaria and die 15-22 days after infection with the parasite, from profound anaemia, 
parasitaemia and monocytosis (Neill et al., 1993).
The argument that P. berghei ANKA. CM is not a good model o f P. falciparum  CM 
because it is characterised by mononuclear cell inflammation rather than sequestration of 
parasitised erythrocytes has been challenged on many grounds. Although the experimental 
murine CM cannot exactly reproduce the brain pathology found in humans, there are some 
similarities between the pathologies seen in several models, and in particular the PbA 
model, and the human pathologies (Chang et al., 2001). Several observations from the 
study o f experimental CM in mice have been extended and confirmed in human disease. 
For example, PRBC sequestration also occurs in murine CM although in a less prominent 
manner than in humans (Hearn et al., 2000). Other similarities include brain haemorrhage, 
plugging o f microvessels, some necrosis o f microvessels and upregulation o f the 
production o f pro-inflammatory cytokines especially TNF (Combes et al., 2006, Grau et 
al., 1987, Grau et al., 1988, Grau et al., 1989). Another study has demonstrated that 
mononuclear inflammation in murine models is associated with protection from lethal CM 
and may not be a part o f CM’s pathogenesis (Jennings et al. 1998). I f  such changes 
occurred in humans, it would be impossible to demonstrate because biopsies are not made 
during recovery from CM (Jennings et al. 1998). It appears that both the human and the 
murine CM involve more complex processes. The experimental model allows one to 
follow protein expression throughout the entire course o f the disease.
In this thesis recent advances in proteomics have been applied to such animal models to 
gain further insight into the pathogenesis of severe malaria. The major difference between 
the proteomic techniques described in the thesis and the non-proteomic techniques 
currently in use, is that the proteomic approach allows identification and quantification o f 
proteins expressed in small amounts even at times during the course o f disease when no 
major pathological changes would have occurred.
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1.6 Proteomics and Disease: Opportunities for Development of 
New Diagnositic Tools and Management Strategies for 
Malaria
Discussions in the preceding sections have shown that severe malaria may be associated 
with production o f compounds including low abundant proteins (LAPS) from the parasite 
or host. Identification o f such compounds may provide opportunities for refinement of 
current methods for diagnosis and management o f malarial. One particular recent 
development that can be exploited in this regard is proteomics. Proteomics is the large- 
scale study o f the structure and functions o f proteins, and includes the rapidly evolving 
field o f disease proteomics. It has been applied to the field o f infectious diseases (Nally et 
al., 2005, Walduck et al., 2004) and this thesis describes application o f recently developed 
proteomic techniques to gain further insight into the pathogenesis o f severe malaria. The 
proteomic strategy and the technological basis o f proteomics are briefly described in this 
section and are well described in chapter 2.
1.6.1 Proteomic Strategies for Detection of Disease-Specific Proteins
Proteome analysis is a direct measurement o f proteins in terms o f their presence and 
relative abundance, and is regarded as a technology independent from, but complementary 
to genome analysis. Proteins contain several dimensions that collectively indicate the 
actual rather than the potential functional state as indicated in mRNA analysis (Gygi et al., 
2000b, Humphery-Smith et al., 1997, Haynes and Yates, 2000) and therefore genomic 
information alone cannot be extrapolated to represent the functional status o f a biological 
system. The overall aim of a proteomic. study is characterisation o f the complex network 
of cell regulation by proteins.
There have been rapid advances in the field o f molecular medicine, which may provide a 
molecular fingerprint o f an individual patient and disease phenotype (Rohlff, 2000). 
Protein-targeting interactions play a central role in most biological processes, and their 
detection and analysis can provide important information on specificity, affinity and
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structure-function relationships (Gromov et al. 2002). Proteome analysis is required to 
determine which proteins have been conditionally expressed, how strongly and whether 
any post translational modifications are affected. Briefly, proteomic analysis involves the 
following critical steps
Protein separation using two dimensionalpolyacrcylamide gelelectophoresis(2-DE)
A commonly used method to separate proteins according to their size and charge is 2D-E. 
First, proteins from biological sources are separated on a thin gel according to their 
isoelectric charge (first dimension). In the second dimension, the proteins are separated 
according to their size.
Protein Separation using liquid chromatography
Recent developments in liquid chromatography (LC) linked to mass spectrometry have 
further refined the separation of proteins from complex biological matrix. LC has been 
used in the past to separate proteins digested on gels but recent advances have enabled 
better detection o f LAPs making it a viable alternative to 2-DE. Another attractive feature 
o f LC is the broad selection of stationary and mobile phases enabling a better separation o f 
highly acidic and basic proteins as well as hydrophobic proteins which are hard to detect 
on 2-DE (Gygi and Aebersold, 2000).
Mass spectrometry
The application o f mass spectrometry to proteins has been made possible by the 
development o f methods for ionising large biomolecules without destroying them. These 
include electrospray ionisation and matrix-assisted laser desorption ionization (MALDI). 
For mass spectrometry, a protein is digested with an enzyme (trypsin) and the resulting 
fragments energised by laser (e.g. MALDI). The charged peptide fragments are then 
separated according to their mass-to-charge ratio by various methods, e.g. “time o f flight 
(ToF) before impinging on a detector which measures the signal intensity o f each mass.
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Bioinformatics for protein databases searching and protein cataloguing 
The identification o f proteins from peptide sequence derived from the mass spectrum has 
been facilitated by developments o f databases for proteomics which has led to enormous 
quantity and variety o f data being produced in the growing number o f molecular databases. 
To fully these valuable data, advanced bioinformatics infrastructures have been developed 
for biological knowledge management. One major challenge lies in the volume, 
complexity, and dynamic nature o f data being collected and maintained in heterogeneous 
and distributed sources. To facilitate scientific discovery, information scattered in 
disparate sources needs to be integrated into a cohesive framework. With data integration, 
interesting relationships among protein family, structure, and function can be readily 
revealed, providing for plausible function and pathway identification.
Applications o f proteomics
Identification o f the proteins expressed in severe disease can be used in effectively 
confirming suspected protein interactions as well as in identifying new binding partners.
Identification o f biomarkers using a proteomic strategy can help gain a mechanistic 
understanding o f the differences in clinical responses to therapeutic treatment. The 
biomarkers could also help in evaluating toxicity, drug efficacy or exposure to xenobiotics 
in man or animals (Kennedy 2001). Biomarker measurements can also help explain 
empirical results of clinical trials by relating the effects o f interventions on molecular and 
cellular pathways to clinical responses (Atkinson et al., 2001). Proteomic patterns have 
been used in the past to predict the risk o f development of ovarian cancer in high risk 
groups and in the general population (Petricoin et al., 2002a) In this study, proteomic 
spectra were generated by mass spectrometry. A preliminary “training” set o f spectra 
derived from patients with ovarian cancer were analysed by an iterative searching 
algorithm that identified a proteomic pattern that completely discriminated cancer from 
non-cancer cases. The discovered pattern was then used to classify an independent set o f
masked serum samples. The algorithm identified a cluster pattern that, in the training set 
completely segregated cancer from non-cancer including patients in stage I cancer 
(Petricoin et al., 2002c). As another example, it was recently reported that it is possible to 
identify patients with sleeping sickness based on a unique proteomic signature 
(Papadopoulos et al 2004). These findings justify a prospective population based 
assessment o f proteomic pattern technology as a screening tool for stages o f this disease. 
Biomarker measurements can also help explain empirical results o f clinical trials by 
relating the effects o f interventions on molecular and cellular pathways to clinical response 
(Atkinson et al., 2001).
The Plasma Proteome
Plasma is the longest studied diagnostic proteome mainly because it is readily and safely 
available in large amounts (70 mg/ml) (Putnam F., 1975). The human plasma proteome is 
likely to contain most, i f  not all, human proteins, as well as proteins derived from some 
infective organisms such as viruses, bacteria, and fungi. Many o f the human proteins, 
introduced by low-level tissue leakage, ought to be present at very low concentrations 
while others, such as albumin, are present in very large amounts (Anderson et al., 2004). 
From a functional viewpoint proteins present in plasma can be grouped into various groups 
as listed in Table 1.1. Numerous post-translational modified forms of each protein are 
likely to be present, along with millions o f distinct clonal immunoglobulin (Ig) sequences. 
This complexity and enormous dynamic range (Figure 1.5) make plasma the most difficult 
specimen to be dealt with by proteomics (Anderson and Anderson, 2002).
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Table 1.1 Classification of Proteins found in Plasm a as in described in Anderson and 
A nderson (Anderson and Anderson, 2002)
Proteins Secreted by Solid Tissues and That Act in Plasma—The
classical plasma proteins are largely secreted by the liver and intestines.
A key aspect o f plasma proteins is a native molecular mass larger than 
the kidney filtra tion  cutoff (45 kDa) and thus an extended residence time 
in plasma (albumin, which is jus t larger than the cutoff, has a lifetime o f
about 21 days)._______________________________________________________
Immunoglobulins—Although the antibodies typically function in plasma, 
they represent a unigue class o f proteins because o f their complexity: 
there are thought to be on the order o f 10 million different sequences o f 
antibodies in circulation in a normal a d u lt
"Long Distance" Receptor Ligands—The classical peptide and protein 
hormones are included in this group. These proteins come in a range o f 
sizes, which may indicate a range o f time scales fo r  their control actions 
(i.e. rapid adjustment with small hormones such as insulin and slower 
adjustments with larger hormones such as erythropoietin).
"Local" R eceptor Ligands—These include cytokines and other short 
distance mediators o f cellular responses. In general these proteins have 
native molecular weights under the kidney filtra tion  cutoff (and hence 
relatively short residence times in plasma) and appear to be designed to 
mediate local interactions between cells fo llow ed by dilution into plasma 
at ineffective levels. High plasma levels may cause deleterious effects 
remote from  the site o f synthesis, e.g. sepsis.
Temporary Passengers—These include non-hormone proteins tha t 
traverse the plasma compartment temporarily on their way to their site 
o f primary function, e.g. lysosomal proteins tha t are secreted and then 
taken up via a receptor fo r  sequestration in the lysosomes.
Tissue Leakage Products—These are proteins that normally function  
within cells but can be released into plasma as a result o f cell death or 
damage. These proteins include many o f the most im portant diagnostic 
markers, e.g. cardiac troponins, creatine kinase, or myoglobin used in the 
diagnosis o f myocardial infarction.
Aberrant Secretions—These proteins are released from  tumours and 
other diseased tissues, presumably not as a result o f a functional 
requirement o f the organism. These include cancer markers, which may 
be normal, non-plasma-accessible proteins expressed, secreted, or 
released into plasma by tumor cells.
Foreign Proteins—Th ese are proteins o f infectious organisms or 
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The CSF Proteome
Cerebrospinal fluid (CSF) is a clear fluid (colour changes usually indicate disease as 
shown on Table 1.2) that functions to cushion and protect the brain from changes in blood 
pressure and trauma. In addition the CSF transports neurosecreted, biosynthesised and 
metabolised cellular products (Romeo et al., 2005). CSF is not a filtrate o f plasma. It is a 
secreted product o f the highly vascular choroid plexus and the ependymal lining o f the 
ventricles, which is reabsorbed by the arachnoid villa (Treseler, 1995, Yuan et al., 2002).
Table 1.2 CSF Supernatant Colours and Associated Conditions or Causes (Seehusen
et al., 2003)
Color o f CSF 
supernatant Conditions or causes
Yellow Blood breakdown products
Hyperbilirubinemia
CSF protein > 150 mg per dL
(1,5 g per L)
> 1 0 0 ,0 0 0  red blood cells per m m 3
Orange Blood breakdown products
High carotenoid ingestion





Analysis o f proteins in CSF is o f great diagnostic importance because o f its close 
proximity to the brain and its clinical availability (Davidsson et al. 2001). Diseases 
involving the CNS markedly affect the protein concentration and protein pattern o f the 
CSF (Andersson et al. 1994; Andreasen et al. 1999). However, similar to plasma, the 
predominant proteins in CSF are isoforms of serum albumin, transferrin and 
immunoglobulins, which represent more than 70% of the total protein amount. 
Furthermore, an unwanted high dynamic range o f protein abundance is found in CSF, 
making the detection o f LAPs extremely challenging with the current analytical methods. 
An additional challenge with analyzing CSF is protein concentration. On average CSF 
contains 100 fold less protein than plasma, therefore, necessitating the need for larger 
sample amounts relative to plasma.
1.7 Scope of the Thesis
This thesis describes studies on the use o f global proteomic strategies to determine the 
changes in protein levels in severe malaria. The hypothesis is that the intravascular 
parasites produce proteins that interfere with the function of tissues in which the parasites 
are sequestered. Some proteins may be produced in excessive amounts (e.g. excitotoxins) 
or others may be unique to the malaria infection.
1.1.2 Components of the thesis
The following are the broad components o f the thesis:
Chapter 1 describes the basic biology o f malaria transmission and the malaria endemicity 
and population with the focus on sub-Saharan Africa. It describes the pathogenesis o f 
severe malaria with emphasis on the different hypothesis’ for the mechanisms leading to 
the impaired neurological syndrome P. falciparum malaria. The chapter ends with a brief 
introduction to global proteomic strategies used in the studies described in this thesis.
19
Chapter 2 describes the materials and methods used in global proteomics. The chapter 
provides detailed background information to the different strategies employed in the thesis 
and also includes the experimental protocols used for each strategy employed.
Chapter 3 presents results o f the global proteomic analysis of plasma from mice infected 
with Plasmodium Berghei ANKA strain using 2-DE and MALDI-ToF MS. The purpose o f 
this analysis was mainly to validate the 2-DE method to be later used on archived human 
plasma and CSF samples o f children diagnosed as having CM in Kilifi. Both chapters 3 
and 4 end with a discussion o f the advantages and disadvantages of the use of 2-DE on 
plasma and CSF and justifies the development o f gel-free strategies in proteomics.
Chapter 4 gives a summary of the results o f proteomic analysis o f human (plasma and 
CSF) samples from African children with severe malaria.
Chapter 5 describes the use o f a gel free proteomic strategy using multiple steps o f LC 
prior to MS. It describes various strategies that have been employed previously and 
describes a modified ‘shotgun’ method of proteomics. The chapter ends with a detailed 
discussion o f the advantages of this method over 2-DE but also discusses alternative 
modifications to the ‘shotgun’ method.
Chapter 6 describes the development o f a method for mass profiling o f CM using MALDI- 
ToF MS. The chapter reviews the various strategies o f mass profiling currently employed 
and their pitfalls. It also demonstrates the difference and similarities between CM and 
other severe diseases commonly diagnosed in Kilifi including acute bacterial meningitis 
(ABM), and other encephalopathies. The chapter concludes by discussing the importance 
o f disease profiling and its uses in prognosis, diagnosis as well as in defining treatment 
strategies.
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Chapter 7 provides a summary o f the thesis emphasising the major findings, overall 
importance o f the findings in terms o f strategies o f prognosis and diagnosis and identifies 
some important areas that demand further investigation.
1.1.3 Objectives
The main objective the work described in the thesis was to employ proteomic strategies to 
define the changes in protein levels in severe malaria, with the specific objectives as 
follows.
1. Separate differentially expressed proteins in severe disease by use o f 2-DE and LC.
2. Identify these proteins using MALDI-ToF and tandem mass spectrometry on an ion 
trap instrument and analyse using bio-informatics sources currently available to us.
3. Identify the proteins produced by the host/parasite in severe malaria.
4. Compare proteomes o f CM, EN and ABM.
The work described in the thesis, therefore, used a variety of research methods to try and 
better understand the pathogenesis o f severe malaria. The results will be used to establish 
a prospective study. Results can also be combined with other studies in search o f 
immunogenic proteins for vaccine design.
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2 Background and Experimental Methods in 
Proteomics
The main goal o f the studies described in this thesis is to try and find proteomic signatures 
from plasma and CSF to define the changes in protein levels in severe malaria, which 
entails using techniques used to analyse proteins in complex mixtures. The strategies 
explored in the thesis include separation of the proteins using 2 dimensional gel 
electrophoresis and liquid chromatography mass spectrometry to analyse and 
bioinformatics tools to identify the proteins. These techniques as employed in proteomic 
analysis are described in detail in this chapter.
2.1 Two Dimensional Gel Electrophoresis
2.1.1 Background
Two dimensional gel electrophoresis (2-DE), is a tool widely used for analyzing complex 
mixtures from cells, tissues and other biological samples. This technique has been applied 
to study protein profiles o f CSF and plasma to identify disease related alterations in protein 
expression in severe malaria disease. High-resolution two dimensional gel electrophoresis 
(O'Farrell, 1975) using immobilized pH gradients (IPG) (Gorg et al., 2000) was employed 
to resolve and array quantitative expression profiling o f large sets o f complex protein 
mixtures according to their isoelectric point (pi), and relative molecular mass (Mr). 
Subsequent analysis o f the visualised protein expression patterns is performed using image 
analysis software, and protein spot identification is then achieved using mass spectrometry 
coupled with genomic database comparisons.
In 2-DE, proteins are separated according to their pi by isoelectric focusing (IEF) in the 
first dimension and according to their Mr by sodium dodecyl sulphate poly-acrylamide gel 
electrophoresis (SDS-PAGE) in the second dimension. Since these two parameters are 
unrelated, it is possible to obtain an almost uniform distribution o f protein spots across a 2-
22
DE gel. The resolving capacity o f the 2-DE gels is dependent on the separation length in 
both dimensions and is usually considered to be proportional to the total gel area available 
for separation. Each spot on the resulting two-dimensional array may correspond to a 
single protein species in the sample, but quite often may be a mixture of proteins. This 
method is characterized by a number of important features; (a) extremely high resolving 
power, (b) tolerance to crude protein mixtures, (c) tolerance to relatively high sample 
loads, (d) efficient fractionation o f sample, and (e) separated proteins are conserved in the 
gel matrix for further analysis at any desired time (Gorg and Weiss, 1999).
In the studies described in this thesis, 2-DE using IPGs was used instead of the classic 2- 
DE, which uses carrier ampholytes (Gorg et al., 2000). The former has the advantage o f 
higher resolution and higher loading capacity; cathodic drift is completely abolished 
improving reproducibility and there is uniform conductivity and buffering capacity which 
extends the basic pH limit for 2-DE (Bjellqvist et al., 1982). In brief, 2-DE using IPGs 
involves: (a) sample preparation, (b) IPG strip rehydration, (c) IEF (d) IPG strip 
equilibration (e) SDS-PAGE, (f) Detection and visualization o f spots and (g) Protein spot 
identification. Details o f the application o f this technique in proteomic analysis are given 
below
2.1.2 Sample Preparation
Sample preparation is a vital factor for the overall performance o f the 2-DE technique 
(Thongboonkerd et al., 2004, Shaw and Riederer, 2003). No single method o f sample 
preparation can be applied due to the diverse nature o f samples. However some general 
considerations apply to all samples. It is essential to minimise, protein disaggregation and 
removal o f interfering components (such as nucleic acids, and lipids), and to minimise 
proteolytic degradation, artifactual oxidation, carbamylation, and conformational alteration 
of proteins (co-analytical modifications) that might lead to artifactual spots on 2-DE gel 
profiles (Rabilloud, 1996).
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Soluble, liquid samples such as plasma and CSF can often be analysed by 2-DE with 
minimal pre-treatment. However in the case of CSF the relatively low protein 
concentration and high salt content can interfere with protein separation during IEF. Such 
samples can be desalted by dialysis or liquid chromatography prior to 2-DE (Gorg et al., 
1997).
For solid tissue samples it is necessary to maximise solubilisation by breaking molecular 
interactions, including disulphide bridges, the main forces holding proteins together; non- 
covalent interactions like ionic bonds, hydrogen bonds, and hydrophobic interactions 
(between proteins and other compounds); and covalent bonds found mainly between 
proteins and some coenzymes. Urea is used as a denaturant in the first dimension o f 2 DE. 
Thiourea is a much stronger denaturant than urea, but cannot be used alone as it is weakly 
soluble in water. However, it is more soluble in a concentrated solution o f urea, so that a 
mixture o f urea-thiourea exhibits increased solubilising power (Molloy et al., 1998, 
Rabilloud, 1998, Rabilloud et al., 1997). To ensure complete sample solubilisation o f the 
hydrophobic residues exposed as a result o f chaotropic denaturation, and prevention o f 
aggregation through hydrophobic interactions, a non-ionic or zwitterionic detergent 
(surfactant) is always included in the sample solution. In recent years the sulphobetaine 
CHAPS, a zwitterionic detergent, has become the surfactant o f choice and is generally 
used at between 2-5% in 8 M urea (Herbert, 1999) to increase the solubility o f hydrophobic 
proteins. Traditionally, nonionic polyol mixtures such as the Triton X-100 and Nonidet P- 
40 have been used (O’Farrell, 1975, Klose and Spielmann, 1975), but are o f less purity 
compared to CHAPS. New sulphobetaine surfactants such as N-decyl-N,Ndimethyl-3- 
ammonio-1-propane sulphonate (SB 3-10), when used in combination with thiourea-urea 
mixture, provide a wide range o f powerful sample solutions for 2-DE. However, they 
suffer from poor solubility in high concentrations (> 5M) of urea (Rabilloud et al., 1990). 
SDS, a commonly used ionic detergent, is poorly compatible with IEF, though low
amounts may be used in the initial sample solubilisation prior to IEF, provided that high 
urea concentrations and non-ionic or zwitterionic detergents are present to ensure complete 
removal o f the SDS from the proteins during IEF. The final concentration o f SDS should 
be 0.25% or lower, and the ratio o f the excess detergent to SDS should be at least 8:1 
(Ames andNikaido, 1976, Wilson et al., 1977).
Inclusion of reducing agents in the sample solution helps to break any disulphide bonds 
present and to maintain all proteins in their completely reduced state. Addition o f an 
excess of a sulphydryl (free thiol containing) reductant such as dithiothreitol (DTT) at 
concentrations ranging from 20 to 100 mM is commonly used. Dithierythritol structurally 
akin to DTT is an alternative. Non-thiol reductant Trialkyl phosphines such as tributyl 
phosphine (TBP), have also been reported to increase the solubility o f proteins during the 
IEF and to increase transfer of proteins to the to the second dimension (Herbert, 1999, 
Herbert et al., 1998). Addition o f carrier ampholytes or IPG buffer (0.5-2% v/v) can be 
beneficial, enhancing protein solubility by minimising protein aggregation due to charge-to 
charge interactions and scavenging cyanate ions (Barrett et al., 2000). They do not disturb 
the IEF very much because they migrate to their pis, where they become uncharged. In 
addition to chemical solubilisation techniques, mechanical procedures o f cell disruption 
like trituration (cells lysed by shear forces resulting from forcing cell sample through a 
small orifice under high pressure) and sonication (in short bursts to avoid heating), 
facilitate disaggregation o f protein molecules.
Protein degradation or modification by proteolysis must be prevented during sample 
preparation. This can be achieved by disrupting the sample using strong denaturants such 
as 8M Urea, 10% TCA or 2% SDS (Harrison and Black, 1982, Wu and Wang, 1984, 
Granzier and Wang, 1993) or by adding commercially available protease cocktail 
inhibitors. Additionally proteolysis can be inhibited by preparing samples at pH 9 and
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above by using Tris base, sodium carbonate or basic carrier ampholytes (Berkelman and 
Lagarias, 1986).
Presence o f nucleic acids, especially DNA may affect the separation o f proteins by IEF. 
DNA complexes are dissociated during denaturing conditions as occurs in sample 
preparation. This inhibits protein entry and slows migration in the IPG gel, and 
furthermore DNA binds to proteins in the sample and causes artifactual migration and 
streaking (Rabilloud, 1996). Nucleic acids are efficiently broken down by sonication and 
may also be degraded by addition of a suitable pure (i.e. protease-free) DNase/RNase 
endonuclease mixture to the sample solubilisation solution. An alternative method is to 
utilise the ability o f synthetic carrier ampholytes to form complexes with nucleic acids and 
then remove the complexes by ultracentrifugation.
2.1.3 First dimension isoelectric focusing (IEF)
Proteins are positively charged at pH values less than their pi and negatively charged at pH 
values greater than their pi. IEF separates proteins in a pH gradient until they reach a 
stationary position where their net charge is zero (pi). This is achieved by subjecting the 
proteins to an electric field; those with a positive net charge migrate to the cathode while 
those with a negative net charge migrate towards the anode, until they reach their pi.
Sample application may be achieved passively by either including it in the rehydration 
solution or by direct application to the rehydrated IPG strip using sample cups or sample 
wells. In-gel sample rehydration or rehydration-loading o f the IPG is the preferred method 
o f sample application, where the protein sample is included in the rehydration solution, 
using the entire IPG gel for sample application, as suggested by (Rabilloud et al., 1994a). 
This has been shown to eliminate the formation o f precipitates at the application point 
often associated with loading using sample cups, because there is no. discrete application 
point resulting in improved resolution throughout the pH range o f the gel, and allows
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precise control o f protein amounts and sample volumes loaded into the IPG gels. The 
method is also technically simpler, avoiding problems of leakage that can occur when 
using sample cups. Regardless o f where proteins start in the pH gradient, they migrate in 
the electric field to their corresponding isoelectric points (pis).
IPG strips are rehydrated prior to IEF. The specific protein solubility requirements o f the 
sample determine the choice o f the optimal rehydration solution. Generally, a typical 
rehydration solution consists o f a chaotropic agent for solubilising and denaturing proteins, 
unfolding them to expose internal ionisable amino acids. Addition o f thiourea to urea, has 
been reported to improve membrane protein solubilisation (Rabilloud et al., 1997, 
Rabilloud, 1998, Molloy et al., 1998). Non-ionic and zwitterionic detergents like CHAPS, 
Triton X-100, or NP-40 usually in concentrations o f 0.5 to 4% are also added to solubilise 
hydrophobic proteins and minimise protein aggregation. To cleave the disulphide bonds, a 
reducing agent like DTT or DTE is commonly added in concentrations o f 20-100 mM. Use 
o f non-thiol reductant tributyl phosphine has also been documented (Herbert et al., 1998). 
To enhance the sample solubility and produce uniform conductivity across the pH 
gradient, a carrier ampholyte mixture or IPG buffer of desired pH range is added. Lastly, a 
tracking dye (bromophenol blue) is added to help visualise IEF progress at the beginning 
o f focusing.
2.1.4 IPG strip equilibration
Prior to transfer o f the IPG strip onto the SDS gel, the strips are treated with SDS along
with other reagents. This denatures the proteins (that is, it unfolds them into long, straight
molecules) and binds a number o f SDS molecules roughly proportional to the protein's
length and because a protein's length (when unfolded) is roughly proportional to its mass,
this is equivalent to saying that it attaches a number o f SDS molecules roughly
proportional to the protein's mass. Since the SDS molecules are negatively charged, the
result o f this is that all o f the proteins will have approximately the same mass-to-charge
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ratio as each other. In addition, proteins will not migrate when they have no charge (a 
result of the isoelectric focusing step) therefore the coating o f the protein in SDS 
(negatively charged) allows migration o f the proteins in the second dimension. This 
equilibration step saturates the IPG with the SDS buffer system required for the second 
dimension separation. Special precautions are taken to minimise protein losses during this 
stage, while maximising transfer o f proteins on to the second dimension, and these are 
reflected in the modified composition o f the equilibration buffer (Gorg et al., 1995).
2.1.5 Second Dimension SDS-PA GE
SDS PAGE is an electrophoresis method for separating polypeptides according to their 
molecular weight (MW). SDS-PAGE consists o f three steps: (a) second-dimension gel 
preparation, (b) transfer o f the equilibrated IPG strip on to the SDS gel, and (c) 
electrophoresis. The technique requires that all the proteins in the mixture have the same 
net charge per gram, for the movement through the gel to be solely based on the molecular 
mass o f the proteins. This is achieved by performing the separation in polyacrylamide gels 
containing SD). The charge modifier SDS is an anionic detergent (surfactant) that 
denatures proteins by binding to them. SDS inundates the intrinsic charge o f proteins, thus 
disrupting hydrogen bonds and hydrophobic interactions and preventing protein 
aggregation, such that they all have the same charge density and free solution 
electrophoretic mobility. Addition o f a reducing agent to cleave disulphide bonds, totally 
unfolds the protein molecules. When proteins are treated with both SDS and a reducing 
agent such as DTT, separations exclusively by molecular weight are possible. There is a 
log-linear relationship between the relative distance o f migration o f the SDS-polypeptide 
micelle and the molecular weight, for a certain molecular weight range depending on the 
polyacrylamide percentage used (Berkelman and Lagarias, 1986). The polyacrylamide gels 
are made by an aqueous free radical polymerization o f the monomer acrylamide and the 
cross-linker N, Af'-methylenebisacrylamide (Bis), using a redox initiator system such as
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ammonium persulphate and V,V,V', V'-tetramethylethylenediamine (TEMED) (Hames, 
1994). Commonly SDS-PAGE in a Trischloride/ Tris-glycine buffer (Laemmli, 1970) is 
employed. A stacking gel is not needed in 2-DE protein separation, because the proteins 
are pre-separated by IEF and migrate from a gel into another gel. Vertical and horizontal 
flatbed systems can be used with similar results (Gorg et al., 1995).
2.1.6 Detection Techniques
Most detection methods used for SDS gels can be applied to second dimension gels. 
Features that characterise an ideal detection technique include; a wide linear dynamic 
range, high sensitivity, ability to be quantitative, compatibility with further analysis using 
mass spectrometry, fastness, non-toxicity, affordability (price) and non-dependence on 
living cells for labelling. None o f the available techniques combines all these features. 
Autoradiography and fluorography are the most sensitive detection methods, although 
silver and Coomassie Brilliant blue staining are the most frequently used methods.
The most sensitive non-radioactive and widely used technique to detect protein spots on 
two-dimensional gels is silver staining, picking up protein amounts down to 0.2 ng. It is 
however much less stoichiometric, with the intensity being linear over 40-50 fold range in
9 9 •concentration from 0.04 ng/mm to 2 ng /mm . There are two main types o f silver stams 
employed for 2-DE gels: silver nitrate and silver diamidine. The latter shows better 
sensitivity for basic proteins, but is incompatible with tricine buffer in the gel, and silver 
mirror development on the gel surface is a common feature. In the silver nitrate method 
used in the studies described in this thesis, the silver is more weakly bound to the proteins 
(silver binds to the amino acid side chains, primarily the sulphydryl and carboxyl groups o f 
proteins), and it can be modified for mass spectrometry compatibility (Shevchenko et al., 
1996, Wilm et al., 1996). Silver staining is a complex, multi-step process, and many 
variables can influence the outcome. High purity reagents (including water used for
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preparing the staining reagents) and precise timing are necessary for reproducible, high- 
quality results.
The Coomassie Brilliant blue staining, although 50-fold less sensitive than silver staining, 
is relatively simpler to use with a quantitative 20-fold linear range o f 10-200ng (Brush et 
al., 1998). It is also more compatible with mass spectrometry. Colloidal Coomassie stain 
as described by (Neuhoff et al., 1988) is highly sensitive and is more commonly used. 
Negative staining with imidazole zinc is very sensitive, detecting protein amounts down to 
0.2 ng. This method stains only the background, and not the proteins and thus provides a 
very good recovery yield for further analysis with mass spectrometry (Matsui et al., 1997). 
The down side of it is that it cannot be used for quantification.
Fluorescence staining methods are less sensitive than silver staining detecting protein
amounts down to 2-8 ng. They however have broad linear dynamic ranges o f about 100-
fold , and they are compatible with subsequent mass spectrometry analysis with enhanced
recovery o f peptides from in-gel digests (Lopez et al., 2000). Currently available
fluorescent dye stains include SYPRO® Ruby (most sensitive), SYPRO® Red and Orange.
Unfortunately all these dyes are relatively expensive, and a fluorescence scanner or a
charged couple device camera is required. Fluorescence labeling with Bimane or Cyanine
dyes prior to isoelectric focusing gives similar sensitivities and dynamic ranges to
fluorescence staining (Unlu et al., 1997, Tonge et al., 2001). Two-dimensional difference
gel electrophoresis (2D DIGE) builds on this technique by adding a highly accurate
quantitative dimension. 2D DIGE enables multiple protein samples to be separated on the
same 2-DE gel. This is made possible by labelling of each sample using spectrally
resolvable, size and charge-matched fluorescent dyes known as CyDye DIGE fluors
(Patton, 2002). 2D DIGE involves use o f a reference sample, known as an internal
standard, which comprises equal amounts o f all biological samples in the experiment.
Including the internal standard on each gel in the experiment with the individual biological
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samples means that the abundance o f each protein spot on a gel can be measured relative 
(i.e. as a ratio) to its corresponding spot in the internal standard present on the same gel. 
Ettan DIGE is the system of technologies that has been optimized to fully benefit from the 
advantages provided by 2D DIGE (Marouga et al., 2005).
2.1.7 Image Analysis
2-DE research utilises software-based image analysis tools. These tools primarily analyse 
bio-markers by quantifying individual proteins, and showing the separation between one or 
more protein "spots” on a scanned image of a 2-DE product. Additionally, these tools 
enable one to match identical spots in serial gels and normalise the gels to compensate for 
non-expression related variations in protein spot intensity. Software packages include 
Delta2D® (Decodon), PDQuest® (Biorad) and Progenesis® software (Nonlinear Dynamics, 
Newcastle upon Tyne, UK) among others. In our studies, we have utilised both PDQuest® 
software version 6.2.1 and Progenesis PG 220® V2006 software (Nonlinear Dynamics, 
Newcastle upon Tyne, UK).
2.1.8 Experimental Protocols
2.1.8.1 Protein estimation
Protein determination was performed using the Bio-Rad Protein Assay, a dye-binding 
assay in which a differential colour change o f a dye occurs in response to various 
concentrations o f protein (Bradford, 1976). The absorbance maximum for an acidic 
solution of Coomassie® Brilliant Blue G-250 dye shifts from 465 nm to 595 nm when 
binding to protein occurs (Reisner et al., 1975). The Coomassie blue dye binds to 
primarily basic and aromatic amino acid residues, especially arginine (Compton and Jones, 
1985). Spector (Spector, 1978) found that the extinction coefficient o f a dye-albumin 
complex solution was constant over a 10-fold concentration range. Thus, Beer’s law may
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be applied for accurate quantitation o f protein by selecting an appropriate ratio of dye 
volume to sample concentration. The Bio-Rad™ micro titre assay was used as follows:
a. The dye reagent was prepared by diluting 1 part Dye Reagent Concentrate with 
parts DDI water. This was then filtered through a Whatman #1 filter (or 
equivalent).
b. A Calibration curve was prepared by making a serial dilution of a 1 mg/ml 
solution o f BSA (10pg-1.25pg)
c. 10pl o f test sample and standard was added to the plate.
d. 200 pi o f diluted dye reagent was added to each well. The sample and reagent 
were thoroughly mixed using a multi-channel pipette.
e. The plate was incubated at room temperature for at least 5 minutes. Absorbance 
increases over time; samples should incubate at room temperature for no more 
than 1 hour.
f. The optical density o f the samples was measured using a spectrophotometer at 
590nm wavelength, using water as the blank.
g. Using the calibration curve, the protein concentration o f the samples was 
determined using the computer software Grafit.
2.1.8.2 First Dimension separation by IEF
The first separation (first dimension) was carried out on a Multiphor II flat bed
electrophoresis system (Pharmacia Biotech, Uppsala, Sweden). Ready made strips,
Immobiline Drystrip gels (IPG) with a pH gradient 3-10 NL (non-linear) 13cm long
(Amersham Pharmacia Biotech, Bucks, United Kingdom) were used. The strips were
passively rehydrated overnight at room temperature with a rehydration buffer (8M Urea,
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3% CHAPS, 0.5% IPG buffer 3-10, lOmM DTT, and a trace amount o f bromophenol 
blue), which contained a volume equivalent o f 75 pg of protein for preparative gels and 
300 pg for analytical gels.. The IPG strips were over laid with 2 mis o f IPG Cover Fluid 
(mineral oil) to minimise evaporation and urea crystallization. The rehydrated IPG strips 
were removed from the reswelling tray with a pair o f forceps, rinsed with deionised water 
to remove excess rehydration solution (in order to prevent formation o f urea crystals on the 
gel surface during IEF), and excess moisture drained off with filter paper. The IPG strips 
were then positioned in the DryStrip aligner with the gel side facing upwards in the 
grooves, with the acidic end near the anode. 11cm x 5mm electrode paper strips, moistened 
with distilled water, were then placed across the cathodic and anodic ends o f the aligned 
IPG strips. The electrodes were then carefully inserted to contact the electrode strips, and 
about 50 ml o f mineral oil poured onto the strips. IEF was carried out using multi-step 
conditions as follows: 150 V for 1 h, 300 V for 1 h, 1500 V for 1 h, and 3000V for a 
minimum of 18 h (Bio-Rad™ power pac 3000). The power supply was programmed in 
gradient mode with the current check option turned off. To establish cooling, the 
temperature on the Multitemp II Thermostatic Circulator was set at 20°C. The 
bromophenol blue tracking dye front migrates toward the anode as isoelectric focusing 
proceeds, but leaves the IPG strip before focusing is complete, therefore clearing o f the dye 
doesn’t imply that the sample is focused.
2.1.8.3 IPG Strip Equilibration
After the IEF run, the strips were equilibrated by incubating for 15 minutes at room
temperature in 10 ml o f equilibration buffer (50 mM Tris-HCl, pH 8.8, 6M urea, 30% w/v
glycerol, 2% w/v SDS and a trace of Bromophenol Blue) with 1% w/v DTT. A second
equilibrating step o f 15 minutes was done in 10 ml equilibration buffer containing 4%w/v
iodoacetamide (Gorg et al., 1998). Both solutions were freshly made prior to IPG strip
equilibration. After equilibration, the IPG strips were aligned on filter paper moistened
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with deionised water. Any excess equilibration solution was drained before the strips were 
applied to vertical SDS gels (Gorg et al., 2000).
2.1.8.4 Second Dimension SDS-PAGE
The second dimension separation was performed with home made 12.5%homogenous 
vertical SDS-polyacrylamide gel slabs (Table 2.1) (gel plate size 180 x 160mm, and gel 
thickness 1.5 mm) employing the tris-glycine system (Laemmli, 1970). The gel sandwich 
was prepared as per the Hoefer SE 600 series user manual. The gels were poured up to 0.5 
cm from the top o f the plates and overlaid with a thin layer (500 pL) o f water-saturated 
with w-butanol, immediately after pouring to minimise gel exposure to oxygen and to 
create a flat gel surface. The focused and equilibrated IPG strips were then dipped in SDS 
electrophoresis buffer for lubrication and then transferred onto the upper edge o f the SDS 
gel and sealed with agarose solution (Tris base 25 mM, glycinel92 mM, SDS 0.1% w/v, 
agarose 0.5% w/v). Electrophoresis was performed at 20°C and a constant current of 25 
mA per gel using SE 600 series vertical slab gel electrophoresis units. A constant current 
setting is traditionally used with a discontinuous buffer system so that the rate of 
electrophoresis migration remains unchanged throughout the run. Under these conditions, 
voltage increases as the run proceeds.
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Table 2.1 Components o f 12.5% SDS-PAGE gel used as second dimension
2 gels 4 gels 6 gels 8 gels
Distilled Water 20 ml 40 ml 60 ml 80 ml
Acryl/Bis Soln 33 ml 66 ml 99 ml 132 ml
1.5M Tris (pH 8.8) 17ml 34 ml 51 ml 68 ml
TEMED 30 ul 60 ul 90 ul 120 ul
10% Ammonium persulphate in 
water (lOOmg/ml)
350 ul 700 ul 1203 ul 1400 ul
2.1.8.5 Detection techniques
Most detection methods used for SDS gels can be applied to second-dimension gels. Using 
staining procedures, proteins can be visualized as spots with varying properties or features, 
such as size, darkness/brightness and location on the gel. Silver staining and Coomassie 
staining were used in these investigations and the protocols used are described below.
Silver Staining
Analytical gels were silver stained using a protocol described by Blum (Blum et al., 1984)
with modifications described by Rabilloud (Rabilloud et al., 1994b, Rabilloud, 1999). To
fix the gels and remove any interfering compounds in the gel (glycine, tris and
amopholytes) gels were placed in fixing solution (40% ethanol, 5% Acetic Acid, 55%
distilled water) and left overnight. Gels were then washed in distilled water for 30
minutes. To increase the subsequent image formation, gels were sensitized with sodium
hydrosulphite 0.3g/L of distilled water for 2 minutes. The gels were then washed 2x 1 min
with distilled water. Silver impregnation was performed by soaking the gel in silver nitrate
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2g/L o f distilled water + 250 pi formaldehyde (added just before use) and stained for 40 
min. Gels were rapidly washed in water for 20 seconds. The images were developed in 30 
g Sodium Carbonate +250ul formaldehyde + lOmg o f Sodium thiosulphate in 1L of water 
for 6-10 min depending on the desired intensity and before the background became too 
dark. The gels were then transferred to the stop solution (50g/L Tris base+ acetic acid 
20ml/L) for a minimum of 2hr and then rinsed and left in deionised water.
Coomassie Staining
Preparative gels were stained using colloidal Coomasie Brilliant Blue G-250 as previously 
described (Neuhoff et al., 1988). Previously prepared Coomassie stock (Table 2.2) was 
used to make the stain by adding 1 part methanol to 4 parts o f stock. The stain was left 
overnight or for a minimum of 2 hrs. The gels were then destained with 10% acetic acid in 
25% methanol for 60 seconds. Using 25% methanol, gels were repeatedly rinsed until 
desired contrast was achieved. The gels were then left overnight in the 25% methanol. 
The methanol was changed for distilled water and stored at room temperature for scanning 
and spot analysis.
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Table 2.2 Recipe for Colloidal Coomassie Stock








8 ml 16 ml 24 ml 32 ml
0.125% w/v CBB- 
G250
0.5 g. 1 g 1-5 g 2 g
Water 400 ml 800 ml 1200 ml 1600 ml
Scanning of Gel Image
The stained gels were scanned using GS-710 Imaging Densitometer (Bio-Rad). The gels 
were analysed using PDQuest® software version 6.2.1 (Bio-Rad) and Progenesis PG 220® 
V2006 software (Nonlinear Dynamics, Newcastle upon Tyne, UK), which enabled us to 
match identical spots in serial gels and normalise the gels to compensate for non­
expression related variations in protein spot intensity.
Image analysis using PDQuest®
The work flow o f PDQuest® comprises o f the following steps following image acquisition 
by scanning:
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(a) 2-DE gel image optimisation and editing which involves smoothing, contrast 
enhancement, edge detection and background subtraction. Background subtraction helps 
to eliminate meaningless changes of the background.
(b) Protein spot detection: is a multiple step procedure in which the gel image is processed 
and spot centres are marked according parameters one selects. The spots are then fitted to a 
Gaussian model. Gaussian fitted spots are more rounded and well defined compared to the 
original gel spots. Having a Gaussian model minimises having areas o f overlapping and 
streaking allowing for more accurate quantitation, and Gaussian fitted spots are the ones 
used for higher level analysis and data in PDQuest®.
(c) Gel matching (comparison of identical spots in serial gels enabling comparative 
analysis o f alterations in protein spot expression, under various experimental conditions): 
this is done by creating PDQuest® “matchsets”. Matchsets are groups of gels with spots to 
be compared and they comprise of the following elements:
(i) Matchset members: which are gel spots images containing Gaussian images o f gels 
created from the original scans. These Gaussian spots are used for matching and 
quantitation.
(ii) Member images: these are copies o f the original gel scans and they contain the original 
spot data as well as the processing associated with spot data. One can toggle between the 
member with Gaussian spots and the member images o f the original spots. The original 
scan files however, remain unchanged and are not included in the matchset.
(Hi) Matchset standard, this is the synthetic gel image from the spots o f the various 
members o f a matchset generated by PDQuest®, that represents all spot data in the 
matchset. It is based on a template chosen from one o f the match set members. The criteria 
for selecting the ideal template gel as the standard include: selecting a gel with a large
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number o f spots, one that is representative of the experiment as a whole, and in which the 
spots are well resolved and are o f good quality. All matching and higher level calculations 
are performed using the standard.
(d) Data handling by generating replicate groups: Because o f the complexity and inherent 
imprecision o f the process o f loading and running 2-DE gels, different gels loaded with the 
same samples may result in spots with differing amounts o f proteins. To circumvent this 
hurdle, the same sample is run on multiple gels and spot data from these duplicate gels are 
combined for more accurate quantitation using PDQuest® replicate groups function. In this 
case the software requires that the duplicate groups are included in the same matchset in 
order to combine them in a replicate group. Using PDQuest® one is then able to show the 
average quantity o f spots in each replicate group (replication group quantitation mode), or 
provide histograms showing the quantity the spot in each member (quantitation mode).
(e) Normalisation o f gels: is a process of compensating for non expression related variation 
in protein spot intensity, important for accurate quantitation (PDQuest® uses house keeping 
proteins for this).
(f) Gel data analysis using analysis sets: involves grouping o f proteins spots generated 
using PDQuest®, based on various statistical criteria (eg using student’s t-test, Boolean 
analysis or higher level analysis based on two other analysis sets) or a manual selection of 
ones own design. Analysis sets are used to create and study categories o f proteins o f 
interest, through determination o f qualitative and or quantitative changes in protein 
expression. Analysis sets are created and displayed in the match set standards.
(g) Data presentation and interpretation: involves assigning detected spots Mr and pi; 
comparison o f spot quantitation and reflection of alteration trends o f spots easily illustrated 
with graphs, scattergrams and bar charts.
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(h) The analysis can be maintained in databases that link this information to the original 
gel images using PDQuest®, and 2-DE databases can be created.
Image analysis using Progenesis (PG 220)
The workflow of PG 220 comprises of the following steps following image acquisition by 
scanning:
a) Spot Detection: For Spot detection to be performed a reference gel of the
experiment and average gels of the replicates are created.
i) Reference Gel: Is an index o f all the spots in an experiment and can be 
used in a single experiment or in several experiments. A reference gel is 
usually based on the slave (original) gel with the most spots.
ii) Averaged Gel: Is an averaged representation o f replicate gels of a 
sample type. One o f the replicate gels is used as base for the average 
gel. The averaged gel takes into account replicate reproducibility and 
averaged gels spot data is represented as an average o f matched spots. 
Each spot in an average is expressed as a mean with a standard 
deviation.
b) Background Subtraction: The software provides three automatic methods of 
background subtraction (mode o f non spot, average on boundary, and lowest on 
boundary); in addition, a manual option is available.
i) Mode o f non-spot: This describes the modal average pixel value around 
the outside of a spot that does not belong to any neighbouring spot.
ii) Average on boundary: uses the mean of all the pixels one pixel beyond 
the boundary of each spot
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in) Lowest on boundary: uses the lowest pixel value one pixel beyond the
boundary o f each spot
iv) Multiple area selections (Manual)', interpolates the background using
the mean pixel value from a range o f user-defined rectangles and the 
distance o f a spot from each of these areas
c) Matching: A single reference gel may be matched to an unlimited number o f gels 
in an experiment and between experiments (shared reference gels). Reference gels 
contain all the spots of interest through a variety o f fully controllable automatic and 
semi-automatic methods. One can automatically match with "user defined seeds" 
to improve matching between very different or poorly run gels.
d) Warping: The image overlay warping function is used to align the reference gel 
spots to the spots of the current gel. Each additional user defined match (or seed) 
causes further localised warping. Real differences between gels can be instantly 
identified. After matching, the user can see the distortions in the gel using match 
vector lines, again a very useful visual aid.
e) Normalisation: This feature allows the user to normalise all gels in a series to 
known values in a gel, or to a value from which to draw comparisons between other 
proteins. This is vital when determining changes in expression across gels.
f) Protein Expression Queries: Once matching is complete a number o f queries can 
be made as described below.
i) Similarity Queries: Find all the proteins that change in expression across 
a series o f gels (or averaged gels) in the same way as any selected 
protein by simply clicking on a spot in the image.
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ii) Ratio Queries: Define an expression ratio pattern across a series of gels
(or averaged gels) and find all those proteins that fall within the limits of 
the defined ratio pattern.
Hi) Expression Query Parameters: Highly flexible and fully visual
parameter settings for broadening or limiting ratio definitions on a per 
gel basis.
i) Statistical Analysis: This tool consist of
i) Differential analysis - allows the user to identify all the series o f 
matched spots that fit within definable ratio boundaries. This is ideal for 
identifying which proteins are within a set variation range across gels.
ii) Student's t-test - analyses sets o f spots in averaged gel pairs in order to 
identify whether differences in measurements between matched spots 
are significant.
Hi) Correspondence analysis - can aid the identification o f spots that are
characteristic of groups o f gels. Using a scatter graph, gels that are close 
to each other on the graph are similar to one another, and in turn spots 
that are close to a group o f gels are characteristic of those gels
2.2 One and Two Dimensional Liquid Chromatography
2.2.1 Back ground
Liquid chromatography (LC) is recognized as an indispensable tool in proteomics research
since it provides high-speed, high-resolution and high-sensitivity separation o f
macromolecules. Chromatography entails the separation o f a mixture o f molecules
dissolved in mobile phase. As the mobile phase travels over a stationary matrix, the
components o f the mixture can interact with the molecules of both the mobile phase and
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the stationary matrix. An attractive feature o f LC is the broad selection o f stationary and 
mobile phases enabling a better separation of highly acidic and basic proteins as well as 
hydrophobic proteins which are hard to detect on 2-DE (Gygi and Aebersold, 2000). In 
addition, the unique features o f chromatography enable the detection o f low-abundance 
species making it an attractive alternative to 2-DE. Components such as phosphorylated 
proteins are often present in complex mixtures at extremely small concentrations.
A major difference between traditional high pressure liquid chromatography (HPLC) and 
the chromatography used in LC coupled to mass spectrometry (MS) is that in the latter the 
scale is usually much smaller, both regarding internal diameter o f the column and even 
more so with respect to flow rate since it scales as the square o f the diameter. For a long 
time 1 mm columns were standard for LC-MS (as opposed to 4.6 mm for HPLC) but more 
recently 300pm and even "capillary" 75 pm columns have become more prevalent. At the 
low end o f these column diameters the flow rates approach lOOnL/min and are generally 
used with nanospray sources for mass spectrometry
Protein mixture analysis can be accomplished from one o f two directions: top-down or 
bottom-up (Kettman et al., 2001). Top-down methods focus on the intact protein whereas 
bottom-up methods concentrate on the peptides that are usually produced from enzymatic 
digestion. Top-down methods, which include gel electrophoresis and liquid-based protein 
chromatography, separate proteins according to their molecular weight, isoelectric point, 
hydrophobicity, and/or binding affinity. These methods can support the resolution of 
protein states, such as the determination of phosphorylated and unphosphorylated forms o f 
a protein.
In bottom-up methods (Wolters et al., 2001), the entire batch o f proteins is digested to 
produce a very complex mixture o f peptides. This is analogous to jigsaw puzzles, with a 
given puzzle representing one protein and its pieces representing the peptide components.
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In bottom-up methods, all the pieces of all the puzzles are mixed together. The protein is 
identified by selecting and sequencing the individual peptides. When a high number of 
peptides are sequenced there is greater confidence that the correct protein is identified. 
Identification is the strength o f bottom-up methods, but the weakness is full protein 
characterisation. Two similar proteins (i.e., phosphorylated and unphosphorylated) would 
have many o f the same peptides. In bottom-up methods, high sequence coverage is rare, 
and characterising individual peptide modifications would be hit-and-miss depending on its 
selection from the massive pool.
Top-down analysis is capable o f differentiating between two similar proteins as they are 
first separated and then analyzed. Unfortunately, the proteins cannot be identified without 
fragmentation either in solution (enzymatic digestion) or the gas phase. Newer techniques 
that allow gas-phase protein dissociation in the mass spectrometer support sequencing, but 
full sequence coverage is not yet possible for most proteins. The best route to fully 
characterise a protein involves protein separation and a multi-pronged 
digestion/sequencing scheme - a blend of top-down and bottom-up.
A variety o f separation modes have been used both alone and in combination (Wang et al., 
2003, Leinweber and Tallarek, 2003, Le Bihan et al., 2003) to achieve increased resolution 
of protein and peptides. The increased resolution reduces ion suppression effects in MS 
which are caused by overlapping signals from high and low abundance ions. Details of 
the application o f LC in proteomic analysis are given below
2.2.2 S eparation Techniques in Proteomics
2.2.2.1 One dimension separation
Currently, most one dimension liquid chromatography (1D-LC) separations are done in 
reversed phase LC (RP-LC) mode because of its compatibility with MS. RP-LC consists 
o f a non-polar stationary phase and a moderately polar mobile phase and involves the
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reversible adsorption o f proteins and peptides to the stationary phase matrix which are then 
eluted using solvent gradients in the mobile phase. RP-LC operates on the principle of 
hydrophobic interactions which result from repulsive forces between a relatively polar 
solvent, the relatively non-polar analyte, and the non-polar stationary phase. The driving 
force in the binding o f the analyte to the stationary phase is the decrease in the area o f the 
non-polar segment o f the analyte molecule exposed to the solvent. This hydrophobic effect 
is dominated by the decrease in free energy from entropy associated with the minimisation 
o f the ordered molecule-polar solvent interface. The hydrophobic effect is decreased by 
adding a more non-polar solvent into the mobile phase. This shifts the partition coefficient 
such that the analyte spends some portion o f time moving down the column in the mobile 
phase, eventually eluting from the column.
The characteristics o f the analyte molecule play an important role in its retention 
characteristics. In general, an analyte with a longer alkyl chain length results in a longer 
retention time because it increases the molecule's hydrophobicity. Very large molecules, 
however, can result in incomplete interaction between the large analyte surface and the 
alkyl chain. Retention time increases with hydrophobic surface area which is roughly 
inversely proportional to solute size. Branched chain compounds elute more rapidly than 
their corresponding isomers because the overall surface area is decreased.
Aside from mobile phase hydrophobicity, other mobile phase modifiers can affect analyte
retention. For example, the addition of inorganic salts causes a linear increase in the
surface tension o f aqueous solutions, and because the entropy o f the analyte-solvent
interface is controlled by surface tension, the addition o f salts tends to increase the
retention time. Another important component is pH since this can change the
hydrophobicity o f the analyte. Organic acids such as formic acid (FA) or trifluoroacetic
acid (TFA) are often added to the mobile phase. These serve multiple purposes: they
control pH, neutralize the charge on any residual exposed silica on the stationaiy phase and
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act as ion pairing agents to neutralize charge on the analyte. The effect varies depending on 
use but generally improve the chromatography. However, TFA concentrations are kept 
low if the column is coupled directly to the mass spectrometer as TFA has been known to 
cause ion suppression (Shi et al., 2004).
ID LC is economic but restricted to samples o f minimal complexity and is often used for 
gel spot analysis. Analysis o f complex protein mixtures using single dimension separation 
systems like the RPLC usually leads to poor chromatographic separation and coelution of 
peptides which leads to poor mass spectra. This compromises the analytical range of 1D- 
LC methods (Liu et al., 2002) and multi dimensional separations are often required.
2.2.2.2 Multiple dimensional Liquid Chromatography
Ion-exchange Chromatography-RPLC
In multiple dimensional liquid chromatography (2D-LC), RPLC is almost always preceded 
by ion-exchange chromatography (IEX) (Shi et al., 2004). In IEX chromatography, 
retention is based on the attraction between solute ions and charged sites bound to the 
stationaiy phase. Ions o f the same charge are excluded. Some types o f Ion Exchangers 
include: (1) Polystyrene resins- allows cross linkage which increases the stability of the 
chain. Higher cross linkage increases the equilibration time and ultimately improves 
selectivity. (2) Cellulose and dextran ion exchangers (gels) - these possess larger pore sizes 
and low charge densities making them suitable for protein separation. (3) And controlled- 
pore glass or porous silica. In general, ion exchangers favour the binding o f ions o f higher 
charge and smaller radius. An increase in counter ion (with respect to the functional 
groups in resins) concentration reduces the retention time. An increase in pH reduces the 
retention time in cation exchange while a decrease in pH reduces the retention time in 
anion exchange.
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One use o f IEX-RP is MudPIT (Multidimensional Protein Identification Technology) 
(Link et al., 1999, Wolters et al., 2001) which is a technique used for the separation and 
identification o f complex protein and peptide mixtures. In this approach, the first 
dimension is normally a strong cation exchange (SCX) column, as these have high loading 
capacities. The second dimension is RP chromatography, which complements the SCX as 
it is efficient at removing salts and has the added advantage o f being compatible with 
electrospray mass spectrometry.
Sample preparation is relatively straightforward, the samples are denatured, the cysteines 
reduced and alkylated, and the proteins digested with a protease such as trypsin. The 
samples are then acidified and loaded onto the SCX column. Charged peptides bind to the 
SCX column, whereas any uncharged peptides pass through and bind to a reverse phase 
trap column. The peptides are then eluted from the trap column onto an analytical RP 
column, using a reverse phase gradient, separated and eluted into a tandem mass 
spectrometer. Peptide fragmentation data is then obtained to identify the peptides and 
hence the proteins from which they are derived. In the next step, salt at a particular 
concentration is injected onto the SCX column, displacing further peptides from it onto the 
RP trap column. Salt is removed by washing and again an analytical RP separation is 
performed and the eluting peptides analysed by mass spectrometry. Incremental increases 
of salt are used (salt step gradient from around 0 - 200 mM). The end result is multiple 
protein identifications from each salt step.
Affinity Chromatography- RPLC
Modified proteins are sometimes present at very low concentrations making them difficult 
to detect and characterise in complex mixtures. Affinity chromatography is an effective 
and reproducible method to specifically isolate proteins and peptides. Immobilised metal 
affinity chromatography (IMAC) (Nuwaysir and Stults, 1993, Watts et al., 1994, Gaberc-
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Porekar and Menart, 2001) utilises immobilised Fe (III) and Ga (III) ions to selectively 
retain phosphorylated proteins and peptides (Chaga, 2001). The method relies on high 
affinity interaction between transition metal ions and phosphorylated side chains o f serine, 
threonine and tyrosine. Potential improvement o f IMAC includes prevention of non- 
phosphorylated peptides to the IMAC column through carboxyl groups by converting 
peptides to methyl esters prior to analysis (Ficarro et al., 2002). Other improvements can 
be made by using strong anion exchange chromatography prior to IMAC to reduce 
complexity o f IMAC purified phosphopeptides (Nuhse et al., 2003).
Immunoaffinity chromatography (IAC) can also be used to isolate and purify 
phosphorylated proteins prior to RPLC. In this technique the antibody is immobilized on 
the column resin. Peptide digests of phosphoproteins are loaded onto the column followed 
by washing and selective elution to antigenic peptides (Shi et al., 2004). IAC is highly 
selective due to high affinity of antigen-antibody interaction (Burgess and Thompson, 
2002).
Size Exclusion Chromatography-RPLC
In size exclusion chromatography, the column is packed with inert beads made o f a porous 
compound such as agarose. Large proteins find a quicker path through the column where 
small proteins take longer. There is no chemical interaction between the solute and the 
stationary phase. This method can be utilised for protein separation prior to tryptic 
digestion. The resulting peptide mixture is then separated by RPLC prior to mass 
spectrometry.




Eppendorf tubes and all utensils were cleaned with 50% v/v acetonitrile/0.1% v/v TFA 
solution and dried. The protein spots o f interest identified on preparative gels were excised 
and transferred to the eppendorf tubes. The chopped gel pieces were washed in 50% 
acetonitrile/ 25mM ammonium bicarbonate, pH 7.8, and dried in a vacuum concentrator. 
4-10 pi digestion buffer (10 pg/ml modified sequencing grade trypsin (Sigma-Aldrich) in 
25 mM ammonium bicarbonate) was added to the dried gel pieces and incubated overnight 
at 37°C. Resulting peptides were extracted by addition o f 4pi water followed by 7pl of 
30% acetonitirile/0.1% TFA followed by vortexing and brief centrifugation. The 
supernatant was transferred to a clean tube and vacuum concentrated to approximately 5 pi.
In Solution Tryptic Digests
Samples were reduced in 3 pi o f 0.01M DTT in water for every lOpg of protein. This was 
done for 30 minutes at 30°C. To prevent the disulphide bonds from reforming, samples 
were then alkylated using 3pl of 0.01MIAA in 50mM NH4HCO3 for eveiy lOpg of protein 
and incubated for another 30 minutes at room temperature (~20°C-22°C). To quench any 
excess IAA an excess of the 0.01M DTT was added to the solution, lpg  (20pg/ml) of 
trypsin was added for eveiy lOOpg of protein to the sample and incubated overnight at 
37°C.
2.2.3.2 Offline HPLC Fraction Collection
The method described here was used to reduce the complexity o f the samples prior to 
proteolytic enzyme digestion. The HPLC was performed on an uitiMate™ 3000 LC system 
(Dionex UK). Samples were separated on a ProSwifit RP-lS™ monolith column (4.6 x 50 
mm Dionex UK). Solvent A was 2.5% Acetonitrile (ACN) in water with 0.1% TFA and 
solvent B was 90% ACN in water with 0.1% TFA. The flow rate was maintained at 
200pl/minute and the proteins eluted into a 396 well plate using an ACN gradient.
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Fractions were collected every half a minute from one minute to 25 minutes resulting in 48 
fractions collected per sample.
2.2.3.3 Online Second Dimension
The method described here was used to separate tryptic peptides from 2DE gel spots and 
digested LC fractions. Samples were injected onto a Monolithic Capillary Column, 200 
pm i.d. x 5 cm (Dionex UK) or Thermo Hypersil-Keystone biobasic C l 8  column (0.18 x 
1 0 0 mm) and peptides were eluted to the mass spectrometer using various isocratic 
gradients depending on the column used and the type o f sample. The gradients will be 
described in the respective chapters.
2.3 Mass Spectrometry for Proteomics
2.3.1 Background
Mass spectrometry is an analytical technique used to measure the mass-to-charge ratio 
(m/z) o f ions. It is most generally used to find the composition o f a physical sample by 
generating a mass spectrum representing the masses o f sample components. A typical 
mass spectrometer comprises three parts: 1 ) an ion source-in which ions are produced 
from the sample, 2 ) a mass analyzer-which separates the ions according to their m/z, 
and 3) a detector system- which is usually an electron multiplier that produces a signal 
proportional to the relative abundance o f each ion resulting in the number o f ions 
produced by each mass. The three parts are not complete without a data system which 
controls the operation o f the instrument as well as process and display data in a mass 
spectrum. The technique has several applications, including: identifying unknown 
compounds by the mass of the compound molecules or their fragments; determining 
the isotopic composition of elements in a compound; determining the structure o f a 
compound by observing its fragmentation; quantifying the amount o f a compound in a 
sample using carefully designed methods (mass spectrometry is not inherently
quantitative); studying the fundamentals of gas phase ion chemistry (the chemistry of 
ions and neutrals in vacuum); determining other physical, chemical, or even biological 
properties o f compounds with a variety of other approaches. Details o f application of 
this technique in proteomics are given below.
2.3.2 Ionisation Techniques
The ion source is the part o f the mass spectrometer that ionizes the material under analysis 
(the analyte). The ions are then transported by magnetic or electric fields to the mass 
analyzer. Techniques for ionisation have been key to determining what types o f samples 
can be analysed by mass spectrometry. Electron ionisation and chemical ionisation are 
used for gases and vapours. In chemical ionisation sources, the analyte is ionised by 
chemical ion-molecule reactions during collisions in the source. Two techniques often used 
with liquid and solid biological samples include electrospray ionisation (ESI) (Fenn et al., 
1989) and matrix-assisted laser desorption/ionization (MALDI) (Hillenkamp et al., 1991, 
Koichi Tanaka, 1988, Karas et al., 1987). Inductively coupled plasma sources are used 
primarily for metal analysis on a wide array o f samples types. Other techniques include 
glow discharge, fast atom bombardment (FAB), thermospray, desorption/ionisation on 
silicon (DIOS), Direct Analysis in Real Time (DART), atmospheric pressure chemical 
ionization (APCI), secondary ion mass spectrometry (SIMS) and thermal ionisation. 
Studies described in this thesis have used MALDI and ESI.
2.3.3 Matrix-Assisted Laser Depsorption and ionisation (MALDI)
In MALDI, the sample to be analysed is dissolved in a matrix, usually an aromatic acid 
such as a-cyano-4-hydroxy-cinnamic acid or sinapinic acid. A sample-matrix mixture is 
then spotted onto a target plate and allowed to dry. The matrix incorporates the 
biopolymers into the crystals formed as it dries. The plate is then placed into the machine, 
and the sample is ionised and vaporised with a pulsed nitrogen laser at 337nm. This leads
to the sputtering of pulses of MH ions from each compound in the sample and these ions 
are then introduced to the MS. MALDI has a useful mass range of over 250,000 Daltons 
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Figure 2.1 A schematic diagram of the mechanism of MALDI
2.3.4 Electrospray ionisation (ESI)
Electrospray is a method where a liquid is dispersed into small charged droplets by 
applying a high electric potential between a liquid in a thin capillary and a counter 
electrode. The charging of the analytes normally takes place in the liquid phase, 
whereupon the ions are transferred to the gas phase. The charging of the analytes can occur 
in different ways: the analytes may already be charged in solution, by adduct formation, 
gas-phase ionisation or electrochemical ionisation. Peptides may attach to one or more 
protons so that they give rise to ions such as (M+H)", (M+2H)2~, (M+3H)3 ". Proteins may 
attach many more protons and give rise to a large number of ions of type (M+nH)1 The 
upper mass range for ESI is uncertain but ions in excess of 2,000,000 have been reported
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(Siuzdak, 1996). It is less tolerant of salt, buffers and detergents than MALDI and it is 
essential to remove these for good results.
Skinmer
Spray Needle
Figure 2.2 A schematic of an ESI source.
2.3.5 Mass Analysers
All commonly used mass analyzers use electric and magnetic fields to apply a force on 
charged particles (ions). The main types of analysers currently in use are magnetic sector, 
time-of-flight (ToF), quadrupole, ion trap and fourier transform ion cyclotron resonance 
(FTICR).
2.3.5.1 Magnetic Sector Mass Analyser
In a magnetic deflection mass spectrometer, ions leaving the ion source are accelerated to a 
high velocity. The ions then pass through a magnetic sector in which the magnetic field is 
applied in a direction perpendicular to the direction of ion motion. A magnetic sector 
alone will separate ions according to their mass-to-charge ratio. However, the resolution 
will be limited by the fact that ions leaving the ion source do not all have exactly the same 
energy and therefore do not have exactly the same velocity. These analysers are used less 
frequently than ToF, quadruple and ion trap as they are less sensitive.
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2.3.5.2 Time-of-flight (ToF) Mass Analyser
A time o f flight mass spectrometer measures the mass-dependent time it takes ions of 
different masses to move from the ion source to the detector. This requires that the starting 
time (the time at which the ions leave the ion source) is well-defined. Therefore, ions are 
either formed by a pulsed ionization method (usually MALDI), or various kinds o f rapid 
electric field switching are used as a 'gate' to release the ions from the ion source in a very 
short time. Ions in the source are subjected to a pulse o f about 25-3 OkV so that in principle 
they all have the same transitional energy (l/2mv2, where m is the mass and v is the 
velocity) hence the lightest ions will travel fastest and reach the detector at the end of the 
tube in the shortest time. The recorded time of flight (ToF) measurements are used to 
calculate the masses o f ions in m/z. Separation of ions is best at low m/z and the resolving 
power falls as m/z rises.
In theory, all ions experience the same potential difference during acceleration and thus 
have the same kinetic energy at the start of the flight tube, and thus different velocities 
depending upon their mass. Therefore, their arrival time at the detector is proportional to 
their mass and they reach the detector in order o f increasing mass. The mass-to-charge 
ratios (m/z) of the ions relate to the flight times t by the following equations:
mv2/2=zV; v=^2zVm ( Equation 1)
t=l/v=Nm/2zV  ( Equation 2)
where / is the length o f the flight tube, v is the velocity o f the ion o f mass m and charge z, 
and V is the acceleration potential. The differences o f flight times are the basis for 
resolving ions o f different m/z in the ToF analyzer and the mass resolution depends on the 
flight time differences, which are proportional to l(^m j-^ lm  2).
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The major deficiency o f a simple linear ToF instrument is its insufficient mass resolution 
resulting from flight time variations of ions of the same m/z. First, the laser pulses used for 
ion generation in MALDI-ToF instruments are fairly long, resulting in a wide distribution 
o f starting times o f the same ions. Further, the ionization process adds a certain amount o f 
initial kinetic energy to the molecules before acceleration. Finally, the different spatial 
positions in the source from where the ions are formed lead to varying values of I 
(Equation 2) and thus leading to flight time variations. As a result, modem ToF 
instruments commonly employ two techniques to enhance resolution-reflectron and 
delayed extraction.
A reflectron ToF is used to focus ions o f the same m/z but o f different kinetic energy. 
There are different designs o f reflectrons but often they consist o f a series o f rings or grids. 
The reflectron is located after the drift tube, creating a retarding field that the ions 
penetrate. Depending upon their kinetic energy, they enter this field at different depths and 
then are reflected back into the flight tube, where they drift to the detector, which is placed 
close to the ion source. Consider the case of ions o f the same m/z but significant energy 
spread, which would be detected as broad peaks in the linear ToF: the ion with a higher 
kinetic energy penetrates deeper and spends more time in the reflectron. The slow ion, on 
the other hand, returns to the flight tube faster, but with the same lower kinetic energy. The 
faster ion will catch up with the slow one at the detector, thereby improving mass 
resolution greatly. However, this increased resolution comes at the expense o f sensitivity 
and has a limited mass range (Siuzdak, 1996).
2.3.5.3 Quadrupole Mass Analyser
The quadrupole is the most common analyzer found in analytical laboratories today. It is 
not only the standard analyzer for GC-MS (which will not be discussed here) but also is 
part o f various designs o f LC-MS instruments. Quadrupoles are not used only as mass
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analyzers; they also are implemented frequently as ion transfer optics, collision cells, and 
linear ion traps {vide infra). This mass analyzer works on the basis o f electric fields 
generated between a set o f four axial rods through which ions pass on their way to the 
detector. The voltages applied to these rods consist of direct current (DC) and radio 
frequency (RF) components, which together create a quadrupolar field, allowing only a 
certain m/z range to pass through for a given combination o f potentials; ions outside that 
m/z region hit the rods and are discharged. The quadrupole therefore is referred to also as a 
mass filter, into which ions are accelerated from the ion source by a small potential. 
Positive ions will be attracted to negative rods, and vice versa. The RF component, 
however, causes the electric field to alternate at a frequency in the megahertz range. The 
applied potential to the rods is o f the form:
<&o=f/+ Fcos cot
where U  is the DC voltage and Tcos cor is the RF potential o f frequency co/2te. T w o  RF 
waveforms are applied to two pairs o f opposing parallel rods, with a 180° phase shift. As a 
result, the trajectory o f an ion fluctuates constantly as it travels between the rods until its 
detection.
2.3.5.4 Ion Trap
The ion-trap mass spectrometer may be looked upon as a three-dimensional quadrupole 
mass analyzer that uses three electrodes to trap ions in a small volume. The mass analyzer 
consists o f a ring electrode separating two hemispherical electrodes. A mass spectrum is 
obtained by changing the electrode voltages to eject the ions from the trap. The advantages 
o f the ion-trap mass spectrometer include compact size, and the ability to trap and 
accumulate ions to increase the signal-to-noise ratio o f a measurement.
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Ions are formed within the ion trap or injected into an ion trap from an external source. The 
ions are dynamically trapped by the applied RF potentials (a common trap design also 
makes use o f a "bath gas" to help contain the ions in the trap). The trapped ions can be 
manipulated by RF events analogous to the events in FTICR to perform ion ejection, ion 
excitation, and mass-selective ejection. This provides MS/MS and MS/MS/MS 
experiments analogous to those performed in FTICR.
Space-charge effects (ion-ion repulsion) severely limit the inherent dynamic range of the 
ion trap. This is usually handled by auto-ranging where a pre-scan is performed to 
determine the ion current, and then the ionising electron current is adjusted to reduce the 
number o f ions formed to within the working range. This can be done wherever the ion 
formation event can be manipulated to control the number o f ions formed (such as in 
electron ionization). In normal operation, a high scan rate is used to improve sensitivity 
but this comes at a cost o f reduced resolving power. A typical commercial ion trap has a 
mass range o f up to 2 , 0 0 0  m/z at normal resolving power but this can be extended to 6 , 0 0 0  
m/z at reduced resolving power.
2.3.5.5 Fourier Transform-ion cyclotron Resonance (FTICR)
This mass analyzer determines the mass-to-charge ratio (m/z) o f ions based on the 
cyclotron frequency o f the ions in a fixed magnetic field. The ions are trapped in a 
Penning trap (a magnetic field with electric trapping plates) where they are excited to a 
larger cyclotron radius by an oscillating electric field perpendicular to the magnetic field. 
The excitation also results in the ions moving in phase (in a packet). The signal is detected 
as an image current on a pair of plates which the packet o f ions passes close to as they 
cyclotron. The resulting signal is called a free induction decay (FID), transient or 
interferogram that consists of a superposition o f sine waves. The useful signal is extracted 
from this data by performing a Fourier transform to give a mass spectrum.
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FTICR is a very high resolution technique in that masses can be determined with very high 
accuracy. Many applications of FTICR-MS use this mass accuracy to help determine the 
composition o f molecules based on accurate mass. This is possible due to the mass defect 
o f the elements. Another place that FTICR-MS is useful is in dealing with complex 
mixtures since the resolution (narrow peak width) allows the signals o f two ions of similar 
m/z to be detected as distinct ions. This high resolution is also useful in studying large 
macromolecules such as proteins with multiple charges which can be produced by 
electrospray ionization. These large molecules contain a distribution o f isotopes that 
produce a series o f isotopic peaks that are close to each other on the m/z axis, due to the 
multiple charges, making the high resolving power o f the FTICR extremely useful in this 
instance.
FTICR-MS differs significantly from other mass spectrometry techniques in that the ions 
are not detected by hitting a detector such as an electron multiplier but only by passing 
near detection plates. Additionally the masses are not resolved in space or time as with 
other techniques but only in frequency. Thus, the different ions are not detected in different 
places as with sector instruments or at different times as with time-of-flight instruments but 
all ions are detected simultaneously over some given period o f time.
2.3.6 Peptide Mass Fingerprinting (PMF)
PMF is an analytical technique for protein identification that was developed by John Yates
and colleagues (Link et al., 1999). In short, the unknown protein o f interest is cleaved into
peptides by a protease such as trypsin. The collection o f peptides resulting from this
cleavage, comprise a unique identifier of the unknown protein. The absolute masses o f the
(still unknown) peptides are accurately measured with a mass spectrometer such as
MALDI-ToF or ESI-ToF. These masses are then compared to the genome. Computer
programs translate the known genome of the organism into proteins, then theoretically cut
the proteins into peptides with the same protease (for example trypsin), and calculate the
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absolute masses o f the peptides from each protein. Then they compare the masses of the 
peptides o f the unknown protein to the theoretical peptide masses o f each protein encoded 
in the genome. The results are statistically analysed to find the best match. Algorithms 
allowing database searching on the basis of peptide mass data were developed 
simultaneously in the early 1990s and have been incorporated in several software packages 
including Bioworks ™ (Thermo Electron), which uses the SEQUEST algorithm developed 
in Yates’ laboratory (Link et al., 1999) and MACOT (Perkins et al., 1999) ™ 
(http://www.matrixscience.com)
The great advantage o f PMF is that only the masses o f the peptides have to be known (so 
de novo sequencing is not necessary). A disadvantage is that the protein sequence has to 
be present in the database o f interest. Additionally most PMF algorithms assume the 
peptides come from a single protein. The presence o f a mixture can significantly 
complicate the analysis and potentially compromise the results.
2.3.7 Fragment Ion Analysis Using Tandem Mass Spectrometry
Tandem mass spectrometry involves multiple steps o f mass selection or analysis, usually 
separated by some form of fragmentation. A tandem mass spectrometer is capable of 
multiple rounds o f mass spectrometry. For example, one mass analyzer can isolate one 
peptide from many entering a mass spectrometer. A second mass analyzer then stabilizes 
the peptide ions while they collide with a gas, causing them to fragment by CID. A third 
mass analyzer then catalogues the fragments produced from the peptides. Tandem MS can 
also be done in a single mass analyzer over time as in a quadrupole ion trap. There are 
various methods for fragmenting molecules for tandem MS, including collision-induced 
dissociation (CID), electron capture dissociation (ECD), electron transfer dissociation 
(ETD), infrared multiphoton dissociation (IRMPD) and blackbody infrared radiative 
dissociation (BIRD). An important application using tandem mass spectrometry is in 
protein identification.
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In our studies we have used the ion trap to cany out tandem mass spectrometric 
experiments as follows. All ions, regardless o f mass, are allowed to enter the ion trap and 
retained. A full scan (MS) generates a spectrum displaying the ion count of each mass 
initially entering the trap. Ions in the trap are exposed to altering voltages and a window of 
ions isolated, thus retaining only ions of interest (parent ions) which have a precursor mass. 
These ions are then subjected to CID and fragment/daughter ions are generated. Peptides 
subjected to CID fragment predominantly along their amide backbone. Fragments 
containing N-teminus are denoted a, b and c using the nomenclature described by 
Biemann (Biemann, 1988). C-terminus ions are denoted as x, y  and z.
The most informative fragments are those in which breakage has occurred along the 
polypeptide backbone because this represent strings o f contiguous and intact amino acids 
(Twyman, 2004). I f  the charge remains on the N-terminus it is known as a b-series ion and 
if is on the C-terminus it is known as a y-series ion.
2.3.8 Bioinformatics for Database Searching and Protein Cataloguing
Bioinformatics is a rapidly growing field which is inextricably linked with protein and 
peptide mass spectrometry. Bioinfromatic tools are normally used to scan databanks of 
sequence information to find potential matches to experimental data. Databases are 
collated, stored and managed by teams of experts such as the National Centre for 
Biotechnology (NCBI), the Sanger Centre and the European Bioinformatics Institute 
(EBI). Choice o f database is dependent on a number of factors including the species one is 
working with, whether that species is well characterised and whether the proteins are 
known or unknown. Most database searching programs will allow users to adjust search 
parameters to suit the data being cross-correlated. Common search parameters include 
mass lists generated from the MS; choice of protease used so as to theoretically digest the 
database o f choice; database species o f choice; expected modifications such as 
phosphorylation (full list on Table 2.3);
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Table 2.3 List o f Common Post Translational Modifications
Sulphydryls
(C)
Disulphide bond -2.0159 Oxidation 15.9994
Cysteinylation 119.1442 Glutathionylation 305.3117
Amines
(K/N-terminus)
Methylation 14.0269 Formylation 28.0104
Acetylation 42.0373 Lipoic acid 188.3147
Farnesylation 204.3556 Myristoylation 210.3598
Biotinylation 226.2994 Palmitoylation 238.4136
Stearoylation 266.4674 Geranylgeranylation 272.4741




-17.0306 Deamidation (Q/N) 0.9847
Carboxylation (E/D) 44.0098
Hydroxyl groups Phosphorylation 79.9799 Sulphation 80.0642
(S/T/Y)
Carbohydrates Pentoses 132.1161 Deoxyhexoses 146.143
(S/T/N) Hexosamines 161.1577 Hexoses 162.1424
N-
acetylhexosamines
203.195 Sialic acid 291.2579
Different databases use different vocabularies to describe the function o f proteins which
has led to a need for an efficient and comprehensive tool for the annotation o f functional
genome information. To harvest the full power o f protein identities, several functional
cataloguing tools have been created to generate standardised functional vocabulary used.
The objective o f these tools is to associate gene products and functional data beyond the
often inconsistent naming conventions used (Ruepp et al., 2004). An example o f these
tools include those used at the Protein Information Resource (PIR) (Barker et al., 2000),
SWISS-PROT (Bairoch and Apweiler, 2000), and FunCat (Ruepp et al., 2004), to name a
few. In this study we have used a tool developed by PIR which integrates the PIR super
family (PIRSF) system, a network classification system based on evolutionary relationship
o f full-length proteins, to facilitate the propagation and standardisation o f protein
61
annotation. Sequence analysis and protein classification based on full-length proteins, 
including the preservation o f domain architecture, can lead to educated predictions for both 
generic biochemical and specific biological functions. The multiple levels of sequence 
diversity, from superfamilies to subfamilies, reflect different degrees of functional 
granularity and, thereby, allow more accurate propagation o f annotation and the 
development o f standard protein nomenclature and ontology. The PIRSF database is 
integrated with other family, function, and structural classification schemes, and is 
accessible at http://pir.georgetown.edu/pirsf/ for report retrieval and sequence 
classification.
2.3.8.1 Gene Ontologies (GO)
The PIR tool integrates gene ontology (GO) terms which were created as part of the Gene 
Ontology project formed as a collaborative effort to address the need for consistent 
descriptions o f gene products in different databases. The project began as collaboration 
between three model organism databases, FlyBase (Drosophila), the Saccharomyces 
Genome Database (SGD) and the Mouse Genome Database (MGD), in 1998. Since then, 
the GO Consortium has grown to include many databases, including several o f the world's 
major repositories for plant, animal and microbial genomes.
There are three separate aspects to the creation o f GO: first, the development and 
maintenance o f the ontologies themselves; second, the annotation o f gene products, which 
entails making associations between the ontologies and the genes and gene products in the 
collaborating databases; and third, development o f tools that facilitate the creation, 
maintenance and use of ontologies.
The use o f GO terms by collaborating databases facilitates uniform queries across them. 
The controlled vocabularies are structured so that they can be queried at different levels:
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for example, one can use GO to find all the gene products in the mouse genome that are 
involved in signal transduction, or one can examine all the receptor tyrosine kinases. This 
structure also allows annotators to assign properties to genes or gene products at different 
levels, depending on the depth o f knowledge about that entity.
The GO project has developed three structured controlled vocabularies (ontologies) that 
describe gene products in terms o f their associated biological processes, cellular 
components and molecular functions in a species-independent manner. A gene product 
might be associated with or located in one or more cellular components; it is active in one 
or more biological processes, during which it performs one or more molecular functions. 
For example, the gene product cytochrome c can be described by the molecular function 
term oxidoreductase activity, the biological process terms oxidative phosphorylation and 
induction o f cell death, and the cellular component terms mitochondrial matrix and 
mitochondrial inner membrane.
Cellular component
A cellular component may be an anatomical structure (e.g. rough endoplasmic reticulum or 
nucleus) or a gene product group (e.g. ribosome, proteasome or a protein dimer).
Biological process
A biological process is series of events accomplished by one or more ordered assemblies of 
molecular functions. Examples of broad biological process terms are cellular physiological 
process or signal transduction. Examples o f more specific terms are pyrimidine metabolism 
or alpha-glucoside transport. It can be difficult to distinguish between a biological process 
and a molecular function, but the general rule is that a process must have more than one 
distinct steps.
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A biological process is not equivalent to a pathway and GO does not try to represent the 
dynamics or dependencies that would be required to fully describe a pathway.
Molecular function
Molecular function describes activities, such as catalytic or binding activities, that occur at 
the molecular level. GO molecular function terms represent activities rather than the 
entities (molecules or complexes) that perform the actions, and do not specify where or 
when, or in what context, the action takes place. Molecular functions generally correspond 
to activities that can be performed by individual gene products, but some activities are 
performed by assembled complexes o f gene products. Examples of broad functional terms 
are catalytic activity, transporter activity, or binding; examples o f narrower functional 
terms are adenylate cyclase activity or Toll receptor binding. It is easy to confuse a gene 
product name with its molecular function, and for that reason many GO molecular 
functions are appended with the word "activity".
2.3.8.2 The MASCOT® Search Tool
The MASCOT® search engine is based on a modified MOWSE computer program (Pappin 
et al., 1993) using a probability based scoring system-the probability that the observed 
match between the experimental data and a protein sequence is random and is calculated 
for each protein sequence in the database. The proteins are classified with increasing 
probability o f being a random match to the experimental data. The probability is based on 
the size o f the database and the frequency of each peptide mass in each database. The 
search tool guidelines state that if the probability score is higher than the database 
probability (p) then the match is significant within 95% confidence limit. Results are 
displayed as a histogram showing the distribution o f the scores and the 95% confidence 
limit.
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2.3.8.3 The TurboSEQUEST®/SEQUEST® Search Tool
The TurboSEQUEST® algorithm in Bio Works™ v 3.1 (Thermo Fisher) is based on the 
SEQUEST® algorithm (Eng et al., 1994, Yates et al., 1995a, Yates et al., 1995b). This 
algorithm enables one to cross-correlate un-interpreted MS/MS mass spectra of peptides 
with single-letter coded amino acid sequences from protein databases or with 3 letter coded 
nucleotide sequences from nucleotide databases. Both versions determine the amino acid 
sub-sequence and thus the protein(s) and organism(s) that correspond to the mass spectrum 
of the peptide being analyzed. Criteria for the database search are the molecular weight 
(MW) information o f the peptide and the MS/MS data.
2.3.8.4 The NCBInr Database
This database contains the translated protein sequences from the entire collection of 
annotated DNA sequences kept at GenBank, and also protein sequences in the protein Data 
Bank (PDB), CDS translations, Protein Research Foundation (PRF), SWISS-PROT and 
Protein Information Resource (PIR) database, covering most o f the publicly available data. 
The NCBI also provide BLAST (Basic Logical Alignment Search Tool), a program 
support for database sequence similarity searching
2.3.8.5 The Plasmodium Falciparum Database
The local P. falciparum  database was constructed by downloading all available sequence 
information from the ftp site o f the Sanger Institute 
(ftp://ftn.sanger.ac.uk/r?ub/r)athogens/Plasmodium/falcipai'um/3D7/) . This database 
includes all submitted sequences from GeneDB (Hertz-Fowler et al., 2004), which 
includes sequences from Ensembl, a joint project between The European Molecular 
Biology Laboratory (EMBL)- European Bioinformatics Institute (EBI), and the Wellcome 
Trust Sanger Institute (WTSI).
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2.3.9 Experimental Protocols
2.3.9.1 MALDI-ToF Mass Spectrometry
MALDI peptide mass fingerprinting was carried out using a AXIMA CFR Plus, (Shimadzu 
Biotech-Kratos Analytical, Manchester UK) operating in positive ion reflectron mode at an 
accelerating voltage o f 20kV. The spectra were externally calibrated using a peptide 
mixture (Sigma, St Louis, MO) with masses 757.39 (Bradykinin), 1046.54 (Angiotensin II) 
and 2465.19 (ACTH). Protein identification was performed using the MASCOT® search 
engine (Matrix Science, London, UK).
2.3.9.2 ESI-lon Trap Tandem Mass Spectrometry
Tandem mass spectrometry was carried out on a LCQ Deca XP Plus ion trap mass 
spectrometer (ThermoFinnigan, USA) equipped with an electrospray source. The mass 
spectrometer was set at different settings depending on whether the source was in 
microspray or nanospray configuration and this will be fully described in the respective 
chapters. The LCQ Deca XP Plus was tuned using Angiotensin I (singly charges at m/z 
1296.7, doubly charged at m/z 648.8 and triply charged at m/z 432.9) and calibrated 
according to the manufacturers’ instructions. The spectra were evaluated using the 
TurboSEQUEST® algorithm in BioWorks ™v 3.1 software provided by ThermoFinnigan.
2.3.9.3 Protein identification Using MASCOT®
The workflow for MASCOT® comprises o f these steps following peptide mass 
fingerprinting:
a. Selecting a mass list
A mass list is copied from the spectra generated by the MALDI-ToF and pasted in to the 
data query window in MASCOT®. The mass tolerance is set at ± lD a
b. Choosing an enzyme
Specify the reagent used for protein digestion. Table 2.4 gives a list o f supported enzymes.
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Table 2.4 A List of Enzymes supported by MASCOT®
Name Cleave Don’t cleave N or C term
Trypsin KR P CTERM
Arg-C R P CTERM
Asp-N BD NTERM
Asp-N_ambic DE NTERM
Chymotrypsin FYWL P CTERM
CNBr M CTERM
Formic_acid D CTERM
Lys-C K P CTERM
Lys-C/P K CTERM
PepsinA FL CTERM
Tryp-CNBr KRM P CTERM
TrypChymo FYWLKR P CTERM
Trypsin/P KR CTERM
V8-DE BDEZ P CTERM






NB: "None" means that MASCOT will search each protein sequence for every sub­
sequence which meets the other search criteria. This may mean testing several orders of 
magnitude more peptides than if trypsin cleavage had been specified. I f  the experimental 
data are from peptides which do not originate from an enzyme digest, such as MHC 
peptides, then "None" is the correct choice. Otherwise, ignoring the enzyme specificity 
increases the number o f random matches, which will reduce scoring discrimination. 
"None" is not an allowed choice for a Peptide Mass Fingerprint, where the specificity of an 
enzyme is essential. "semiTrypsin" means that MASCOT® will search for peptides that 
show tiyptic specificity (KR not P) at one terminus, but where the other terminus may be a 
non-tryptic cleavage. This is a half-way house between choosing "Trypsin" and "None". It 
will only fail to find the rare peptides that are the product of double non-specific cleavage
c. Assigning number o f mass cleavages allowed 
Setting the number o f allowed missed cleavage sites to zero simulates a limit digest. This 
would only be used if  confident that a digest is perfect, with no partial fragments present. 
This will give maximum discrimination and the highest score.
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Our digest mixtures usually include some partials, that is, peptides with missed cleavage 
sites, and setting 2  missed cleavage sites is normally used.
d. Choosing a database
The databases available on the MASCOT® server include EST (EST divisions o f Genbank, 
currently EST_human, EST_mouse, EST_others), MSDB (a comprehensive, non-identical 
protein database) NCBInr (a Comprehensive, non-identical protein database) and 
SwissProt (a high quality, curated protein database. For a Peptide Mass Fingerprint, the 
EST databases are not available because the entries are just short stretches o f sequence, not 
complete proteins.
e. Selecting Taxonomy
The Taxonomy parameter allows searches to be limited to entries from particular species 
or groups o f species. This can speed up a search, and ensures that the hit list will only 
contain entries from the selected species. I f  the search data are marginal, and you are 
completely confident o f the origin o f the protein, this can help bring a weak match to the 
top o f the list.
f. Setting modifications
Select any known or suspected modifications. MASCOT® supports two types of 
modification. Fixed modifications are applied universally, to every instance of the 
specified residue(s) or terminus. There is no computational overhead associated with a 
fixed modification, it is simply equivalent to using a different mass for the modified 
residue(s) or terminus. For example, selecting Carboxymethyl (C) means that all 
calculations will use 161 Da as the mass of cysteine.
Variable modifications are those which may or may not be present. MASCOT® tests all 
possible arrangements o f variable modifications to find the best match. For example, if  
Oxidation (M) is selected, and a peptide contains 3 methionines, MASCOT will test for a
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match with the experimental data for that peptide containing 0, 1, 2, or 3 oxidised 
methionine residues.
2.3.9.4 Searching Using TurboSEQUEST®/SEQUEST®
The workflow for SEQUEST/TurboSEQUEST comprises o f the following steps after 
MS/MS mass spectra acquisition. 
a. Generating data files 
A data (DTA) file contains the calculated singly protonated peptide mass (MH+) and 
the peptide charge state as a pair of separated values. I f  a zoom scan is present the 
protonated peptide mass is calculated from the zoom scan. Subsequent lines in the 
DTA file contain space separated pairs of fragment ion m/z and intensity values which 
come from the MS/MS data of the peptide mass (MH+).
A separate DTA file is created for every MH+ peptide mass in a single LCMS 
experiment.
1. Theoretical Database digestion
A theoretical digestion o f the database using an appropriate enzyme is performed. The 
generated theoretical peptides are then mass sorted and for each peptide, a theoretical 
list o f b andy  ions is predicted to generate a series o f ‘virtual spectra.’
2. Searching the DTAs
Each DTA file created from the LCMS experiment is searched against the theoretical 
‘digested’ database. All peptide candidates from the database with the same MW as 
our DTA ± a specified mass tolerance is now compared to the “theoretic MS2 
spectrum” of each o f the database peptide candidates selected by MW. Each peptide 
candidate is given a primary match (Sp). The scoring is based on the number o f b and 
y  ions in the theoretical MS2 spectrum of the peptide candidate which match the b and y  
from the DTA. Larger peptides and “noisy” spectra tend to have bigger Sp values as 
ion intensities are not taken into account. Each candidate is then given a relative
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primary score (RSp) from the best match (250-500 peptide candidates are normally 
considered). The XCorr value is the cross-correlation value from the search. The #1 hit 
will always have the highest value of Xcorr, as Xcorr is used to produce the final 
ranking o f the candidate peptides in the search. XCorr values above 2.0 are usually 
indicative o f a good correlation. However, as with Sp, XCorr values are usually higher 
for well-matched, large peptides, and lower for smaller peptides. It's not uncommon for 
a 20 residue peptide to have an Xcorr o f 5, while a 6 residue peptide might be around
1.5.
2.3.9.5 Characterisation and Cataloguing of Identified Proteins
GI accession numbers or P. falciparum IDs were used to retrieve molecular function, 
cellular component and biological process annotations according to gene ontology (GO) 
terms using the PIR batch retrieval tool (http://pir.georgetown.edu/cgi-bin/batch.pl) by 
selecting a specific identifier or a combination o f identifiers:
a. Selecting the database: Before entering the protein identifiers the most 
convenient database was selected. If  retrieving information about protein 
families, the PIRSF database was selected, however when analyzing individual 
proteins, the iProClass database was selected.
1. Rules fo r  entering IDs: Multiple Entry IDs should be separated by lines or spaces. 
The maximum numbers of entries allowed is 50. IDs may be specified as a single 
category or as mixed categories. However, if your entries have the same type o f ID, 
it is recommended that you define the ID field to speed up the retrieval process. 
Retrieved results and/or their respective sequences were saved as a tab de-limited 
text file for further analysis. To check the correspondence between search 
identifiers and the ones from the selected database, the list was generated using the 
"Show Match List"
2. GO Slims: These are smaller versions o f the Gene Ontologies containing a subset 
o f the terms in the whole GO. They give a broad overview of the ontology content 
without the detail o f the specific fine grained terms. GO slims are particularly 
useful for giving a summary o f the results o f GO annotation o f a genome or 
proteome when broad classification of gene product function is required. You can 
view the GO slim terms for molecular function, cellular component, and biological 
process by selecting the “Show GO Slim” button in the analysis tool bar. You can 
then view statistics for the individual ontologies (function, component, and process) 
by checking entries o f interest and selecting the ontology to show.
2.4 Mass Profiling of CM
2.4.1 Background
Application o f MS techniques in a broad-based screening approach to biomarker discovery 
has the potential to detect biomarkers that would not otherwise be studied. Further, 
biomarkers discovered in plasma and CSF would allow measurement of biological 
responses in a relatively non-invasive manner. MALDI-ToF MS and Surface Enhanced 
Laser Detector and Ionisation (SELDI)-ToF MS allow for the elucidation o f individual 
protein masses from complex mixtures. By measuring the ToF of each protein or peptide 
after excitation with a laser pulse, a profile can be generated containing peaks representing 
the proteins or peptides found in an individual’s plasma or CSF. Applying biostatistical 
methods to the acquired spectra allows MALDI-ToF MS technology to be used to 
investigate biomarkers in complex mixtures. ToF technology has been applied to blood 
biomarker detection o f cancers o f the ovary (Petricoin et al., 2002c, Ye et al., 2003, Alexe 
et al., 2004), prostate (Adam et al., 2002, Banez et al., 2003, Petricoin et al., 2002b), 
pancreas (Rosty et a l , 2002, Valerio et al., 2001), breast (Li et a l, 2002b), renal cells 
(Won et al., 2003), and head and neck (Wadsworth et al., 2004), as well as biomarkers for 
tropical diseases such as sleeping sickness (Papadopoulos et al., 2004). Most o f these
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studies have been carried out using SELDI-ToF instruments. Initial studies reported near 
perfect and perfect classification o f ovarian cancer from control using SELDI profiles 
(Petricoin et al., 2002c, Petricoin et al., 2002d). However, it is clear from recent re­
analysis o f these data that early optimism of these results may be premature. Analysis of 
the same data set by outside groups could not reproduce the results (Baggerly et al., 2004, 
Sorace and Zhan, 2003). Furthermore, the use o f SELDI for diagnostic pattern 
development has been met with some skepticism as it relies on pattern differences, which 
cannot be validated by other methods and are not biologically defined (Diamandis, 2003, 
Diamandis, 2004a, Diamandis, 2006). Alternatively, some SELDI studies are beginning to 
identify the protein(s) corresponding to a few classifying peaks (Rosty et al., 2002, Ye et 
al., 2003, Nomura et al., 2004). These identifications may strengthen the case for using 
ToF-MS in biomarker discovery. Despite the criticism and setbacks, ToF-MS has the 
potential for enormous impact on the field o f biomarker discovery as it can offer a high- 
throughput analysis method applicable to complex biological mixtures. The overall pattern 
o f protein expression can be a useful diagnostic tool, and the peaks produced on the spectra 
are diagnostic without necessarily identifying the proteins to which they correspond.
The profiling study described in this thesis has utilised MALDI-ToF to create protein 
profiles in plasma and CSF of children with CM. In brief the technique used involves (a) 
sample preparation (b) MALDI -ToF in linear mode (c) statistical analysis o f peaks of 
interest. These are described in detail below
2.4.2 Sample Preparation
Sample preparation is important for the overall performance o f mass profiling as it is 
essential to isolate the proteins while minimising protein disaggregation. Ideally one 
would like to mix the sample with matrix and apply sample on a MALDI target but this 
yields no results as the proteins in the sample need to be isolated. For this purpose,
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detergents possessing the following properties are very useful: (1) high solubilising power; 
(2) no denaturation o f proteins; (3) high critical micelle concentration; (4) non-ionic; (5) 
optical transparency; (6) chemical purity; (7) high solubility in water; (8)stability; (9) no 
effect on other assays (for example, protein assay); and (10) easily obtainable (Saito and 
Tsuchiya, 1984). The detergent n-octyl_-D-glucopyranoside possesses most o f the 
desirable properties described (Baron and Thompson, 1975, Racker et al., 1979).
The matrix o f choice for protein studies is sinapinic acid which is suitable for proteins with 
a mass greater than 10000 kDa. Sinapinic acid facilitates the resolution o f the protonated 
molecule ion signal from the photochemically generated adduct signal by using a simple, 
linear time-of-flight mass spectrometer (Beavis and Chait, 1990).
2.4.3 Statistical Analysis of MALDI-ToF Spectra
Analysis o f MALDI data can be separated into two distinct steps: (1) pre-processing and 
(2) processing or statistical analysis. The process o f pre-processing is to reduce 
experimental variance within a data set, conditioning it for subsequent statistical analysis. 
Raw spectra are conditioned through removal o f background, normalisation of intensity 
and alignment. The goal o f statistical analysis o f MALDI spectra is to use established 
statistical methods to either make a biomarker discovery or to classify samples into groups.
2.4.4 Experimental Protocols
2.4.4.1 Sample Preparation
10pg of plasma or CSF protein was added to 5ul of 1% n-Octyl p -D - glucopyronaside 
(NOG) and topped up to lOOul with dFLO. 2ul o f the sample mixed with 2ul o f matrix 
solution made o f 50% saturated solution of sinapinic acid prepared in 30% Acetonitrile in 
0.1% TFA was then spotted on a MALDI-ToF target plate for and air dried.
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2.4.4.2 MALDI-ToF Linear mode analysis
Mass spectrometry was performed using a AXIMA CFR Plus™ (Shimadzu Biotech-Kratos 
Analytical, Manchester, UK) mass spectrometer operated in a linear mode_2ghz. The 
following parameters were set for the data acquisition: mass range from 0 to approximately 
180 000 d; laser power at 90; profile at 300; and five shots per spot. The instrument was 
calibrated using m/z ratios for the standards bovine serum albumin (66,429.09 Da), m/z 
ratios were determined for all data points. Pulsed extraction was set at 66,000Da. Average 
smoothing o f spectra was applied using the company supplied algorithm with a peak width 
set at lODa. The peak detection was set at Threshold-Apex at an offset of O.lmV.
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3 Proteomic Analysis of Plasma from Mice 
Infected With Plasmodium Berghei ANKA 
Strain Using 2-DE MALDI-ToF Mass 
Spectrometry
3.1 Introduction
The principle theme o f this thesis is the use o f proteomic platform technologies to provide 
insights into the biochemical changes that occur during severe malaria that would facilitate 
future development o f novel diagnostic and techniques for monitoring and treatment of 
disease strategies. The genetic constitution o f an individual may determine that 
individual’s susceptibility to diseases and the time course o f disease progression. Thus, the 
biochemical changes that occur in an individual in response to disease may be influenced 
by the individual’s genetic background. Genes determine protein expression and proteome 
analysis is a direct measurement of proteins in terms of their presence and relative 
abundance. Proteomics is regarded as a complimentary technology to genome analysis. 
Proteins contain several facets that collectively indicate the actual functional state rather 
than the potential functional state as indicated in mRNA analysis. Moreover, although the 
pattern o f gene activity may be perturbed in a tissue with a pathological lesions, there can 
often be a poor correlation between the level o f transcription and translation i.e. the 
relative abundance o f a protein within the specific cell type or tissue (Kennedy, 2001) . As 
a consequence o f this, genomic data alone cannot be extrapolated to represent the 
functional status o f the biological system. The overall aim o f a proteomic study is the 
characterisation o f the proteins in a system independent o f but complementary to gene 
expression.
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Characterisation o f changes in protein levels in an individual with severe malaria can be 
complicated by a number o f issues. There are the multiple factors involved and the 
condition itself of “severe malaria” probably reflects a number of distinct 
pathophysiological conditions all of which are compounded by the fact that there are rapid 
changes in disease condition, as it progresses. An animal model o f malaria may provide be 
a useful tool in the initial efforts to characterise and understand the proteomic changes 
induced by the disease. . Cerebral malaria can be induced in susceptible strains o f mice 
infected with the rodent malaria species Plasmodium berghei ANKA strain. These murine 
models o f cerebral malaria have been used by many investigators to help understand the 
pathogenesis o f the human condition (Rest, 1982, Reed et al., 1997, Thumwood et al., 
1989, Jennings et al., 1997). As a prequel to the human studies described in chapters 4 and 
5, this chapter describes a global investigation o f the differences in protein expression 
profiles o f plasma collected from infected and non-infected mice. This study had two 
functions firstly to develop and validate experimental procedures which we could then use 
to analyse human samples and secondly to start to understand the proteomic changes that 
accompany malaria infection in this model system.
3.2 Methodology
The general workflow for this proteomic study is summarized in Fig. 3.1 and the
background to these methodologies is described in detail in chapter 2 section 2.1. Briefly, a
two platform strategy was employed based on (a) two-dimensional polyacrylamide gel
electrophoresis (2-DE) to separate proteins coupled with gel imaging software to identify
qualitative and semi-quantitative alterations in protein expression patterns followed by (b)
mass spectrometry, to formally characterise the protein repertoire deemed to be of
relevance to the biological processes active during murine CM. The high resolution 2-DE
(Herbert, 1999, Gygi et al., 2000a) using immobilized p R  gradients (IPG-Dalt) enabled the
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resolution and array of Rodent and Plasmodia! proteins from plasma collected from 
infected and non-infected mice. Subsequent analysis of the visualised protein expression 








Figure 3.1 The 2-DE-MALDI Workflow. Proteins from the sample of interest are 
separated in the 1st dimension according to their pi and in the 2nd dimension according to 
there molecular weight. Replicate gels of each sample are then analysed using 2DE gel 
analysing software and average gels maps of each sample are then analysed for differential 
expression. Spots of interest are digested and applied onto a mass spectrometer. Resulting 
mass is then searched against sequence databases and a protein identity is made.
3.2.1 Preparation of plasma samples from mice
Plasma was collected from 4-week-old GDI male mice (n= 3) infected with Plasmodium 
Berghei (0 .1 ml of a culture with 2% parasitaemia). A control set of plasma was collected 
from mice (n=2) without infection. The sample was separated into two aliquots and 
albumin was depleted from one aliquot using the Montage Albumin kit (Millipore, USA).
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3.2.2 P rotein Determination Using the Bradford Assay
Total plasma protein concentration was determined as described in chapter 2 section
2 . 1.8.1
3.2.3 Tw o Dimensional Gel Electrophoresis
Following determination o f the protein concentration (chapter 2 section 2.1.8.1), proteins 
were separated using 2-DE as described in detail in chapter 2 section 2.1.8.2-2.1.8.4. 
Analytical gels used to provide master maps were loaded with 75 pg o f protein and 
preparative gels to be stained with Coomassie stain for eventual MALDI analysis were 
loaded with 300pg of plasma protein.
3.2.4 P rotein Visualisation and Image Analysis
Analytical gels were silver stained as described in chapter 2, section 2.1.8.5 and 
preparative gels stained with Coomassie as described in section 2.1.8.5. The stained gels 
were scanned using a GS-710 Imaging Densitometer (BioRad, Hemel Hempstead, 
Hertfordshire UK). The gels were analysed using PDQuest® software version 6.2.1 (Bio 
Rad, Hemel Hempstead, Hertfordshire UK ) an d Progenesis PG 220® V2006 so ftware 
(Nonlinear Dynamics, Newcastle upon Tyne, UK) as described in chapter 2 section
2.1.8.5. PDQuest® enabled the matching of identical spots in serial gels and normalisation 
of gels to compensate for non-expression related variations in protein spot intensity. The 
software also enabled the tracking and reporting o f all the protein patterns in the samples. 
By using the comparison tool for master gels, the software enabled the comparison of
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differences between disease and control groups. Semi-quantitative analysis of spots was 
performed using Progenesis PG220®
3.2.5 Trypti c ln~gel Digestion
Gels spots were digested as described in chapter 2 section 2.2.3.1
3.2.6 Characteri zation of protein spots by MALDI-ToF-MS
Spot digests were analysed using MALDI-ToF as described in chapter 2 section 2.2.3.1.
3.2.7. Database Searching and Protein Characterisation and 
Cataloguing
All searches were performed using the Mascot™ algorithm as described in chapter 2 
section 2.3.9.3. Mass lists generated from MALDI were used for searches against the 
NCBInr database. All searches were performed with the search parameters as : Database: 
NCBInr, Taxonomy: Rodentia and Alveolata, Enzyme: Trypsin, Tolerance: ±0.2Da, Fixed 
Modifications: Carbamidomethyl (C), Variable Modifications: Oxidation of methionine, 
Charge State MH+, Maximum missed cleavages: 1. Protein categorisation cataloguing 
was done according to the GO terms using the tool provided by PIR as described in detail 
in chapter 2 section 2.3.9.5
3.3 Results
3.3.1 P rotein Separation
Plasma samples from infected mice together with control samples were applied to 2-DE
and proteins visualised by silver stain for analytical gels and coomassie blue stain for
preparative gels. F igure 3.2 shows representative gel maps for plasma from infected mice,
and control mice before and after albumin depletion as created using PDQuest®. The gel
maps are synthetic gels prepared by analyzing four replicate silver stained gels o f each
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sample. Spots from the match-set are represented on the master gel. As an example, 
F igure 3.3 shows the match-set used to create the control with albumin depleted gel map. 
Figure 3.4 is an example o f a scattergram which demonstrates the good correlation of 
protein spot locations between the match-set replicate gels. Master gels o f controls, 
infected, albumin depleted control and infected had 752, 639, 921, and 610 spots 
respectively. Using the PDQuest® comparison tool, composite gels showing differences 
in the infected master gel map compared to the control master gel map before and after 
albumin depletion were made as shown on Figures 3.5 and 3.6. There were protein spots 
that were differentially expressed in the infected gel and some proteins were missing 
completely. Removing albumin improved the quality o f gels and helped identify some 
additional spots o f interest.
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Figure 3.2 Representative gels maps created using PDQuest® for (A), Plasma from 
control mice (A), plasma from infected mice (B), album in depleted plasma from 
control mice (C) and albumin depleted plasma from infected mice (D). The gel maps 
are synthetic images generated in silico from four replicate gels of a match-set. The plasma 
was drawn from 4-week old male mice infected with P. Berghei and had a parasitaemia of 
over 30%. Control plasma was from non-infected mice. The first dimension was carried 
out using commercial pre-cut IPG 3-10 strips 130mm (24 h at 3000Vmax). Second 
dimension was run using vertical SDS-PAGE (12.5% T constant).
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F igure 3.3 A gel m atch  set created  using P D Q u e st' for p lasm a w ith  album in dep leted  draw n  
from  the control m ice. Gel A represents the gel standard (gel map/average gel) and gels B-E 
represent the individual member gels. Spots were included in the gel map if found in every gel 










Quantity of spots in Gel C (Figure 3.3)
F igure 3 .4 Show s a scattergram  d em onstrating  the extent of correla tion  o f  protein  spots 
betw een  the G el C and the iMaster G el included  in the C ontrol w ith  a lb u m in  dep leted  m atch- 
set (F igu re 3 .3). The quantity of each spot in the first gel (X-axis) is plotted on a log scale against 
its quantity in the second gel (Y-axis). If the spot quantity is the same in both gels, its point will fall 
on the black center line in the graph (slope = 1.00). If the quantities are not the same, the point will 
fall above or below the center line. The regression line generated from the plot is shown in green. 
The correlation coefficient for the regression line is displayed on the graph. A coefficient of 1.00 
indicates that the two gels are perfectly similar, while a low coefficient value (e.g., 0.40) indicates 
that the two gels are not very similar. The number of spots that appear in both gels is also listed on 
the graph. Spots that fall within the reda and blue line fall within a 2-fold range.
Coer coeff = 0.772241 
Slope = Q.781Q8Q, Intercept 
Spot count = 141 
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Figure 3.5 Composite gel showing the differences between gels from infected and 
control plasma. Composite gels were created using the comparison tool in PD Q uest\ 
The composite gel demonstrates qualitative differences in the infected gel map compared 
to the control gel map. Red spots are spots found in the controls gel map and blue spots 
are those from the infected gel map. Green spots depict spots found in both
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Figure 3.6 Composite gel showing the differences between albumin depleted infected 
and control plasma. Composite gels were created using the comparison tool in 
PDQuest1^. The composite gel demonstrates qualitative differences in the infected 
(albumin depleted) gel map compared to the control gel map. Red spots are spots found in 
the control (albumin depleted) gel map and blue spots are those from the infected (albumin 
depleted) gel map. Green spots depict spots found in both
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3.3.2 P rotein Identification by Mass Spectrometry (MS)
When stained with Coomassie between 60 and 104 spots per gel were visualised. (Figures 
3.7-3.10). show the spots excised from the Coomassie stained gels. These spots were 
digested and prepared for MALDI analysis. It was possible to definitively identify 51, 63, 
30 and 18 proteins from the infected, control, albumin depleted infected and albumin 
depleted control plasma samples respectively. Table 3.1-4 gives a complete list of the 
proteins identified. In accordance with the cut-score provided by Mascot® described in 
detail in chapter 2 (section 2.3.9.3) the protein was considered to be tentatively identified if 
a significant score was achieved. For Rodents a protein score o f 63 was considered to be 
significant and for P. falciparum  a score of 57 was considered significant. Removing 
albumin improved the quality o f gels and helped identify some additional proteins, but 
caused a reduction in our ability to identify spots by MALDI because o f sensitivity issues. 
For semi-quantitative differential analysis silver stained replicate gels were analysed using 
Progenesis PG 220® 2DE software. The software created representative gels o f replicates 
of each sample using one o f the replicates as a base gel. Spots were given a match number 
if matched to 3 out o f 4 replicates. Spots matched to each representative gel were then 
analysed for any changes in intensity. Figure 3.11 shows some spots that were identified 
as having a greater than two fold increase in normalized spot intensity. Table 3.2 gives a 
list o f protein identities for these spots. Figure 3.12 shows the differential expression of 
one o f the spots in Figure 3.11 and the resulting protein identification from Mascot®.
86




































Figure 3.7 2-D PAGE gel of plasma from an infected mouse after loading with 300pg 
of sample protein. The plasma was drawn from 4-week old male mice infected with P. 
Berghei that had a parasitaemia of over 30%. The first dimension was carried out using 
commercial pre-cut IPG 3-10 strips 130mm (24 h at 3000Vmax). Second dimension was 
run using vertical SDS-PAGE (12.5% T constant). The gel was stained with Coomassie 
blue stain. The numbered spot (1-103) were characterised by MALDI-MS and spot protein 
identities are listed in table 3.1
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Figure 3.8 2-D PAGE gel of plasma from control mice after loading with 300pg of 
sample protein. The plasma was drawn from 4-week old male mice. The first dimension 
was carried out using commercial pre-cut EPG 3-10 strips 130mm (24 h at 3000Vmax). 
Second dimension was run using vertical SDS-PAGE (12.5% T constant). The gel was 
stained with Coomassie blue stain. The numbered spot (1-84) were characterised by 

















Figure 3.9 2-D PAGE gel of albumin depleted plasma from infected mice after 
loading with 300pg of sample protein. The plasma was drawn from 4-week old male 
mice infected with P. Berghei and had a parasitaemia of over 30%. Prior to 2DE, albumin 
was depleted using a commercial albumin depletion kit. The first dimension was carried 
out using commercial pre-cut IPG 3-10 strips 130mm (24 h at 3000Vmax). Second 
dimension was run using vertical SDS-PAGE (12.5% T constant). The gel was stained 
with Coomassie blue stain. The numbered spot (1-54) were characterised by MALDI-MS 
and are listed on table 3.3
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Figure 3.10 2-D PAGE gel of albumin depleted plasma from control mice after 
loading with 300(ig of sample protein. The plasma was drawn from 4-week old male 
mice. Prior to 2DE, albumin was depleted using a commercial albumin depletion kit. The 
first dimension was carried out using commercial pre-cut EPG 3-10 strips 130mm (24 h at 
3000Vmax). Second dimension was run using vertical SDs-PAGE (12.5% T constant). The 
gel was stained with Coomassie blue stain. The numbered spot (1-60) were characterised 
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F igure 3.11 D ifferentia lly  expressed  spots o f  gels from  p lasm a from  in fected  m ice(A ) 
com pared  to control m ice(B ), a lbum in  dep leted  p lasm a from  in fected  m ice (C) com p ared  to 
a lbum in depleted  plasm a from  control m ice(D ). The analysis was done using Progenesis 
P G 220K w hich made reference gels o f  replicate gels and matched all spot in the replicates to the 
reference gels. The spots identified had an increase in normalized spot intensity by tw o-fo ld  or 
more. Spots o f  interest were digested and analysed using M ALDI follow ed by M ascot \  T ab le  3.5  
lists the proteins identified from the spots.
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F igure 3.12 Spot 276 from  F igure 3 .11 . Progenesis PG 220®  2-DE gel analysis software show ed  
a >2-fold  increase in normalized spot intensity in the plasma from infected m ice compared to the 
plasm a from control m ice. The histogram show s the intensity levels in each group. The spot was 
identified as Apolipoprotein A -1 and the M ALDI spectra and subsequent M ascot®  result are 
show n on F igure 3.13
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3.3.3 Functio nal Cataloguing of Proteins
Protein functions were identified using the PIR id mapping tool and catalogued according 
to their gene ontology (GO) number. Table 3.6 gives a summary o f all the proteins 
identified on the gels. GO gave the molecular functions, cellular components and 
biological processes o f the proteins. 153 proteins were identified from all the gels and of 
these 47 were not fully catalogued as they were either hypothetical proteins or had no GO 
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Animal models have been developed to provide insights into the pathogenesis of 
neurological complications o f malaria. Mouse and rodent models have been studied most 
extensively to examine the function o f the blood brain barrier in malaria. In this study the 
Plasmodium berghei ANKA mouse model includes neurological signs such as ataxia, 
hemiplegia and coma (Neill and Hunt, 1992), which are similar to the clinical features of 
human CM. However, in contrast to human CM, there is little evidence of sequestration of 
parasitised red blood cells (PRBCs) in the brain (Polder et al., 1992), but rather monocytes 
and non-PRBCSs predominate (Neill et ah, 1993). Recent studies have found PRBCs in 
the cerebrum and cerebellum of infected mice (Hearn et ah, 2000). Although the 
pathogenesis o f the neurological complications of murine malaria appears to be more 
immunologically mediated (Polder et ah, 1992, Hearn et ah, 2000) than in human malaria, 
changes in protein components of mouse plasma may be indicative of disease related 
alterations.
Two-dimensional gel electrophoresis, though still the mainstay in proteomic research, has 
the main limitation of only having a dynamic range o f 104. This creates difficulties when 
analysing crude plasma, which potentially has protein components ranging from the 
millimolar range to the low femtomolar range (Anderson and Anderson, 2002, Kenyon et 
ah, 2002). Reducing the complexity o f protein mixtures by depletion and fractionation of 
intact proteins greatly simplifies the task for 2-DE. There are essentially two patterns of 
depletion: depletion only o f albumin or Ig or both, and depletion o f the top-6 proteins, 
which are albumin, IgG, IgA, haptoglobin, alpha-1 anti-trypsin and transferrin. There is 
clear evidence that depletion makes it significantly more feasible to visualise, detect, and
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then identify lower abundance proteins (Eehan et al., 2005, Li et al., 2002a, Zolotarjova et 
al., 2005, Huang et al., 2005). To effectively identify low abundant proteins (LAPS) in 
plasma in this study, albumin, which together with another nine proteins accounts for 
almost 90% o f the proteins in plasma, was removed. Although this made for better gel 
resolution, it was found that the many “new” spots detected after depletion were unmasked 
isoforms o f high and medium-abundance proteins, rather than LAPS. Another 
counterbalancing problem noted by many authors is the non-target or inadvertent removal 
of other proteins, which could be due to peptides and proteins bound to the target proteins, 
especially albumin; cross-reactivity with the bound antibodies; or non-specific binding to 
the column or resin or dye (Granger et al., 2005). One solution for this would be pre­
fractionating the sample prior to gel separation or to skip the gel separation and digest the 
fractions and then separate the resulting peptides by liquid chromatography. However, due 
to time constraints this was not explored in this study.
Protein alterations implicated in murine malaria include cell adhesion molecules such as 
P-selectin (Combes et al., 2004) and cytokines such as tumor necrosis factor (Grau and 
Lou, 1995). These proteins have been studied extensively using more conventional 
biochemical techniques, such as immunoassays (de Kossodo and Grau, 1993, Grau et al., 
1989, Grau et al., 1990). Unfortunately, the dynamic range o f the 2-DE approach, as well 
as the dynamic range o f the stains used in this study is such that such proteins can 
theoretically only be detected after extensive work on developing a pre-fractionation 
strategy allowing enrichment of LAPs, which was not possible due to the limited time 
available. The dynamic range o f the technique thus limited analysis to the more abundant 
acute-phase proteins, which are known markers o f inflammatory disease including serum
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albumin and various isoforms of apolipoproteins. Achieving the level of detection 
commensurate with immunoassay will only be possible on 2-DE using pre-fractionated 
plasma in which the major serum proteins (albumin and immunoglobulins) are 
substantially reduced, but not at the expense o f the non-specific depletion of minor 
proteins. When this occurs, it will be possible to identify many subtle changes in protein 
expression, permitting protein enrichment to determine the mass spectrum and hence 
identity prior to development of specific immunoassays.
Proteins excised from preparative gels were processed for MALDI-ToF-MS. In the 
literature a number o f cleavage enzymes have been used to digest proteins for MS. Here 
trypsin has been used as it displays a high level o f specificity, cleaving the proteins 
explicitly after lysine or arginine residues. In addition trypsin is acknowledged to produce 
autoproteolytic fragments which can be used for internal calibration o f the mass spectra 
(Beranova-Giorgianni and Desiderio, 2000). Trypsin digestion results in quite small 
peptides, which can be efficiently eluted from the gel matrix and which “fly” well in 
MALDI time o f flight machines. All proteins were in-gel digested with tiypsin, the 
resulting peptides were extracted from the gel piece and PMF was performed using 
MALDI-ToF-MS. PMF was selected as the preferred tool for protein identification in this 
study because the technique is fast and straight forward and therefore appropriate given the 
study duration and number o f spots to be analysed.
Although MALDI is a very sensitive technique, not all spots investigated provided a
statistically significant score on analysis. The Mowse Score reported by Mascot® is
denoted by the expression -10*Log(P) where P is the probability the observed match is a
random event. For Rodents proteins the scores were considered significant (p<0.05) if they
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were greater than 63 while for Alveoli proteins scores greater than 57 were considered 
significant. The sequence coverage for proteins identified varied and results show high 
sequence coverage gave a high Mowse score.
O f the 157 proteins identified 54 were found to be uniquely expressed in the plasma from 
infected mice. One o f these unique proteins was identified as similar to spectrin non- 
erythroid alpha chain brain protein (spot 36 infected gel map). This protein has recently 
been shown to correlate with severity o f CM in Gabonese children (Guiyedi et al., 2007). 
Another o f the proteins unique to plasma from infected mice was identified as similar to 
macrophage galcotose-type C-type lectin 2 (MGL2) (Spot 12 and 14). MGL2 is induced in 
diverse populations o f activated macrophages, including peritoneal macrophages elicited 
during infection with the protozoan Trypanosoma brucei brucei or the Helminth Taenia 
crassiceps and alveolar macrophages elicited in a mouse model o f allergic asthma (Raes et 
al., 2005). Raes et al also demonstrated that in vitro, interleukin-4 (IL-4) and IL-13 up- 
regulate MGL2 expression and that in vivo, induction o f MGL2 is dependent on IL-4 
receptor signaling. Moreover, expression o f MGL on human monocytes is also up- 
regulated by IL-4. The study concluded that macrophage galactose-type C-type lectins 
represent novel surface markers for murine and human activated macrophages and could 
be important markers o f immune response in murine malaria Another o f the proteins 
identifies as unique to plasma drawn from infected mice is Baculoviral IAP repeat- 
containing protein 3 which is an apoptotic suppressor. This protein interacts with TNF 
receptor associated factors 1 and 2 to form an heteromeric complex, which is then recruited 
to the TNF receptor 2 (Liston et al., 1997). The presence o f this protein could be as a
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protective measure to stop apoptosis which has been shown to occur in murine liver cells 
during malarial infection (Guha et al., 2007, Guha et al., 2006).
There were 49 proteins uniquely expressed in the control gels. These included transthyretin 
(spot 72 control gel) which sometimes acts as a retinol carrier through an association with 
retinol binding protein (Sasaki et al., 1985). It is normally found at high concentrations in 
plasma and the fact that it was not detected in the plasma from infected mice would 
suggest that the levels in rodent malaria are too low to detect or some protein modification 
had occurred. Transthyretin is an acute phase protein that decreases during an acute phase 
response (Schreiber et al., 1989). Together with other acute phase proteins such as 
transferrin, and albumin, these proteins that decrease during an acute phase response have 
no apparent immune function (Schreiber et al., 1989). Their main role is to transport 
nutrients and, therefore, their reduction during infection and inflammation may lower the 
concentration o f specific nutrients. The serum concentration of retinol, the alcohol form of 
vitamin A, decreases during malarial infections. This reduction has been characterised as a 
direct consequence o f the inflammatory response to Plasmodium infections (Thurnham and 
Singkamani, 1991, Tabone et al., 1992). Previously, several proteins have been associated 
with a reduction in retinol (Filteau et al., 1993, Das et al., 1996, Friis et al., 1997). The 
proteomic results suggest that transthyretin may be a useful predictor o f plasma retinol 
during malarial infection. This information would be useful because the inclusion o f a 
measure o f the acute phase response would help interpret plasma retinol concentrations 
during malarial infection (Thurnham and Singkamani, 1991, Filteau et al., 1993).
Proteins found to be common to infected and non-infected plasma were mainly variants of
albumin and apolipoproteins and were identified to many spots in different regions o f the
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2-DE gels suggesting that these proteins had gone through some form of post translational 
modification.
3.5 Conclusion
This study helped to validate the technique of proteomics for characterising differentially 
expressed LAPS in different stages of the severe forms o f murine malaria. It also 
highlighted several problems in applying this technology to plasma due to the limitations 
o f 2-DE that is known to have a systemic bias against very large, veiy small and LAPs 
(Wilkins et al., 2006). This only leaves proteins expressed at medium or high levels from 
the 2-DE. Using 2-DE together with pre-fractionation techniques could greatly reduce the 
problems associated with this technique (Tam et al., 2004) increasing the amount of 
information that can be derived from this technique. Some of these problems are addressed 
in the next chapter which deals with characterisation o f LAPs in plasma samples from 
patients.
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4 CSF and Plasma Proteomes from Archived 
Samples from CM, ABM and EN
4.1 Introduction
The successful completion of the human and Plasmodium falciparum genome projects has 
created an opportunity to increase our understanding of the molecular basis of severe malaria. 
However, a comprehensive understanding of the dynamic protein pathways involved in a) 
normal and disease states and b) response to medical treatment, is required to improve the 
outcome.
Traditional analysis of biomarkers has concentrated on identifying one marker for a particular
disease. However, there is now a general agreement, supported by a statistical argument, that
for complex disease states a panel of independent but disease-related proteins, considered in
an aggregate, would be more relevant as they should be less prone to the influence of genetic
and environmental ‘noise’ than is the case for a single marker protein (Anderson, 2005).
Importantly proteomics has the power to identify such panels of proteins. The 2-DE
proteomic approach has been most successfully used to identify protein profiles in various
disease states. For example, it was demonstrated that leukaemias could be classified into their
different subtypes using 2-DE (Hanash et al., 2002). This methodology has also been applied
in the investigation of infectious diseases, diseases of the central nervous system, heart and
cancer (reviewed in (Zolg and Langen, 2004, Engidawork and Lubec, 2001, Rohlff, 2000,
Banks et al., 2000, Tyers and Mann, 2003, Petricoin et al., 2002e, Hanash, 2003, Bichsel et al.,
2001, Alaiya et al., 2000, Fountoulakis and Lahm, 1998, Fountoulakis, 2001). This chapter
describes the application of methods developed in chapter 3 to create gel maps of plasma and
CSF collected from children diagnosed with cerebral malaria (CM) and compared these
findings to patients with undiagnosed encephalopathy (EN) and acute bacterial meningitis
(ABM), in an effort to tiy and understand differences in protein expression. The diseases
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pheonotypes were chosen based on results of previous analyses of CSF samples using NMR 
(Figure 1.3) spectrum of CSF from patients with CM is considerably different from children 
with meningitis and other neurological conditions e.g. stroke and multiple sclerosis. Table 4.1 
highlights some of the differences between the 3 groups. We have employed the 2-DE 
approach to try and define multiple markers for severe malarial disease.
4.2 Materials and Methods
4.2.1 Patient Samples
Archived plasma and CSF samples(stored at -80°C in heparinised tubes) from children 
diagnosed with CM, EN and ABM were collected to study the changes in CSF using 
techniques other than those described in this study (SSC Protocol No. 480 "Mechanisms of 
neurological damage in Kenyan children with cerebral malaria and acute bacterial meningitis" 
Newton CRJC et al). The analytical methods described in this thesis are more sensitive and 
selective and were used in place of those described earlier in the SSC Protocol No. 480. The 
change in analytical methods used was described in SCC protocol No. 772 which was 
approved during the 103rd KEMRI/National Ethical Review Committee meeting held on 3rd 
June 2003. Based on results o f previous analyses o f CSF samples using NMR (Fig. 1.1) 
spectrum o f CSF from patients with CM is considerably different from children with 
meningitis and other neurological conditions e.g. stroke and multiple sclerosis, suggesting 
presence o f compounds uniquely expresses in CM. Due to the invasive nature of sample 
collection it would not be ethical to have samples collected from healthy children, therefore 
samples from children with a diagnosis of ABM and EN were used as control groups. 
Table 4.1 gives a clinical comparison o f these disease phenotypes and table 4.2 gives 
































































































































































4.2.2 S ample Preparation
To minimise protein loss, plasma samples were used with no prior sample preparation. 
However, CSF contains a high salt concentration (>150 mmol/L) and a low protein 
concentration (the CSF/serum ratio of protein concentration is 4 x 10~3, 200-700 pg 
protein/mL).(Yuan and Desiderio, 2005a). This causes interference with electrophoretic 
separation of proteins because of the high electrical current that is carried by the salt load. This 
in turn reduces the efficiency of the 2-DE. Therefore, CSF samples were prepared as follows: 
the CSF samples were desalted using Microcon YM-3 centrifugal filter units (Millipore, USA) 
according to manufacturer’s instructions using water as the buffer of choice. These units filter 
out anything with less than 3kDa and also enabled the concentration of the CSF samples.
4.2.3 P rotein Determination Using the Bradford Assay
Protein concentration of diluted plasma (1:100 v/v with water) and desalted CSF was 
determined as described in chapter 2  section 2 .1 .2 .1
4.2.4 Two Dimensional Gel Electrophoresis
Following determination of the protein concentration (Section 4.2.3), proteins were separated 
using 2-DE as describe in chapter 2 sections 2.1.8.2-2.1.8.4. Analytical gels used to provide 
master maps were loaded with 75pg of protein and preparative gels to be stained with 
Coomassie stain were loaded with 300pg of protein. Due to the low amount of protein content 
in CSF, preparative gels were not prepared and analytical gels stained with silver stain were 
used for MS analysis.
4.2.5 P rotein visualisation and image analysis
Analytical gels were silver stained as described in chapter 2 section 2.1.8.5 and preparative 
gels stained with Coomassie as described in chapter 2 section 2.1.8.5 The stained gels were 
scanned using GS-710 Imaging Densitometer (BioRad) and analysed using PDQuest®
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software version 7.0 (Biorad) (chapter 2 section 2.1.2.7) and Progenesis® 200 software 
(Nonlinear Dynamics, Newcastle upon Tyne, UK) (chapter 2 section 2.1.8.5). The software 
enabled the matching of identical spots in serial gels and normalisation of gels to compensate 
for non-expression related variations in protein spot intensity.
4.2.6 Try ptic in-gel digestion
For plasma, spots cut from gels stained with Coomassie were digested as described in chapter 
section 2.2.3.1. For CSF, spots cut from silver stained gels were digested using a modified 
method described by (Terry et al., 2004). The silver stained spots were washed twice in 50% 
ACN in lOOmM ABC for five minutes. The spots were then dehydrated using 100% ACN 
until they turned opaque white, followed by evaporation of excess ACN in a vacuum 
concentrator. Digestion buffer (5-10|il of 10|ig/ml modified sequencing grade trypsin (Sigma- 
Aldrich) in 25mM ABC), was added to the dried gel pieces and incubated overnight at 37°C. 
Resulting peptides were extracted by first incubating the digestin 7pl of distilled water and 
then adding 30%ACN in 0.1% TFA and sonicating for 30 minutes. The digest was then vortex 
mixed and centrifuged for 2 minutes. The supernatant was transferred and vacuum 
concentrated to about 2 pl.
4.2.7 M ass Spectrometry
4.2.7.1 Characterisation of protein spots by MALDI-ToF-MS
All spots digests were analysed using MALDI-ToF as described in chapter 2 section 2.3.9.1.
4.2.7.2 Characterisation of Protein Spots by RP-LC-MS/MS
To increase the number of proteins identified, the remaining spot digest was diluted using 15 pi
of a 50% acetonitrile/5% formic acid v/v mixture and analysed by tandem mass spectrometry
using a LCQ Deca XpPlus mass spectrometer (ThermoFinnigan, USA) equipped with an
electrospray source connected to a reversed phase Thermo Hypersil-Keystone biobasic C l8
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column (0.18 x 1 0 0 mm) as follows: after sample injection, peptides were eluted on a 60 min 
gradient 2% to 50% ACN at a flow rate of 500ul/min. To maintain a stable spray, the spray 
voltage was adjusted to (1.5-1.8kV). The capillary temperature was set at 250°C and the 
normalised collision energies were set at 35% for MS/MS. The mass spectrometer was 
operated on a data-dependent “triple play” mode where the 3 most intense ions in the full scan 
were subjected to a zoom scan followed by MS/MS. Dynamic exclusion set at 0.5 min was 
used to obtain MS/MS spectra from any co-eluting peptides.
4.2.8 Data base Searching and Protein Categorisation
Mass lists generated from MALDI-ToF were searched against the NCBInr database using the 
search parameters described in chapter 3 section 3.2.7. MS/MS data generated from the LC- 
MS/MS experiment were searched using TurboSequest® described in detail in chapter 2 
section 2.3.5.4. The tandem mass spectra were searched against the NCBInr database as well 
as the Plasmodium falciparum database downloaded from the Sanger Institute. Proteins were 
accepted if they were identified with 2  or more peptides and only if they were identified from 
both the subset database as well as from searching the entire NCBInr database. Protein 
cataloguing was done according to the GO terms (chapter 2 section 2.3.8.1) for molecular 
function, cellular component and biological process using the tool provided by PIR as 
described fully in chapter 2 section 2.3.9.5
4.3 Results
4.3.1 P rotein Determination Using the Bradford Assay
The mean plasma protein concentrations were 43.44 g/L (s.d. 19.51), 51.17 g/L (s.d. 19.72) 
and 47.44 g/L (s.d. 15.83) for CM, ABM, and EN respectively. Table 4.3 gives CSF total 




























































































4.3.2 P rotein Separation
In order to compare protein expression profiles of plasma and CSF, representative samples 
collected from children diagnosed with CM, ABM and EN were applied to 2-DE and the 
proteins visualised by silver stain and coomassie stain. To prepare gel maps of proteins 
PDQuest® 2D software was used. Gel maps for plasma were created from both silver and 
Coomassie stained gels. Figure 4.1 shows master gel maps for plasma from CM, ABM and 
EN respectively from the coomassie stained gels. The master gel maps for CSF are shown on 
Figures 4.2. The master gels were prepared by analysing duplicate gels of 12 patients and 
spots matched in 75% of the gels included into the master gel. Figures 4.3-4.4 represents a 
composite gel showing differences identified between plasma gel maps of CM compared to 
ABM and CM compared to EN respectively Figures 4.5-4.6 shows a composite gel showing 
differences between CSF gel maps of CM compared to ABM and CM compared to EN.
Semi-quantitative analysis of the gels was performed using the Progenesis® 200 software 
which highlighted any spots that may have been up or down regulated. Figures 4.7 and 4.8 
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Figure 4.3 Composite gel showing the differences between gels of plasma collected from 
children diagnosed with CM and ABM. Composite gels were created using the comparison 
tool in PDQuest*. The composite gel demonstrates qualitative differences in the CM gel map 
compared to the ABM gel map. Red spots are spots found in the CM gel map and blue spots 
are those from the ABM gel map. Green spots depict spots found in both. Some of the 
numbered spots were identified using MS and are listed on Table 4.4
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Figure 4.4 Composite gel showing the differences between gels of plasma collected from 
children diagnosed with CM and EN. Composite gels were created using the comparison 
tool in PDQuest\ The composite gel demonstrates qualitative differences in the CM gel map 
compared to the EN gel map. Red spots are spots found in the CM gel map and blue spots are 
those from the EN gel map. Green spots depict spots found in both. Spots successfully 
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Figure 4.5 Composite gel showing the differences between gels of CSF collected from 
children diagnosed with CM and ABM. Composite gels were created using the comparison 
tool in PDQuest\ The composite gel demonstrates qualitative differences in the CM gel map 
compared to the ABM gel map. Red spots are spots found in the CM gel map and blue spots 
are those from the ABM gel map. Green spots depict spots found in both. Spots successfully
identified using MS are listed on Table 4.6
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Figure 4.6 Composite gel showing the differences between gels of CSF collected from 
children diagnosed with CM and EN. Composite gels were created using the comparison 
tool in PDQuestT The composite gel demonstrates qualitative differences in the CM gel map 
compared to the EN gel map. Red spots are spots found in the CM gel map and blue spots are 
those from the EN gel map. Green spots depict spots found in both. Spots successfully 
































































































































































4.3.3 P rotein Identification by MS
Preparative gels for plasma were stained with Coomassie however due to the low protein 
content CSF protein spots were cut out from the analytical silver stained gels. Tables 4.5-4.8 
list protein identifications of the spots of interest labelled on Figures 4.3-4.6 and Tables 4.9 
and 4.10 list proteins identified from spots labelled on Figures 4.7 and 4.8. Of the Coomassie 
stained gels 22% -42% of the spots on each gel were identified, while of the silver stained gels 
approximately, 10% of the spots per gel were identified. Irrespective o f the staining method 
protein identification from ABM gels were very low (22% for Coomassie and 9% for silver 
stain).
4.3.4 Characteri sation and Cataloguing of Proteins
Protein functions were identified using the PIR batch retrieval tool and catalogued according to 
their gene ontology (GO) number. The gene ontologies gave the molecular function, the 























































































































































































































































































































































































































































































e  «  ^  
§
S « ~Vi w
-5 ?• —
"a a c/2 s





O 3o  . . . .
*  u 0 0  >r>
■ ' > O rr 
6  '5 M 't  
O S ^  N O. > O Tf
2  'E o  o  
£ • 0 0 0  
2  73
7! ~o. S S
o -o £ c
VO C C3 3
S S o
012 bfi 
.£ ~ "O -3 




2  $ C. V]
v> O
30
—  V i— sc
•E o
© j z< E
< § 
^  ”  c
°  <
u
■2 a> 3 o 
322 P
oo  3 
00 ^  O  eo o  >>
0  £  • •  ©  O
VO . .. yov 3 >
30 3  •©0 ^ 0  lO 3 C3o s <u 
0 0  s-
3 
30 • -





o  • •© 30O  ro
• - v>£ O £Vi -T ’A
' - 3  ©  • —O © O
X) X)




022 2  >> ?3 hr ^o  a> OU
0 ^ 0  —(N u OO X 00o ----
s  3 c 2  V5 S* 1> O
o "u 




n °s  o
—  ,r>  
o  ^
oi)§
.5 © -S' 
" 3  ot>. — 
2 -  u
_  -3 3!2 C u
0  O 3 ~
2  a ©
0 1  I.2 .0 3 .. > is
-3 3 103  2  i g
3 : 3 VI ©© r5 . . ©^  is . r-S — 2? >v
3 022 V} ■- .3?! *3 o
0  —•3- r--
30o  3"
§ *.g7.. Ji 0  P - 
> ji a
u

















































































































































































































































i n  O 
ON w  — cS 
o  3  
°  59 






a s f .
£ o o 
3  .2 «0 .-0  o




ON _ rNO oOO JO
NO c3
§ I  _O £ Q- -
M S  S
§ I Io £  2  - a o
5  o  
.£ '5b«
o o o 
S. 3  o
OO
3  .1  =3 ° l  
2  s-5 13
2 ^ 0  °  00 C- - 1) =
C l  o n  
22 oo — 
£ r^ - •2 o o v
, § ° g— Go• • v5 o
O' —  . *
s -s  0
8 * 2  
O  G Q-
CS C 
.2 §  00 — o o
.2 «
-O o
o fm 0 
oo ■§
§ • 3  o  ^
t f  >0O '■© 0 . 0












2 oO  tC 
O  Cl
t/5 ^ 
£ \E  CJ a>< I 
. £  °
5 1< <
00 <
< 1  
8 ' 5  
< 2 '7 ' D-§ 1 
3  O  U O- 




























































































































































3  2  ST $ 3> *O
•eoa.
N ^  O ~■£ © 1>
§ . § ? „ §  O 73 c »— 3  u.otS *3 o ° o. •• 3
3
• •
— OSO CN— o • • 
0 ^ - 0  O O —. . o  oov> . „  s o""5 2 —  X>




— 3_,<i = « ? —
g  §■£ « •- i> «® 13 £  = g :a s












vi O e m 
2  © ■fa o






O•n rn00 <N•o0 Tf0 O0 O
S . „"3 1>
I  I  3O « u
s  o -  
•3 T3 0» i—» £2 3H * > <—
o  vo r -  so
o  o  o  o  
o  o  o  o




1/3 • * K n
22 © 2?
2 2 = 5 ' 
" 5  ©  .£  










00 IT oo r~ rs ©
CS ©1) <N -5
J i
a  - 2
p  2  
c  on
a
2 2 . 2
3> j>s





0  ■.“>-5 BJ ©
=3 a  0  00P  2  J 3  o
“ J: ^  o







The work described in this chapter demonstrated the use of 2-DE gel analysis to study unique 
LAPS associated with CM, the most severe neurological complication of falciparum malaria 
that leads to significant mortality and morbidity including neurological sequelae. P. 
falciparum appears to have a particular propensity for the brain, since the other human malarial 
parasites rarely cause neurological dysfunction. This is thought to be directly linked to 
sequestration and binding o f the infected red cell within the brain microvasculature (Gitau 
and Newton, 2005). The working hypothesis was that by studying both the plasma and CSF 
proteome it would be possible to identify unique biomarkers for the early-stage diagnosis or 
the staging of the neurological disease, offer potential insights into the biochemical 
perturbations induced by sequestration including affects on specific neuronal populations, 
and clarify the basic molecular basis of the pathology.
Patients in this study had a mean age of 34, 26, and 37 months for CM, ABM, and EN 
respectively. The number of seizures per disease group ranged between 8  and 11 seizures and 
none of the patients were severely anemic. The average mortality was 25% , 17%, 33% for 
CM, ABM and EN.
The functional integrity o f the BBB is usually assessed by examining the passage of
molecules into the CSF. The passage o f the molecules from the blood into the brain is
determined by the size, and charge o f the molecules, and the presence o f specific receptors
in the BBB for transporting molecules. Thus in human studies, the ratio o f CSF to blood
concentrations are often used to determine the integrity o f the BBB. In particular, the
concentrations o f relatively small proteins such as albumin are used widely. An elevated
CSF albumin/serum albumin ratio indicates increased permeability of the BBB. The three
disease groups studied are all infectious diseases associated with increases in cytokines and
acute phase proteins which are common to these diseases. However, there are fundamental
differences as the BBB is greatly impaired in ABM, less so in CM and least in EN. The
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initial protein content o f CSF determined using the Bradford method (table 4.4) gives a 
clear indication that protein levels increase with BBB impairment (3.34g/L, 0.53g/L and 
0.23g/L for ABM, CM and EN respectively). Normal levels o f total protein levels of CSF 
in children remain unknown as it is impossible to obtain.
Majority o f the proteins differentially expressed are acute phase proteins (APPs) which 
either decrease (ne gative) or increase (positive) during an acute phase response. The 
functions o f APPs are many; some positive APPs participate in host-adaptive and host- 
defense mechanisms by binding to foreign substances or by having opsonizing activities 
and modulating phagocytic cell functions. Other APPs have more specific actions, such as 
inhibiting serine proteinases or serving as transport proteins with antioxidant activity. On 
the other hand, negative APPs such as transthyretin, retinol binding protein, transferrin, 
and albumin have no apparent immune function (Schreiber et al., 1989). Their main role is 
to transport nutrients and, therefore, their reduction during infection and inflammation may 
lower the concentration o f specific nutrients such as vitamin A in malarial infection 
(Schreiber et al., 1989).
At present, 2-DE is a popular method to separate a complex mixture of proteins. The ability to 
monitor many proteins simultaneously yields a global view of protein expression and post- 
translational modification, which is much more informative than monitoring a few proteins 
(Powell and Timperman, 2004). However, limitations of 2-DE, including reproducibility and 
limited sample load continue to create problems when trying to analyse complex samples such 
as plasma and CSF. The application of a commercial immobilized pH gradient (IPG) strip has 
greatly improved 2-DE reproducibility and although not applied in this study the use of longer 
(18 or 24 cm) and narrower-p/ ranges strips have increased significantly the electrophoretic 
resolution of proteins and the sample load (Yuan and Desiderio, 2005b). Some 2-DE systems 
can simultaneously analyse up to 1 2  gels to minimise any difference between-gels that would
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be caused by instrumental conditions. To account for any technical and biological variations, 
1 2  patient samples per disease group were analysed in duplicate in thus study.
For quantitative analysis the samples were stained with silver stain. Although silver stain is 
not very compatible with MS, it was not possible to identify many proteins after staining the 
CSF gels with coomassie due to the low amount of protein found in the sample and the limited 
sensitivity o f coomassie staining. Most proteomic studies of neurological pathologies that 
use CSF try to overcome the problem of low protein content by pooling samples (Fukuyama et 
al., 2000, Puchades et al., 2003, Davidsson et al., 2002a, Davidsson et al., 2002b, Yuan et al., 
2002, Hammack et al., 2003). However, in proteomics, one problem with pooling is how to 
sort out highly abundant single case contaminations from the pool (low abundant 
contaminations are diluted). This can be achieved by differential displays from the total pools 
(e.g. each 30 patients) and a set of subpools (each group 5 x 6  patients). In this case a 
minimum of six differential displays can unambiguously identify the general serum biomarkers 
and discard single fates only apparent in one of the subpools (Schrattenholz, 2004). Another 
major disadvantage of pooling samples before proteomics analysis is that information on the 
sensitivity and reliability of each candidate marker in detecting disease onset and/or 
progression will be lost, as this information can only come from analyzing sets of individual 
samples (Jing, 2007). In this study samples were not pooled and any proteins identified 
were found in majority o f the patients in the disease phenotype.
The overall success of differential protein display in proteome research depends critically on 
the accuracy and the reliability of the analysis software. In addition, the software has a 
profound effect on the interpretation of the results obtained, and the amount of user 
intervention demanded during the analysis. In this study both PDQuest® and Progenesis® 
software were used to analyse the gels. While PDQuest gave a robust spot overlay analysis, 
when matched spots were missing in some gels, the PDQuest software assigned an arbitrary 
value to the missing spots, introducing a false normalised quantity in the calculation of the
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Student’s Mest and for this reason all quantitation was done using the Progenesis® software. 
However as our results showed spots can contain more than one protein due to insufficient 
resolution. In such cases the measured spot volume ratios will not reflect the real quantitative 
situation, a good example being spot 10 (Figure 4.5) which had more than one protein 
attributed to it. Using Progenesis® Alpha-1-antitrypsin precursor and it’s variant were found 
to be unique to CM plasma (Spot 4, Table 4.5 and spot 9, Table 4.6). However, this protein 
was also identified on a different spot (spot 7 and 8 Table 4.1) but only spot 8 was identified as 
unique using PDQuest®. The identification of different spots as the same protein would 
indicate that different isoforms of this protein migrate differently and understanding what the 
roles the different isoforms may have in a disease would be very useful. The result on alpha- 
1- antitrypsin justifies the need to understand how it’s different isoforms work especially 
because one would expect to see it in all the disease groups studied as the protein is normally 
increased in acute inflammation. Chain A transthyretin (retinol binding protein) was found 
uniquely expressed in CSF from CM (Spot 18, Table 4.4). This protein has sometimes been 
attributed to transfer of thyroxine from plasma to the brain (Dickson et al., 1987, Schreiber et 
al., 1990, Chanoine et al., 1992, Southwell et al., 1993). As discussed in chapter 3 this acute 
phase protein is decreased in an acute phase response and the presence of it in CM would 
suggest that the response is not as strong as in the other phenotypes
Orosomucoid 2; alpha-1-acid glycoprotein, type 2 is one of the proteins that was found to be
up-regulated in plasma CM when compared with both EN and ABM gels. This protein has
been shown to inhibit neutrophil activation and production of superoxide radicals and TNF-a
(Costello et al., 1984, Scuderi et al., 1989).49-51 Furthermore, increased production of
orosmucoid, caeruloplasmin, and of glutathione, enhance antioxidant defences and limit the
stimulatory effects of oxidant molecules on cytokine production. The sorting nexin (SNX)
protein family is implicated in regulating membrane traffic, and SNX3 is associated with
endosomal function. In our study SNX3 was expressed in lower content in CM compared to
both ABM and EN (spot 3 Table 4.5 and spot 8 Table 4.6).
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Two different types of mass spectrometry were used in this study. MALDI-ToF mass 
spectrometry is the widely used approach in proteomics for identification of proteins using 
PMF data from spots. During this study about 60% of proteins identified from coomassie 
stained spots were identified using MALDI-ToF and about 97% of the proteins identified using 
LC-MS/MS. A study comparing the 2 techniques found that identification of 2-DE separated 
proteins that matched with the most number of peptides by LC-MS/MS were also the proteins 
exclusively identified as the number 1 ranked proteins in the first round of a PMF search. No 
unique proteins were identified exclusively by PMF (Lim et al., 2003). This study shows that 
MALDI-ToF is complementary to MS/MS identification of 2-DE proteins, but lacks the 
dynamic range of LC-MS/MS. Improved dynamic range is obtained through the LC separation 
process to enable the acquisition of tandem mass spectra for proteins present in a spot in less 
abundance. MS/MS database searching uses fragmentation patterns indicative of specific 
amino acid sequences to match a protein and thus has a higher level of specificity than PMF. 
Thus, only one peptide MS/MS spectrum with good signal to noise, fragmentation, and length 
can identify a protein in the database. Another drawback of the PMF approach in protein 
identification can be found when judging a search result. If  the score of the first ranked protein 
is around or below the boundary of the criteria set by the software, the user cannot be confident 
with the result and has to manually inspect the data to obtain additional information (e.g., 
sequence) to increase the confidence of the result. In most cases, the protein has to be 
reanalyzed preferably by MS/MS
Although 2-DE is a powerful technique, one of its limitations is that it remains relatively low
throughput and requires large amounts of starting material (~50pg) with low sensitivity for
detection of low abundance proteins such as cytokines and signalling molecules. In addition,
certain basic proteins, and very high- or very low-molecular weight proteins are not separated
well by 2-DE. Techniques such as free-flow electrophoresis (FFE) have been developed to
help resolve complex protein mixtures using a combination of FFE (liquid based IEF method)
and 2-DE (Hoffmann et al., 2001). The use of narrow range, overlapping pH gradients in the
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first dimension also improves the number of proteins visualised on 2D gels (Gorg et al., 2004). 
Until recently, a limitation in 2-DE technology was the reproducibility, necessitating the use of 
multiple gels to obtain statistical validity. A major advance in this area has come from the 
introduction of Cy dye fluorophores for pre-labelling of protein samples Two-dimensional 
fluorescence difference gel electrophoresis (2D-DIGE) technology adds a quantitative 
component to conventional 2-DE analyses, allowing for comparison of protein expression 
changes across multiple samples simultaneously without gel-to-gel variation, and hence with 
statistical confidence (Tonge et al., 2001, Unlu et al., 1997). 2D-DIGE utilises Cy dye 
fluorophores for protein labelling prior to fractionation. This facilitates multiplexing of protein 
samples, allowing for direct comparison of different samples within the one gel (Unlu et al., 
1997), and more importantly, enables the introduction of a standardised internal control.
Separation of a very complex mixture of larger proteins is best performed by 2-DE. While the 
presence of large proteins hinders the separation of smaller ones, the presence of small proteins 
does not interfere with 2-DE, so they do not need to be removed if one is only interested in the 
larger ones. The advantages of 2-DE are resolving power sufficient often to separate various 
forms of the same proteins (e.g. proteins with different glycosylation or phosphorylation 
patterns), multiplexing (hundreds or thousands of proteins separated and visualised per gel), 
and ease of comparison and quantitation (especially through the technique of difference gel 
electrophoresis known as DIGE). The disadvantages include marginal applicability to proteins 
with extreme isoelectric points or hydrophobicity (membrane proteins) and to proteins of small 
size, and technical difficulties associated with the technique. For less complex samples, 
digestion prior to separation avoids gels and allows more convenient analysis but, since not all 
fragments are identified, this approach forfeits the opportunity offered by gel-based analysis to 
obtain more information on the different (post-translationally modified) forms of the same 
gene.
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Some of the main challenges facing 2-DE of plasma and CSF include the great dynamic range 
of protein abundance and a wide range of protein properties, including mass, isoelectric point, 
extent of hydrophobicity and post-translational modifications. One strategy to simplify 
complex samples is to deplete abundant proteins with a variety of affinity-based depletion 
columns, e.g., a multiple affinity removal system by Agilent Technologies, which is 
commercially available (Shen et al., 2006). This technology has been used for various body 
fluids, including serum, saliva, and CSF (Ramstrom et al., 2005, Li and Lee, 2004, Bjorhall et 
al., 2005), resulting in more proteins being identified after depletion of abundant proteins. 
However, as discussed in chapter 3, others have presented data questioning the utility of this 
approach (Omenn et al., 2005). In addition, as affinity depletion of abundant proteins is 
performed at non-denaturing conditions, it is likely that a significant number of other proteins 
will be depleted along with abundant proteins. This is particularly true for albumin, as it is one 
of the major carrier proteins in all body fluids. Given the caveats associated with affinity 
depletion of abundant proteins, making use of columns with various binding mechanisms, e.g., 
cation exchange, ionic exchange, and solid phase extraction, may better isolate protein 
populations, hoping that CSF proteins can be fractionated and thereby enriching proteins of 
low abundance.
Various studies have applied a straightforward method, graduating organic fractionation 
approach, which is comparable to both qualitative and quantitative proteomics for simplifying 
CSF protein profiles (Abdi et al., 2006, Zhang et al., 2005a, Zhang et al., 2005b). Briefly, CSF 
was mixed with 1.5 volume of ACN to generate the first pellet (PI), and then the supernatant 
was mixed with another 1.5 volume of ACN (i.e., a final 3.0 volume of ACN) to generate the 
second pellet (P2) and a supernatant (S2), which was dialyzed with a porous (0.5 kDa) 
membrane to desalt. With this approach, more than 90% of albumin and IgGs were found in 
the first pellet (Zhang et al., 2005a). However, increasing another step prior to 2-DE would 
further increase the time taken and hence a non-gel based method of separation is best explored 
for high throughput proteomics.
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4.5 Conclusions
Undoubtedly, various non-gel-based schemes that rely on liquid based separations of proteins 
or peptides, with or without tagging, will have utility for disease proteomics, particularly given 
their potential for automation. Additionally, advances in microfluidic technology will likely 
allow automated separation of proteins in complex lysates using much reduced sample 
amounts. Microfluidic systems already have been integrated with mass spectrometry for 
protein digestion and identification (Brivio et al., 2002). In this chapter, it has been shown that 
by applying the 2-DE technique protein profiles of severe disease can be created. Although 
some differences in the protein profiles of the different disease groups were identified, the 
limitations of the technique did not help identify as many proteins as expected. The next 
chapter describes a non-gel based method of protein separation prior to mass spectrometry and 
explores the utility of the tool.
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5 Modified ‘Shotgun’ Analysis of Plasma and 
CSF Proteomes from Cerebral Malaria 
patients
5.1 Introduction
The use o f the 2-DE approach for global proteomics analysis o f plasma and CSF from 
children diagnosed with cerebral malaria was discussed in chapter 4. While this approach 
continues to be the mainstay in proteomic analysis, there are well known limitations to the 
technique, especially for complex samples such as plasma and CSF. As discussed in 
chapter 4, one o f the limitations is the fact that the sample load capacity o f 2-DE gels is 
severely limited by the presence of high abundance proteins which makes detection of 
potential biomarker proteins found in relatively low concentrations very challenging. 
Moreover, as discussed in chapter 2, strategies for depletion o f high abundance proteins, 
although very useful, have the main disadvantage o f binding a large number o f proteins 
non-specifically resulting in their loss to analysis. One alternative to 2-DE is the use of 
non-gel based separation techniques such as liquid chromatography.
Chromatographic techniques have developed into powerful separation techniques, capable 
o f separating large numbers of proteins and peptides. However, any given 
chromatographic technique will still only separate a small fraction o f proteins in a complex 
mixture. The driving analytical platform behind the emergence o f non 2-DE MS-based 
proteomic methods has been the coupling of various orthogonal chromatographic 
separations prior to mass spectrometry. This has led to the introduction o f what is known 
as ‘shotgun proteomics’ which refers to the direct analysis of complex protein mixtures to 
generate a global profile of the protein complement within the mixture (Wu and MacCoss, 
2002).
161
Initial shotgun approaches involved digestion o f the complex sample followed by 
multidimensional separation of the peptide mixture prior to mass spectrometry. This 
method is commonly referred to as the “bottom-up method” (Keltman et a l , 2001), and is 
the basis o f the MudPit Technology (Link et al., 1999). It uses two dimensional 
chromatography where the first dimension separates the proteins according to charge using 
a strong cation exchange (SCX) column. The advantage of this method is that breaking 
proteins into peptides allows separation and identification of those proteins that are missed 
by gel electrophoresis, such as hydrophobic, membrane bound proteins and LAPs. 
However, one o f the main disadvantages of this approach is the complexity o f the peptide 
mixture (Washburn et al., 2001, Wolters et a l, 2001), resulting in ion suppression in ESI 
(Steiner et al., 2000) which hampers the subsequent protein identification. This chapter 
describes a pre-fractionation technique prior to protein digestion that can be used to 
overcome this limitation. It involves using a monolithic column and a LC-MS method that 
has a shorter gradient time than the usual reversed phase (RP) - MS.
5.2 Materials and Methods
5.2.1 S ample Source
As described in Chapter 4, plasma and CSF samples collected from children in Kilifi with 
a diagnosis o f cerebral malaria (CM) (n=12) were compared to CSF and plasma samples 
collected from children in the same population with a diagnosis o f non-specific 
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5.2.2 Fi rst dimension Liquid Chromatography
The sample preparation protocol described previously chapter 2 section 2.2.3.2 was 
followed for the fractionation o f proteins in CSF and plasma. Samples were first separated 
as described in Chapter 2, section 2.2.3.2. To normalise for protein content, an equivalent 
o f lOOpg of CSF protein and 200|iig o f plasma protein was injected onto the column. 
Protein content had been estimated as describe in section 2.1.2.1. Fractions were collected 
every 30 seconds starting from 1 minute to 25 minutes. The fractions were then dried 
down overnight in an oven set at 50°C. 25pl of lOOmM ammonium bicarbonate (ABC) 
was added to the sample using a repeat pipette followed by 5 pi o f a 20pg/mL solution of 
trypsin in 25mM ABC. Samples were thoroughly mixed using a multi-channel pipette and 
incubated overnight at 37°C to achieve complete digestion.
5.2.3 S econd Dimension Reversed Phase Liquid Chromatography
The second dimension HPLC separation was performed on an UltiMate™ 3000 LC system 
(Dionex UK). An aliquot (5 pL) o f the sample solution (in a 10 pL sample loop) was
injected from the autosampler (using the full loop mode) onto a M onolithic Capillary Colum n (200 pm  i.d. x  5 cm;
Dionex Corporation). Solvent A was 2.5% v/v Acetonitrile (ACN) in water with 0.1% 
formic acid and solvent B was 90% v/v ACN in water with 0.1% formic acid. The flow 
rate on the micro pump in the LC system was maintained at 1.5 pL/min. The gradient was 
started at 5% solvent B, ramped to 40% solvent B in 12 min, and then to 90% solvent B for 
another 2 min. Solvent B was then decreased to 5% and this was maintained to the end of 
the run at 27 minutes.
5.2.4 M ass Spectrometry
The LCQ Deca XP Plus ion trap mass spectrometer (ThermoFinnigan, USA) was equipped
with a nanospray source using a PicoTip connected to the column. To optimise the spray,
the tip was moved close to the entrance of the mass spectrometer (approx. 2mm) and the
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spray voltage adjusted (normally 1.5kV-1.8kv) to maintain a consistent spray. The 
temperature o f the ion transfer tube was set at 240 °C and the normalised collision energies 
were set at 35% for MS/MS. The mass spectrometer was operated on a data-dependent 
“big-three” mode where the three most intense ions in the full scan were subjected to 
MS/MS. Dynamic exclusion was set at a repeat count of 2, a repeat duration o f 0.5 minute, 
and exclusion duration of 3 min. to obtain MS/MS spectra from any co-eluting peptides.
5.2.5 P rotein Identification
As described in Chapter 2 section 2.3.5.4,the peptide fragmentation data were searched 
against the non redundant NCBI database and the P. falciparum  database downloaded from 
the Sanger Institute using the TurboSEQUEST® algorithm in BioWorks v 3.1 software 
provided by ThermoFinnigan™.
5.2.6 Data base Search Parameters
All spectra were searched against the human and P. falciparum  subset o f the NCBInr 
database and P. falciparum  database downloaded from the Sanger Institute. Searches were 
then repeated on the entire NCBInr database and only proteins which were called after both 
searches were accepted.
5.2.6.1 Protein Identifications
Proteins were accepted as legitimate identifications if they had two or more peptides with cross- 
correlation scores (Xcorr) of >1.5 for singly charged, >2.00 for doubly charged and >2.50 for triply 
charged peptides each with a delta correlation (DelCn) >0.1.
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5.2.6.2 Characterisation and Cataloguing Of Identified Proteins
Protein characterisation and cataloguing was done according to GO annotations using the 
PIR batch retrieval tool as described in chapter 2 section 2.3.5.5
5.3 Results
5.3.1 P rotein Identification by Mass Spectrometry
Appendices I-IV  give a complete list o f all identified proteins identified from the plasma 
and CSF. In plasma, a total o f 236 human proteins and 323 P. falciparum  proteins were 
identified from the database searches. From the 236 human proteins, 33 were present in 
CM, 40 in EN and 217 in ABM. 3 proteins were found to be unique to CM, 15 to EN and 
180 to ABM. 1 protein was common to CM and EN, 13 proteins were common to CM and 
ABM, 8 common to EN and ABM and 16 proteins were found in all three disease groups. 
Of the 323 P. falciparum  proteins identified, 160 were present in CM, 21 in EN and 237 in 
ABM. 79 were found to be unique to CM, 4 unique to EN and 154 unique to ABM. 66 of 
the P. falciparum  proteins were common to CM and ABM and 2 were common to EN and 
ABM. 15 proteins were found to be common to all three disease groups. O f the 323 P. 
falciparum  proteins 222 were identified as hypothetical. Table 5.2 gives a list o f the non- 
hypothetical unique proteins found in plasma drawn from patients with CM.
In CSF, a total o f 143 human proteins were identified. O f the 143, 21 were found in CM,
34 in EN and 121 in ABM. 8 proteins were unique to CM, 11 to EN and 93 unique to
ABM. There were 5 proteins found only in CM and ABM and 26 proteins found only in
EN and ABM. 8 o f the proteins were found in all 3 disease groups. A total of 66 P.
falciparum  proteins were identified and o f these, 7 were found in CM, 3 in EN and 61 in
ABM. 2 o f the proteins were unique to CM, 3 unique to EN and 56 unique to ABM. 5 of
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the proteins were found common to both CM and ABM. 41 human and 34 P. falciparum 
proteins were found in both CSF and plasma and these are summarised in Appendices V 
and VI. Table 5.2 gives a list of the unique proteins found in CSF drawn from children 
diagnosed with CM. The 2 P. falciparum proteins were not included in the list as they 
were hypothetical proteins. A list of proteins found in both plasma and CSF drawn from 
children with CM are listed on Table 5.3. Appendix V gives a complete list of the 
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5.3.2 P rotein Characterisation and Categorisation
Tables found in Appendices VII-X give a summary o f all the proteins that had 
corresponding GO numbers. 159 human and 288 P. falciparum  proteins identified from 
the database searches o f the plasma samples were catalogued. 102 human and 62 P. 
falciparum proteins identified from the CSF spectra were catalogued using the GO 
annotations. Figures 5.1-5.3 give a graphic distribution o f the 26 P. falciparum  proteins 
unique to plasma drawn from patients diagnosed with CM. 2 o f the 3 human proteins 
found unique in the plasma (Table 5.2) had corresponding GO functions and both were 
associated with protein binding. Figures 5.4-5.6 give a graphic distribution of the 8 
human proteins unique to the CSF drawn from children diagnosed with CM (Table 5.3). 
The 2 P. falciparum  proteins were hypothetical and were not analysed. 8 human and 6 P. 
falciparum  (Table 5.4) proteins were found in both plasma and CSF drawn from children 
diagnosed with CM and graphic distributions using GO categories are shown on figures 
5.7-5.12.
177
c a r b o h y d r a t e  b in d in g n u c l e o t i d e  b in d in g
h y d r o l a s e  a c t iv i ty
:a t a ly t i c  a c t iv i ty
activity
o x i d o r e d u c t a s e  a c t i v i t y  J







Figure 5.1 Distribution of 26 P. falciparum proteins found only in plasma drawn from children with CM, 
categorised according to gene ontology (GO) annotation for molecular function.____________________
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Figure 5.2 Distribution of 26 P. falciparum  proteins found only in plasm a draw n from 
children diagnosed CM. The proteins were categorised according to gene ontology (GO) 
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Figure 5.4 Distribution of 8 human proteins found only in CSF draw n from children with
CM, categorised according to gene ontology (GO) annotation for molecular
function.
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Figure 5.5 Distribution of 8 human proteins found only in CSF draw n from children with CM
categorised according to gene ontology (GO) annotation for cellular component.
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Figure 5.7 Distribution of 8 human proteins found in both CSF and plasm a draw n from  
children with CM categorised according to gene ontology (GO annotation for molecular function.
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Figure 5.8 Distribution of 8 human proteins found in both CSF and plasm a draw n from  
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Protein expression profiles in CSF and plasma have previously been produced through a 
combination o f ID and 2D gel electrophoresis (2-DE) and MS. Despite being a powerful 
tool o f protein separation 2-DE combined with MS has a limited dynamic range and is not 
sensitive enough for identification o f the LAPs in complex samples. Another major 
disadvantage is the time and labour needed for spot-by-spot analysis making it less suitable 
for rapid large scale analysis o f complex protein mixtures. A substitute for 2-DE should 
therefore allow for the rapid identification o f proteins and deal equally well with all 
proteins regardless o f their abundance in the sample.
Non gel based approaches such as MudPIT have become a real alternative for high through 
put proteomic investigations. A higher number of proteins are identified in non-gel based 
methods a good example being yeast samples where 2-DE has been reported to resolve 
~1200 proteins (Futcher et al., 1999) but only 148 (Futcher et al., 1999) and 279 (Perrot et 
al., 1999) o f the resolved proteins have been identified by MS. By contrast, the MudPIT 
technology has resolved and identified 1484 proteins (Washburn et al., 2001). However, 
the abundances o f individual proteins may range over several orders o f magnitude in a 
crude mixture thus providing an analytical challenge especially when MudPIT is used. 
Consequently, high abundance proteins such as albumin interfere with the detection o f 
other proteins degrading the overall performance o f the process (Ahmed et al., 2003, Butt 
etal., 2001).
Complexity o f starting sample plays a key role in protein profiling o f biological samples.
Pre-fractionation o f the sample (by SDS-PAGE or liquid chromatography steps or sub
cellular fractionation) can help reduce the sample complexity and this improves the
184
resolving power o f the analysis. A variety of multi dimensional chromatographic steps 
have been described to replace 2-DE based protein separations prior to MS (Liu et al., 
2002). In this chapter the use of LC-MS/MS as an alternative to 2-DE and a comparison of 
various separation techniques were explored. The one that gave the most data in the least 
amount o f time was then chosen for subsequent work. The MudPIT approach (Link et al., 
1999, Mitulovic et al., 2004) was initially tried, and resulted in only 35 proteins being 
identified in a CSF sample. With the modified shotgun method the samples were first 
fractionated prior to enzyme digestion resulting in a higher number o f proteins. The 
significant difference can be explained by the fact that trypsin digestion is more efficient 
when smaller numbers of proteins are presented which influences the subsequent peptide 
fragmentation data retrieved. Another major difference in the method described in this 
chapter is that instead o f using a SCX column for the pre-fractionation step it was found 
that using the monolithic column resolved albumin and other abundant proteins better and 
albumin was only found in 2 fractions compared to 4 or more fractions when SCX was 
used as a first dimension column. Furthermore, the albumin isoforms were all in the same 
fraction and not separated as with the SCX. It is worth mentioning that the number of 
proteins identified increased with the number o f fractionation steps done prior to LC- 
MS/MS but this would increase the time taken to analyse one sample reducing the high 
through put capability o f the technique. It should also be taken into account that the more 
dimensions performed the higher the amount o f loading sample one would need to ensure 
that there is enough material to characterise low abundant proteins.
For the second dimension separation, a monolithic silica based column rather than a RP 
column was used. The former had the added advantage o f shorter gradients o f 30 minutes
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compared to 60 minutes on the RP column. Use o f these columns has also been noted to 
enhance chromatographic resolution (Tanaka et al., 2001, Motokawa et al., 2002, Ishizuka 
et al., 2002, Walcher et al., 2002), providing a perfect means by which to reduce ion 
suppression.
Several CSF studies described in literature with used pooled patient samples. However 
this approach does not give a clear picture of what protein profiles are constant in each 
disease manifestation. In the study described in this chapter, samples were not pooled, 
which greatly limited the amount o f starting material but ensured that any protein profiles 
identified were actually present in all patient samples.
Bioinformatics plays an essential role in a successful proteomic analysis. Access to the 
fully sequenced genomes o f the human and P. falciparum  database has enabled the 
identification o f many proteins from our samples. The TurboSequest® algorithm based on 
the SEQUEST® algorithm described by Yates (Yates, 1998, Link et al., 1999, Yates et al., 
1999, Washburn et al., 2001) was used in this study and it enabled us to search all our data 
against databases o f the human and P. falciparum  subsets of NCBI and the P. falciparum  
database downloaded from the Sanger Institute. However, when data from the two P. 
falciparum  databases were compared, there were some differences, which concurs with 
findings from other studies (Pan et al., 2007, Carr et al., 2004) and therefore any study 
should standardise the database used to avoid differences.
Despite protein amount normalisation (200ug in plasma and lOOug in CSF), a significant 
number o f non-hypothetical human proteins in plasma (76%) and CSF (66%) were found 
only in the ABM diseases group. This would suggest that there are quite a few proteins
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that are either present in lower quantities or completely absent in the other 2 disease groups 
and quantitative analysis would have to be done to determine this. Orosomucoid alpha 
glycoprotein, one o f 2 proteins found unique to the plasma from the CM group had also 
been found unique to the CM plasma gels in the previous chapter. This protein is an acute 
phase protein and has previously been studied in connection with malaria (Beesley et al., 
2000). However, one would expect to see it in ABM too as it is associated with 
inflammation. Spectrin beta chain, brain 3 (Spectrin, non-erythroid beta chain 3) was 
identified as unique to CSF samples drawn from patients diagnosed with CM. This protein 
was also found to be uniquely present in infected mouse plasma in chapter 2. One study 
has recently found a correlation between CM and the presence o f non-erythoid alpha 
spectrin protein in Gabonese children (Guiyedi et al., 2007). However the study also found 
that the alpha chain was more abundant than the beta chain in the brain material studied. 
The repertoire o f brain antigens recognized by plasma IgGs was more diverse in infected 
than in uninfected individuals. Anti-brain reactivity was significantly higher in the CM 
group than in the uncomplicated malaria and severe non-CM groups. IgG self-reactivity to 
brain antigens was also correlated with plasma IgG levels and age. 90% of CM patients 
displayed reactivity to a high-molecular mass band containing the spectrin non-erythroid 
alpha chain. Reactivity with this band was correlated with high TNFa concentrations in 
CM patients. These results strongly suggest that an antibody response to brain antigens 
induced by P. falciparum  infection may be associated with pathogenic mechanisms in 
patients developing CM.
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Out o f the 323 P. falciparum proteins identified in the plasma, 15 were common to all 
three disease groups and these could represent proteins normally found in this malaria 
population. However, a very high number of P. falciparum proteins were found in both 
CM and ABM (66) and another 154 unique to ABM. However, this is not unexpected as 
all children in the study area are exposed to malaria, with up to 300 infected bites per year. 
The high number o f P. falciparum proteins in ABM also correlates to a high number o f 
human proteins identified in this disease group and this would suggest that although there 
was normalisation for protein amount, the proteins are either present in too low a 
concentration to determine with this method or a larger number o f post translational 
modification o f proteins is occurring in the CM and EN group hence making it harder to 
get protein identifications with this technique. Further analysis using other techniques 
would be needed to understand these results.
5.5 Conclusion
The ability to identify a significant number o f proteins related to severe disease (typically 
low in abundance) is largely due to the utilisation o f proteomic platforms based on 
different separation strategies as well as mass spectrometers with different ionisation 
sources and mass analyzers. The benefits o f the multi-dimensional orthogonal sample 
separation described in this chapter far outweigh the use o f 2-DE. However, to completely 
eliminate the use o f gel based methods there is a need to incorporate quantification of the 
proteins in the LC system. One way of doing this is by use o f reagents such as ICAT 
which tags proteins containing cysteine residues only, which also enhances the analytical 
dynamic range, and thus, improves the identification o f low-abundance proteins (Zhang et 
al., 2005a). Results in this chapter have demonstrated that ‘shotgun’ sequencing
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approaches (LC-MS/MS) not only can profile high-abundance proteins in complex 
biological fluids but also have the potential to identify some low-level proteins present in 
such complex mixtures without extensive pre-purification protocols. A key to such studies, 
however, is to use targeted approaches that reduce the complexity o f the solute mixture 
that is presented to the mass spectrometer at a given time point.
It would be interesting to determine the prevalence and levels in endemic residents o f anti- 
auto-antibodies o f the 2 proteins found unique in plasma of CM patients. I f  two cohorts 
distinguished by significantly different levels o f these antibodies could be constituted, then 
it will be possible to conduct a prospective study that could allow determining whether 
high autoantibody levels predispose an individual to develop CM.
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6 Mass Profile of Proteins Associated with 
Cerebral Malaria in Children
6.1 Introduction
Molecular profiling experiments performed directly on tissues using MALDI mass 
spectrometry are gaining considerable popularity (Rohner et al., 2005, Reyzer and 
Caprioli, 2005, Crossman et al., 2006, Altelaar et al., 2006, Garrett and Yost, 2006). When 
proteins are added to a matrix solution such as a-cyano-4-hydroxycinnamic acid, they 
become charged and can be detected as peaks in a mass spectrum with unique mass to 
charge ratio (m/z) values. Since most o f the proteins are singly charged during the 
analysis, each peak usually corresponds to a single protein with a molecular weight 
equivalent to the m/z value. The normalised peak intensity is directly proportional to the 
concentration o f the corresponding protein in the sample. MALDI-ToF MS offers a 
technique for rapid determination o f molecular masses and the heterogeneity of small 
amounts o f peptides and proteins (Karas et al., 2000, Sottani et al., 1997, Belgacem et al., 
2002, Sekiya et al., 2005). The technique is characterised by a number o f useful features 
including minimal sample preparation, ease o f use, heightened throughput, and cellular 
specificity. It is increasingly being used to refine disease characterization in some patient 
populations. Recently, for example, there has been a great deal o f interest in using this 
technique to try and identify quantitative or qualitative differences in serum protein 
components between cancer patients and control subjects. The existence o f such 
differences is postulated on the basis that, when cancer cell proliferation products such as 
tumor-specific proteins enter the circulation, they change the profile o f circulating serum 
and/or plasma proteins. Serum profiling (i.e., the characterisation o f proteins, peptides,
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and macromolecules from serum) by surface enhanced laser desorption/ionization (SELDI) 
mass spectroscopy (Petricoin and Liotta, 2004) coupled with statistical algorithms has been 
used to distinguish patients with cancer from control subjects and patients with benign 
conditions (Adam et al., 2002, Petricoin et al., 2002c, Valerio et al., 2001). However, the 
use o f SELDI involves long and expensive preparative steps with potential losses of 
selected protein components (Hortin and Remaley, 2006)
In contrast, application o f MALDI-ToF MS in medical research has great promise because 
i) fingerprints will help define disease states rather than just pathogen detection, ii) the 
analysis requires no prior assumptions about the nature o f proteins, iii) protein 
identification is not essential for diagnostic utility and iv) it accommodates biological 
heterogeneity in disease expression.
The primary aims of this study were to evaluate methods o f CSF and plasma processing for 
MALDI-ToF analysis and to use MALDI-ToF combined with bioinformatics analysis in a 
proof o f principle study to describe a mass profile o f proteins in plasma and CSF from 
children with CM. These profiles were compared to mass profiles o f samples collected 
from children with EN, ABM, severe malaria with seizures (SZ) and prostate children with 
severe malaria (PR)
6.2 Methodology
The general workflow for this study is summarised in Fig. 6.1 and the background to these 
methodologies is described in detail in chapter 2 section 2.4. In brief the technique used 
involves (1) sample preparation (2) MALDI-ToF in linear mode (3) qualitative analysis o f 
peaks o f interest.
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F igure  6.1 M ass S p ec tra l A nalysis W o rk  Flow. The mass spectra generated using M A LD I-ToF 
are treated to processing algorithm s responsible for the rem oval o f  noise, realignm ent o f  the m/z 
scale, and peak selection and m atching. The mass list generated is exported to a table and 
form atted for qualitative analysis using a num ber o f  established m ethods. The result o f  the 
analysis is a list o f  biom arker candidates that are subjected to further validation steps.
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6.2.1 Sample Source
Plasma and CSF samples collected from children in Kilifi with different presentation of 
malaria-Cerebral Malaria (CM), Malaria+ seizures (SZ), Malaria + prostate (PR)were 
compared to samples collected from children having a final diagnosis o f ABM and EN 
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Protein determination was determined as described in chapter 2 section 2.1.2.1. Samples 
were then prepared for mass spectrometry as described in chapter 2 section 2.4.2.1
6.2.3 Mass Spectrometry
Mass spectra were generated using an AXIMA CFR Plus™ (Shimadzu Biotech-Kratos 
Analytical, Manchester, UK) mass spectrometer operated in a linear mode_2ghz which 
was set as described in chapter 2 section 2.4.2.2. After baseline subtraction and 
normalization using the Kratos software provided with the MALDI-ToF MS, a mass list o f  
all masses present from 500-180,000 Daltons (Da) was generated for each sample.
6.2.4 Qualitative Analyses
The mass list generated from the MALDI-ToF was then exported on to an excel sheet. The 
mass and intensity o f the peaks were then transported to STATA and the masses sorted and 
masses below 2000kD dropped from the plasma samples. Samples from each patient in a 
disease phenotype were compiled into one file and representative spectra were then 
generated using R® version 2.5.1 (2007-06-27) fhttp://www.r-proiect.org/) and the scripts 
for generating the spectra are attached as Appendix XI.
6.3 6.3 Results
Figures 6.2-6.11 show representative spectra per disease group. Despite sample dilution 
and protein normalisation prior to spotting o f the MALDI target, the spectra yielded from 
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Disease marker discovery is one of the most promising applications o f MS in biomedical 
research (Petricoin et al., 2002c, Steel et al., 2003, Rai et al., 2002, Li et al., 2002b, Adam 
et al., 2002). In addition to structural analysis o f proteins , MS is now being used in 
biomedical research to search for biomarkers in extremely complex mixtures (Petricoin et 
al., 2002c, Steel et al., 2003, Rai et al., 2002, Li et al., 2002b, Adam et al., 2002), quantify 
changes in protein abundance (Gygi et al., 1999, Sinz et al., 2002), and generate profiles 
for diagnosis o f different disease states by direct analysis o f proteins extracted from 
biological fluids (Sinz et al., 2002, Catinella et al., 1999), cells (Palmer-Toy et al., 2000, 
Xu et al., 2002), and tissues (Caprioli et al., 1997, Stoeckli et al., 1999). SELDI, the 
coupling o f surface retentate chromatography with MALDI MS, is already widely used for 
clinical research because of the convenient packaging o f a low resolution, automated ToF 
mass spectrometer with ready-made “ chips”  modified with different functional groups for 
performing surface retentate chromatography (Weinberger et al., 2002, Issaq et al., 2003). 
However, findings from re-analysis of the raw data o f some o f the studies suggested that 
the identified diagnostic SELDI peaks could be due to artifact o f sample processing 
(Baggerly et al., 2004, Baggerly et al., 2005). Moreover, where the protein peaks have 
been identified, they have turned out to be well-known, acute phase proteins. Critics of 
SELDI have claimed that it is inherently limited in its depth o f coverage, with a dynamic 
range that prevents the detection o f low abundant proteins (Diamandis, 2004a, Diamandis, 
2004c). As for predictive patterns, no two studies have found the same patterns to date. In 
addition, none o f the patterns have been validated in an independent study by another 
laboratory. In one study, both the sensitivity and the specificity o f the pattern declined
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significantly when samples were processed in the same laboratory after a delay of several 
months (Rogers et al., 2003). Analysis o f serum or plasma by SELDI-TOF MS offers 
some fractionation o f components before MS, but unless immunocapture is applied, the 
efficiency o f fractionation generally is modest, so that the major serum or plasma 
components predominate (Rossi et al., 2006).
In the study in this chapter, unfractionated plasma and CSF have been analyzed by 
MALDI-ToF MS. The observed profiles of peaks for unfractionated CSF specimens are 
largely in agreement with reported profiles of plasma proteins. Despite dilution, the 
plasma proteins did not ionise as well as expected probably due to over abundance in 
albumin leading to low matrix to sample ratio. Another problem noted was that despite 
baseline subtraction there was still a major drift in the spectra from plasma which made 
data analysis difficult. Representative spectra from the CSF were generally better 
consistently yielding a few peaks in the high mass range as well as yielding sharper less 
broad peaks suggesting that the ratio of high abundant proteins to matrix provided a more 
efficient ionisation o f the sample. Another factor that may have led to better spectra o f the 
CSF was the fact that the CSF samples had been desalted prior to analysis. The CSF 
spectra yielded similar patterns but a few differences were noted. In the ABM spectra 
there were many peaks between 5 kD -8kD compared to the other disease phenotypes. All 
phenotypes had a peak at around 34kD-36kD except PR. In literature a mass varying 
between 32kD and 36 kD is normally attributed to ai-acid glycoprotein (Chait and Kent, 
1992, Sekiya et al., 2005). The range in masses is explained by the fact that loss o f sialic 
acid may vary depending on technique o f analysis. All spectra had abundant masses 
ranging from 64kD to 69kD which are attributed to albumin. However the peaks in the
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CSF from the CM group were not as an abundant as in the other group and only 2 well 
defined peaks at around 66500 were seen. The SZ group had a peak at 146kD not seen in 
other disease phenotype.
The CSF profiles are dominated by the most abundant components. Major peaks were 
observed corresponding to reported masses of IgG (-144 kD), albumin (-66 k D ) , doubly 
charged albumin (-135 kD), transthyretin (-14 kD), apolipoprotein C-II(~8.9kD), 
apolipoprotein C-I (~6.7kd) and lysozyme (-14 kD). The measured mass values serve as a 
database for the expected positions for a number o f plasma and CSF components when 
analyzed by MALDI-ToF MS. These data may be o f value in helping to identity which 
proteins are forming peaks and in identifying the peaks that may be used as internal 
calibration masses in MS analysis o f plasma and CSF. However, masses o f some proteins 
may vary owing to sequence polymorphism, variable posttranslational modification, or 
degradation during processing or storage. Measured masses o f highly sialyted proteins 
also may vary. It must also be considered that there is structural variation o f proteins in 
different physiological states that may lead to changes in glycoprotein mass (Higai et al., 
2005).
Direct analysis of diluted plasma and CSF by MALDI-ToF MS may offer a direct
approach to analyze several major components with minimal modification or selective loss
of components. For proteins that are not modified by post-translational modifications, the
mass measurements determined by MALDI-ToF MS should be accurate measures o f
protein mass. However, the sensitivity of MALDI-ToF protein profiling remains poor
when compared with antibody-based methods, as previously pointed out by Diamandis
(Diamandis, 2004b, Diamandis, 2004a). Furthermore, protein profiling experiments o f
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unfractionated plasma and CSF are restricted to the limited mass range for protein 
detection with MALDI ToF MS (most ion signals between mlz 2 ,000and mlz 30,000). 
This is due to the fact that dominance o f the albumin peaks for monomer, doubly charged 
monomer and singly charged monomer interfere with the ability to detect other peaks with 
m/z > 30,000. Future analysis will include use o f other analytic methods, including LC 
fractionation prior to MS as well as profiling enzymatic digests o f plasma proteins, which 
not only increase the sensitivity and widen the accessible mass range for the protein 
detection, but also enable direct identification using tandem mass spectrometry peptide 
sequencing. To add value to the data, analysis o f purified plasma and CSF proteins would 
help further identify the proteins corresponding to the mass values and also identify any 
modifications that may occur during sample preparation.
6.5 Conclusions
Some information about profile variation of major proteins in plasma and CSF may be 
obtained by the simple technique described here. As presented here, the analysis is 
primarily qualitative in nature. There are major issues with the results presented here and 
this study has just made a start but needs significant investment to see if this is a solution to 
CM biomarker discovery. Any effort to apply this as a quantitative technique for profiling 
the relative amounts o f different proteins would require extensive investigation of 
appropriate dilutions, the linearity, and calibration o f responses and standardisation 
procedures. Qualitative analysis of the global pattern may have value for a number of 
purposes. It may assist in evaluating the degree o f fractionation achieved by other 
techniques such as SELDI-ToF MS. However, available algorithms for analysing both
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SELDI-ToF and MALDI-ToF data have had problems when other laboratories have tried 
to validate them.
Nevertheless, owing to its simplicity, the approach described here may be o f clinical value 
during the acute phase response, where analysis o f abundant components provides valuable 
information. However, if  profiles o f low abundant proteins are to be created, there needs 
to be an extensive effort at specimen fractionation.
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7 General Discussion and Conclusions
7.1 Introduction
Proteome alterations in disease may occur in many different ways that are not predictable 
from genomic analysis, and it is clear that a better understanding o f these alterations will 
have a substantial impact in medicine. A useful repertoire o f proteomics technologies is 
currently available for disease-related applications, although further technological 
innovations would be beneficial to increase sensitivity, reduce sample requirement, 
increase throughput and more effectively and uncover various types o f protein alterations 
such as post-translational modifications. The use of these technologies will likely expand 
substantially, particularly to meet the need for better diagnostics and to shorten the path for 
developing effective therapy.
The overall aim o f the studies described in this thesis was to analyse the global proteome 
of CSF and plasma collected from children diagnosed with CM. Samples were first 
analysed using 2DE followed by mass spectrometry and a gel free alternative using LC 
MS/MS. The latter method employed orthogonal liquid chromatography steps in 
conjunction with automated tandem mass spectrometric analysis. The final study 
described in the thesis was the creation o f a mass profile o f rare proteins associated with 
CM using MALDI-ToF analysis.
7.2 2-DE Gel Analysis of Plasma and CSF
Over the years 2-DE has proven to be a reliable and efficient method for separation of 
several hundred to a few thousand proteins on the basis o f differences in their isoelectric
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point (pi) and molecular weight. Although gel electrophoresis has many advantages, there 
are also several disadvantages. The procedure is long, labour-intensive and lacks sufficient 
reproducibility. The insolubility of hydrophobic proteins and the difficulty in detection and 
separation o f LAPs are additional weaknesses.
In the studies described in chapters 3 and 4 the dynamic range o f the technique limited 
analysis to the more abundant acute-phase proteins, including serum albumin and various 
isoforms o f apolipoproteins, which are known markers o f inflammatory disease. 
Achieving the level o f detection commensurate with immunoassay will only be possible on 
2-DE using pre-fractionated plasma/CSF in which the major proteins (albumin and 
immunoglobulins) are substantially reduced, but not at the expense o f the nonspecific 
depletion o f minor proteins. When this occurs, it will be possible to identify many subtle 
changes in protein expression, permitting protein enrichment to determine the mass 
spectrum and hence identity prior to development o f specific immunoassays.
7.3 LC MS/MS of Plasma and CSF
In this thesis the use o f LC-MS/MS as an alternative to 2-DE and a comparison of various 
separation techniques were explored. RP-LC has been used in many studies to overcome 
the shortcomings o f 2-DE. However, the same problem of identifying the abundant 
proteins only is not overcome and in chapter 5 the use o f a pre-fractionating method prior 
to multi-dimensional HPLC was described. This alternative method helped reduce the 
complexity o f the sample being introduced into the MS. This technique enabled the 
identification o f some LAPs with some measure o f reproducibility. However, further 
validation with more samples would have to be done to ensure that the proteins are present
I
with every sample run. The large number of proteins identified would also need to be
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confirmed using techniques such as western blots to substantiate any further use of the 
expensive tool.
Despite improvements made, the proteins identified still did not account for even a third of 
those reported in literature and there were still a number o f small proteins including several 
cytokines and interleukins implicated in malarial infection that were not identified. This 
may be due to the fact that some of the LAPs may have broken down or been modified due 
to long storage as well as due to how the sample was initially collected. This can only be 
done by using freshly collected samples and testing whether heparin and EDTA affect 
proteomic results o f CSF and plasma.
7.4 Mass Profiling of Plasma and CSF
MALDI-ToF protein profiling has been applied in proteomics biomarker research in our
study as well as in the study described in chapter 6; however, several aspects o f MALDI
protein profiling need further evaluation and optimisation before clinical use (Hortin,
2005). First, high-throughput MALDI protein profiling is presently confined to the
detection of highly abundant proteins (Hortin, 2006). Sensitivity in clinical proteomics can
be effectively improved with extensive preffactionation strategies, which still need critical
evaluation before they can be used in high-throughput protein profiling. In one study, the
use o f reversed-phase HPLC and MALDI protein profiling to analyze plasma samples in a
medium-throughput setup led to improved sensitivity (Tammen et al., 2005). Second,
MALDI protein profiling provides only a limited mass window. The matrix molecules
produce highly intense signals in the low-mass range (-0-1000 Mr) that obscure some of
the signals o f small peptides, and larger proteins have a lower detection limit, primarily
because they fly slower than smaller proteins and detector response is related to ion
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velocity (Hortin, 2006). The 3rd challenge in MALDI protein profiling is establishing the
reproducibility o f peak intensity. In biomarker research with MALDI protein profiling, the
aim is to identify peak intensities (or peak areas) that are different between case and
control samples, and the reproducibility o f peak intensities is o f highest importance.
However, poor reproducibility has been considered one o f the major problems in protein
profiling with MALDI-ToF MS. The matrix (co)crystallization and desorption/ionization
steps in MALDI-ToF MS have been derived empirically, and the processes are poorly
understood. Different matrix molecules crystallize in different shapes and dimensions,
proteins tend to accumulate at the droplet periphery, and the composition of the matrix
solution and the rate o f crystal growth influence the spectral output (Cohen and Chait,
1996). These phenomena produce shot-to-shot variation, which are related to sampling
different parts o f the target surface and progressive sample ablation with repeated
sampling. The desorption/ionization step in MALDI-ToF MS is a complex process
involving optical and mechanical phenomena, as well as thermodynamic and
physicochemical processes of phase transition and ionization, which are not well
understood (Dreisewerd, 2003). Studies have demonstrated ion suppression effects in
MALDI-ToF MS. Ion suppression occurs when an ion suppresses the peak signal o f other
ions in the sample, and peptides with greater hydrophobicity show the greatest suppression
effects. The presence o f basic residues may favour ionisation in MALDI-ToF MS analysis
(Bohring et al., 200 I). One study found that highly acidic compounds produced weak
signals in MALDI-ToF MS analyses, but when such compounds were mixed with a basic
peptide to form a noncovalent complex, the signals improved (Juhasz and Biemann, 1994).
In summary, peak intensity in MALDI protein profiling has significant analytical variation
and is poorly understood. Peak intensity is related to the concentration o f the individual
214
protein, to its primary structure, and to the complexity o f the sample. To enhance 
quantitive capability o f protein profiling it will be necessary to develop better peak 
isolation methods.
Masses found to be unique to the disease groups are generally attributed to common acute 
phase proteins. To further enhance the peak capability in CM biomarker studies extensive 
studies using samples that have been fractionated will have to be done. Using a larger 
sample size to validate any spectra will also be done.
7.5 Suggested Future Studies
The results presented in this thesis present a basis for further studies aimed at utilising 
proteomic tools to better understand the pathophysiology o f severe disease in the hope of 
identifying new biomarkers. The following is an outline o f studies that could be 
conducted:
a) A prospective study to confirm that any o f the differences in protein profiles are not 
due to long-term storage of samples
b) Use o f prefractionation steps to improve mass profiles created using MALDI-ToF.
c) The use o f newly developed quantitative proteomic techniques such as isotope- 
coded affinity tags (ICAT), iTRAQ and DICE to improve quantification of 
differentially expressed proteins in severe disease.
7.6 Conclusion
In so far as biological implications, the results in this thesis partly support the hypothesis
that CM is an inflammatory like process because some of the regulated proteins are
physiologically linked to the control o f inflammation. However, the difference between
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proteins identified in ABM and CM would indicate a difference in the overall 
inflammation process between the two groups.
BBB permeability in CM is still described as moderate despite the major neurological 
complications associated with it and results on total protein content in CSF supports this 
claim. One way o f testing the level o f breakdown is by assessing the albumin and IgG 
CSF/serum ratios. In the thesis other acute phase proteins such as transferrin seem to be 
more abundantly available than IgG, in both CSF and plasma and may prove to give a 
better ratio in trying to understand the mechanism behind BBB permeability in CM. 
Another protein identified in both the CSF and plasma is human Spectrin beta chain brain 
3 protein and it would be o f interest to see whether there are self reactive antibodies to this 
protein as in the Gabon study described by Guiyedi et. al on the alpha chain o f the same 
protein and whether these antibodies are as a consequence to parasite ex posure, and 
whether their levels might parallel the degree of neuronal damage.
Work in this thesis has laid groundwork for establishing the proteomic component of 
eventual systems biology o f severe malaria as well as other severe tropical diseases such as 
HIV. O f interest to immunologists, is whether the repertoire o f parasite proteins identified 
in this study plays a role in immunity against malaria. However, verification o f the parasite 
proteins identified would need to be done before any conclusions can be made.
In summary, work on the aspects of proteomics studied has generated renewed confidence 
that such approaches will reveal important features o f normal biology and physiology and 
assist in the discovery, validation, and application o f protein biomarker panels in early 
diagnosis o f disease and monitoring responses to therapies. However, before the full
216
impact o f these technologies can be realised, some technical hurdles must be resolved. 
This can be done by combining novel protein separation technologies and mass 
spectrometiy approaches to improve the detection and identification o f low abundance 
proteins. New technology platforms for global analysis using LTQ-FT, LC-MS/MS/MS, 
and LTQ-Orbitrap (Olsen et al., 2004) and new platforms for targeted proteomics using 
heavy-isotope- labeled N-glycosite-containing proteotypic peptides (Kuster et al., 2005, 
Aebersold and Mann, 2003) and/or multiple reaction monitoring (MRM) with or without 
anti-peptide antibodies (Polanski and Anderson, 2006) offer great promise. Additional 
mining o f high-quality spectra may increase yields o f protein identifications, as well. As 
mentioned earlier methods of quantitative proteomics, such as ICAT, iTRAQ, and DIGE 
may be essential. Aebersold et al are developing a resource that will offer chemically 
synthesized peptides tagged with heavy isotope for each gene and eventually each protein 
isoform needed for high discrimination as biomarkers (Aebersold, 2003). These 
“proteotypic peptides” would permit spiking o f specimens to facilitate identification of 
mass pairs with the same peptides in the biological specimen and quantitation o f the 
peptide and its protein (Kuster et al., 2005). Another approach could be the use of 
sensitive anti-peptide antibody-enhanced assays for quantitation lower-abundance proteins 
(Anderson and Hunter, 2006).
Technological improvements will have an impact on the ability to discover novel and 
important markers. The development o f a fast and cost-effective mass spectrometry based 
assay, will greatly improve the ability to validate (or invalidate) promising new markers 
and will eventually lead to a credible application o f protein biomarkers in population 
screening and eventually in patient care.
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APPENDIX V List of human proteins found in both plasma 
and CSF
Reference Accession Plasm a CSF
1
B34611 3',5'-cyclic-GMP phosphodiesterase (EC 3.1.4.35 alpha 
chain - human








K2C1 HUM AN Keratin, type II cytoskeletal 1 (Cytokeratin 1 (K1 
(CK1 (67 kDa
1346343 CM, ABM CM, EN, 
ABM
4
A l AT_HUMAN A lpha-1-antitrypsin precursor (Alpha-1 protease 
inhibitor (Alpha-1
1703025 CM, EN, 
ABM
EN, ABM
5 138344 titin, cardiac muscle [validated] - human iciency viru 2136280 ABM ABM
6
S69339 Ig heavy chain V region precursor - human ain-binding 2146957 CM, EN, 
ABM
EN, ABM
7 A Chain A, Crystal Structure O f Human Apolipoprotein A-I 2914175 EN ABM
8
C Chain C, Human Serum Transferrin, Recombinant N-Terminal 
Lobe, Apo Form





Human Serum Albumin In A Complex With Myristic Acid And Tri- 
Iodobenzoic Acid





guanylate cyclase 2F; RetGC-2; guanylate cyclase 2D-like, 
membrane (ret
4504219 CM, ABM CM
11
delta globin [Homo sapiens] 4504351 EN CM, EN, 
ABM
12
orosomucoid 2; alpha-1-acid glycoprotein, type 2 [Homo sapiens] 4505529 EN ABM
13




thyrotrophic embryonic factor; Thyrotroph embryonic factor [Homo 
sapien
4507431 ABM ABM
15 zinc finger protein 91 (HPF7, HTF10 [Homo sapiens] 4508041 EN, ABM ABM
16
alpha 2 macroglobulin precursor [Homo sapiens] 4557225 CM, EN, 
ABM
ABM
17 apolipoprotein A-I precursor [Homo sapiens] 4557321 EN ABM
18
Propionyl-Coenzyme A carboxylase, alpha polypeptide precursor 
[Homo sap
4557833 CM, EN EN, ABM
19
transferrin [Homo sapiens] 4557871 CM, EN, 
ABM
EN, ABM
20 nuclear mitotic apparatus protein 1 [Homo sapiens 5453820 CM, ABM EN
21
v-rel reticuloendotheliosis viral oncogene homolog B, nuclear factor 
o f
5730007 CM, ABM CM, ABM
Human proteins in both plasm a and CSF cont’d
Reference Accession Plasm a CSF
22




zinc finger protein 281; ZNP-99 transcription factor [Homo sapiens] 6912752 EN ABM
24
DnaJ (Hsp40 homolog, subfamily C, member 8; splicing factor 
similar to
7657611 CM, ABM ABM
25
epithelial protein lost in neoplasm beta; sterol regulatory element bin 7705373 EN, ABM ABM
26 beta-ureidopropionase [Homo sapiens] 7706509 ABM ABM
27









T46337 hypothetical protein DKFZp43402413.1 - human (fragment 11360154 ABM CM, ABM
30
ZN93_HUM AN Zinc finger protein 93 (Zinc finger protein HTF34 12643428 EN ABM
31








SPCQ_HUMAN Spectrin beta chain, brain 3 (Spectrin, non- 17368942 CM, EN, 
ABM
CM
34 MOT3_HUMAN Monocarboxylate transporter 3 (MCT 3 17433295 ABM ABM
35
enhancer o f  zeste homolog 1 (Drosophila ; enhancer o f  zeste 
(Drosophil
19923202 EN ABM
36 PRES_HUMAN Prestin 20139418 ABM ABM
37




NCK2_HUMAN Cytoplasmic protein NCK2 (NCK adaptor protei 20532395 ABM CM, ABM
39
BA2B HUMAN Bromodomain adjacent to zinc finger domain 2B 
(hWALp4
22653668 ABM CM, ABM
40








APPENDIX VI List of falciparum proteins found in both 
plasma and CSF
Reference Accession Plasma CSF
1 MAL13P 1.234 MAL13P1.234 hypothetical protein 
18926092:18944453 forward MW:696786 MAL13P 1.234
CM, ABM
ABM
2 MAL13P1.256 MAL13P1.256 phosphatidylinositol 
transfer protein, putative 19107032:19112954 
forward M
MAL13P1.256 CM, ABM, 
EN
CM, ABM
3 MAL7P 1.167 MAL7P 1.167 hypothetical protein, 
conserved 7977659:7985980 reverse MW:329471
MAL7P1.167 CM, ABM, 
EN CM, ABM
4 PF08 0080 PF08 0080 hypothetical protein 
8784777:8786324 reverse MW:61577 PF08 0080
CM
ABM
5 PF10 0267 PF10 0267 hypothetical protein 
12217392:12218954 forward MW:61468
PF10_0267 CM, ABM, 
EN CM, ABM
6 PF11 0129 PF 11 0129 hypothetical protein 
13238995:13241723 reverse MW:102084
P F I1_0129 CM, ABM, 
EN ABM
7 PF11 0374 PFI 1 0374 hypothetical protein 
14189790:14193247 forward MW: 128546
P F I1_0374 CM, ABM, 
EN CM, ABM
8 PF11 0392 PFI 1 0392 hypothetical protein 
14254640:14263189 forward MW:335925 P F I1 0392
ABM
ABM




10 PF13 0078 PF13 0078 hypothetical protein 
17650234:17655544 reverse MW:209078 PFI3 0078
ABM
ABM
11 PF14 0081 PF14 0081 DNA repair helicase, 
putative 20286443:20289925 reverse MW: 135547
PF14_0081 CM, ABM, 
EN ABM
12 PF14 0112PF14 0112 POM1, putative 
20433869:20439919 reverse MW:235822 PF14 0112
CM, ABM
ABM
13 PF14 0175 PF14 0175 hypothetical protein 
20703161:20717149 reverse MW:548876 PF14 0175
ABM
ABM
14 PF14 0326 PF14 0326 hypothetical protein 
21350759:21375076 reverse MW:969736
P F 140326 CM, ABM
ABM
15 PF14_0334 PF14_0334 NAD(P)H-dependent 
glutamate synthase, putative 21394312:21403632 
reverse MW:353 PF14 0334
CM
ABM
16 PF14_0364 PF14_0364 cleavage and 




17 PFI4 0372 PFI4 0372 hypothetical protein 
21566916:21572918 forward MW:221690
PF14_0372 CM, ABM, 
EN ABM
18 PF14 0392 PF14 0392 Ser/Thr protein kinase, 
putative 21654202:21661568 forward MW:263797 PF14 0392
ABM
ABM
19 PFI4 0419 PFI4 0419 hypothetical protein 
21774372:21797737 reverse MW:857945 PF14 0419
CM, ABM
ABM




21 PF14 0626 PF14 0626 dynein beta chain, putative 
22634424:22655109 forward MW:771768 PFI4 0626
CM, ABM
ABM
Falcjparum proteins in both plasma and CSF cont ’d
Reference Accession Plasma CSF
22 PFA0180w PFA0180w hypothetical protein 
161365:166464 forward MW: 175729
PFA0180w CM, ABM
ABM
23 PFA0290w PFA0290w DNA binding protein, 
putative 253399:255169 forward MW:54941 PFA0290w
EN
ABM
24 PFD0200c PFD0200c hypothetical protein 
2881723:2888678 reverse MW:271093 PFD0200c
ABM
ABM
25 PFD0535w PFD0535w hypothetical protein 
3143210:3147106 forward MW:150271 PFD0535w
CM, ABM
CM




27 PFE0240c PFE0240c hypothetical protein 
4042406:4059325 reverse MW:672034 PFE0240c
CM
ABM
28 PFF1440w PFF1440w SET-domain protein, putative 
6420088:6441070 forward MW:797045 PFF1440w
CM, ABM
ABM
29 PFF 1470c PFF1470c DNA polymerase epsilon, 




30 PFI0260c PFI0260c hypothetical protein 
9789022:9807378 reverse MW:720597 PFI0260c
CM, ABM
ABM
31 PFI0665w PFI0665w hypothetical protein 
10122388:10126083 forward MW: 147869 PFI0665w
CM, ABM, 
EN ABM
32 PFL0410w 2277.t00083 hypothetical protein 
15181933:15192864 forward MW:418854 PFL0410w
CM
ABM
33 PFL 1330c 2277.t00266 hypothetical protein 
15919401:15926469 reverse MW:273651
PFL1330c CM, ABM, 
EN ABM
34 PFL2375c 2277.t00475 cutA, putative 
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APPENDIX XI Example of R version 2.5.1 script used to 
generate representative spectra in chapter 6
zap () 
rm(.data)
## Spectrum for abm 
u s e ("abm.dta") 
pdf(file="abm.pdf")
plot(.data, type="l", xlab="mass in daltons") 
title("a)abm raw spectrum")
plot(.data, type="l", xlim=c ( 5 0 0 0 , 5 0 0 0 0 ) ,xlab="mass in daltons") 
title("b)abm raw spectrum")
plot(.data, type="l", xlim=c (10000,20000),xlab="mass in daltons") 
title("b)abm raw spectrum")
plot(.data, type="l", xlab="mass in daltons", xlim=c(6 4 0 0 0 , 6 9 0 0 0 ) )  
title("c)abm raw spectrum with restricted mass values")
bseoff<-bslnoff(.data, method="loess", bw = 0 .1 ,xlim=c ( 7 0 0 0 , 1 5 0 0 0 0 ) ,  
xlab= "mass in daltons", plot = TRUE) 
title (" c)Spectrum with baseline removed")
dev.o f f ()
360
